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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a well-known glycolytic enzyme, exhibits 
moonlighting functions, including catalysis of glyceryl trinitrate (GTN) to release vasoactive 
nitrite (NO2
–) or nitric oxide (NO). GTN catalysis generates a thionitrate (E-Cys-NO2) 
intermediate at the catalytic thiol of GAPDH. Thus, we investigated decomposition of CH3SNO2, 
a model compound for E-Cys-NO2, using state-of-the-art quantum mechanics techniques. We 
showed that the well-studied homolysis pathway, which releases NO, is energetically unfavorable. 
Instead, hydrolysis and thiolysis pathways that release NO2
– are energetically favorable. The 
release of NO2
– upon the attack of anionic nucleophiles (e.g. OH– or CH3S
–) along the S–N bond 
is barrierless which could explain the instability of thionitrates in aqueous solutions. We also 
looked at the effect of protonation on the stability of the S–N bond of CH3SNO2 to mimic the 
effect of proton donation from the protein. We found that O- and S-protonation stabilize and 
destabilize the S–N bond, respectively. We evaluated the electronic structures of the protonated 
isoforms of CH3SNO2 to elucidate the observed stability/instability of the S–N bond. Further 
investigation of nitrite release by hydrolysis of E-Cys-NO2 in the active site of GAPDH using 
quantum mechanics / molecular mechanics (QM/MM) techniques revealed similar activation 
barriers as shown by the QM methods.  
Each subunit of the GAPDH homotetramer binds the cofactor nicotinamide adenine 
dinucleotide (NAD+). The tetramer binds NAD+ with negative cooperativity. We carried out 
normal mode analysis and molecular dynamics (MD) simulations of GAPDH-NAD+ to probe the 
iv 
 
mechanism of negative cooperativity and define the subunit interactions that contribute to this 
phenomenon. We compared the dynamics of GAPDH-NAD+, GAPDH-NADH, and apo-GAPDH 
and observed concerted motions between subunits of GAPDH-NAD+ and GAPDH-NADH. These 
motions are lost in apo-GAPDH, indicating that NAD+ binding induces these dominant and 
functionally relevant motions of GAPDH. We also indicated the changes in the NAD binding-site 
residues and active-site residues that are observed in the crystal structure of apo- vs. holo-GAPDH. 
Many moonlighting functions of GAPDH depend on its oligomeric state. MD simulations are 
thus carried out for the three oligomeric states, tetramer, dimer or monomer. Our study shows that 
the dimer and monomer are less stable than the tetramer and functionally important motions are 
centered on the NBDs in tetramer and dimer, but they are centered on the S-loop in the monomer. 
The importance of the dynamics of the S-loop are highlighted. This disordered loop in the dimer 
and particularly monomer could promote binding of the GAPDH dimer and monomer with 
multiple protein partners to affect different functions.  
We modeled GAPDH and the seven in absentia homolog 1 (Siah1) protein-protein interactions. 
By investigating complex formation between the different oligomeric states of each protein, we 
show that the GAPDH monomer binds more tightly to Siah1 than the GAPDH tetramer. Thus, 
GAPDH monomer could stabilize Siah1 and the complex could be translocated to the nucleus to 
initiate apoptosis. 
Overall, our study provides molecular-level insights into novel functions of GAPDH. We have 
highlighted the importance of the dynamics of its various structural domains, which contribute to 
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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a well-known glycolytic enzyme, 
catalyzes the reversible oxidation and phosphorylation of glyceraldehyde-3-phosphate to 1,3-
biphosphoglycerate in presence of the cofactor NAD+ and inorganic phosphate. GAPDH, a 
homotetramer, is composed of four 37-kDa subunits, referred to as subunit-O, -P, -Q and -R. Each 
subunit is composed of two subdomains, namely a NAD-binding domain (NBD; residue 1-151 
and 315-335), which adopts a Rossmann fold, and the glyceraldehyde-3-phosphate catalytic 
domain (CTD; residue 152-314). Each subunit of GAPDH binds one nicotinamide adenine 
dinucleotide (NAD+) cofactor.1,2  
GAPDH is ubiquitous in nature and abundant in cells. This led to investigations of its various 
physiological and pathological functions. GAPDH is now known as a moonlighting protein, a 
single protein’s ability to exhibit alternate functions apart from its classical function.3 For example, 
GAPDH exhibits acyl phosphatase 4 and esterase 5 activities, endocytosis,6,7 RNA transport,8,9 
DNA replication,10 DNA repair,11,12 apoptosis13,14 and many other physiological functions.3,15 
GAPDH also is implicated in pathological conditions like cancer,16,17 Alzheimer’s,18,19  
Parkinson’s,20,21 and Huntington’s diseases.22,23  
These multifold physiological and pathological functions of GAPDH may require its post-
translation modification, oligomerization, protein-protein interactions, binding of cofactors, or 
exposure of intrinsically disordered subdomains.2,3,15,24 Various proteins like Huntington protein,25 
the androgen receptor,26 ataxin,26 β-amyloid precursor protein,27 seven in absentia homolog 1 
(Siah1),14 GOSPEL,28 transferrin29 are known to interact with GAPDH. GAPDH is also known to 
interact with RNA30,31 and single-stranded DNA.32 These protein-protein or protein-nucleic acid 
interactions give rise to different functions. Apart from its interactions with protein partners, many 
3 
 
post-translational modifications (PTMs) such as S-nitrosation, S-thiolation, sulphonation, and 
phosphorylation are known to occur in GAPDH. These PTMs could change GAPDH’s function 
by altering its conformation and/or oligomeric states, which could trigger a change in cellular 
localization and/or interaction with other protein partners, and alter its reactivity.3,33  
GAPDH also is a target for the drug design to combat protozoan parasites like Leishmania 
mexicana,34–37 Trypanosoma cruzi,37–39 Trypanosoma brucei,36,40 and Plasmodium falciparum.41,42 
These parasites rely on glycolysis for survival in a human host, thus selective inhibition of the 
parasitic GAPDH is proposed as an effective strategy to cure diseases caused by such parasites. Its 
multifold functions and involvement in disease makes GAPDH one of the most studied enzymes 
over the last decade.2,43 
1.1.1. GAPDH’s role in nitric oxide biochemistry 
GAPDH is a known target for nitric oxide (NO), NO donors and reactive oxygen species 
(ROS).44,45 We observed that stimulation of isolated human erythrocytes by glyceryl trinitrate 
(GTN), a prodrug, leads to a rapid increase in ATP, 46 a well-known vasodilator.47 We further 
demonstrated that GAPDH interacts with GTN and releases nitrite (NO2
–) and 1,2-GDN as major 
products.48 We found an increase in the rate of GAPDH-catalyzed NO2
– release from GTN upon 
addition of NAD+. These observations implicate GAPDH in the formation of NO2
– during GTN 
biotransformation. Many other enzymes are implicated in GTN biotransformation, including 
cytochrome P-450,49 xanthine oxidase,50 glutathione S-transferase,51 and mitochondrial aldehyde 
dehydrogenase (ALDH2).52  
The underlying mechanisms of GTN biotransformation are not very well understood. It 
produces NO2
– and/or NO to rapidly trigger vasodilation.53 However, the extent of NO2
– or NO 
release from GTN remains the subject of much debate, as does the relative contribution of these 
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two metabolites to the vasodilatory effect of GTN. In addition, the reaction mechanism involved 
in the enzymatic bioactivation of GTN has been debated for a long time. According to a recent 
review,54 there seems to be a consensus that GTN interacts with small-molecule thiols or active-
site thiols in proteins to form an enzyme thionitrate (E-Cys-NO2) complex.  
An E-Cys-NO2 intermediate is observed in the crystal structure of an ALDH2 triple mutant 
variant following reaction with GTN.55 The three mutations, C301S, C303S and E268Q, are in the 
vicinity of the catalytic cysteine, Cys302. A +46 amu mass adduct of the GTN-treated triple variant 
of ALDH2 was observed by mass spectrometry, which was attributed to the E-Cys-NO2 formation 
at Cys302. Thus, we speculate that E-Cys-NO2 is formed upon GTN binding to the catalytic 
Cys152 of GAPDH. However, the mechanism of E-Cys-NO2 decomposition is not known. Several 
pathways for the decomposition of E-Cys-NO2 are proposed based on computational and 
experimental studies of small-molecule thionitrates (RSNO2).
52,56–58 No detailed computational 
studies have been carried out to rigorously investigate all the proposed pathways.  
Depending on the E-Cys-NO2 decomposition pathway, the catalytic cysteine (Cys152 in 
GAPDH) would be chemically modified to cysteine disulfide (Cys152-S–S-Cys156), cysteine 
sulfenic acid (Cys152-S-OH) due to hydrolysis, or di-thiolsulfinate (Cys152-S(O)–S-Cys156) 
and/or di-thiolsulfonate (Cys152-S(O2)–S-Cys156) due to homolysis. Also, these different 
pathways of decomposition require the involvement of different residues. Thus, understanding the 
pathway involved in GTN denitration will help us identify the residues that can be selectively 
mutated to better understand the complete mechanism of GTN denitration in GAPDH. 
Furthermore, E-Cys-NO2 decomposition could affect the functions and oligomeric states of 
GAPDH by alteration of its active-site. Thus, a detailed understanding of the GTN denitration will 
shed light on the possible fate of GAPDH. Also, understanding the GTN denitration mechanism 
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will inform the design of new NO donors that have fewer side effects and do not induce tolerance 
like GTN.59,60 
Oae et al. synthesized small-molecule thionitrates and reported that some t-alkyl thionitrates 
were stable at room temperature.61,62 Recent crystal structures of aromatic thionitrates indicate that 
they can be protected from decomposition by large cage-like structures.63,64 The study of the 
decomposition of tertiary butylthionitrate (t-BuSNO2) reveals its rapid decomposition in aqueous 
solution at neutral pH.65 These reports raise questions about the stability of thinoitrates. 
1.1.2. Cofactor binding to the GAPDH tetramer 
GAPDH is an asymmetric homotetramer (subunit-O, -P, -Q, and -R), which is functionally and 
structurally a dimer of dimers.2 Subunit-O interacts with subunit-P, -Q and -R as interaction across 
the P-, Q- and R-axes, respectively. The number of contacts across the axes are in the order P > R 
> Q. GAPDH’s NBD features the well-known Rossmann fold, which is highly conserved in all 
dehydrogenases.66 The mechanism of NAD+ binding and subsequent changes in the conformations 
of the NBD were examined in the crystal structures of the apo-GAPDH (NAD+-free) and holo-
GAPDH (NAD+-bound) of Bacillus stearothermophilus.67 The adenosine and nicotinamide 
moieties of NAD+ bind away from and close to the active-site, respectively. According to the 
published study, the adenosine moiety of NAD+ binds first to apo-GAPDH because it does not 
require any conformational change. Several attractive interactions lead to the tight binding of 
adenosine moiety, which induces conformational changes to form the binding site for the 
nicotinamide moiety close to the active-site. However, this requires NAD+ to move deeper into the 
active-site and necessitates thermal fluctuations of the enzyme and cofactor to overcome local 
energy barriers. These conformational changes create an H-bond between the catalytic Cys152 and 
His179 residues in the active-site, which enhances reactivity. The reactive thiolate form of Cys152 
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also stabilizes the positively charged N-atom of the nicotinamide moiety of NAD+.  These 
interactions additionally optimize the phosphate binding site.67  
Considering that the NAD+ binding-site is mostly conserved in B. stearothermophilus and 
human GAPDH,67 structural changes induced by NAD+ in the bacterial enzyme might also occur 
in the human enzyme. NAD+ binds in the NBD of human GAPDH with negative cooperativity, 
where binding of one NAD+ decreases the affinity of the next NAD+, which causes loose binding 
of additional NAD+ molecules.68,69 However, the structural details of NAD+ binding to GAPDH 
with negative cooperativity are not very well understood in the human enzyme.  
NADH also binds to GAPDH with negative cooperativity but has 100-fold less binding affinity 
than NAD+.70 NAD+ binding promotes tetramer formation,71 but NADH binding results in 
conformational changes that lead to destabilization of the tetramer.72,73 Also, NBD of GAPDH is 
involved in the binding of nucleic acids9,74 and glutathione conjugates.75,76  NAD+ or NADH inhibit 
the binding of nucleic acid to GAPDH.74 Thus, the effect of NAD+ or NADH binding on dynamics 
of NBD could help understand the binding mechanism of nucleic acids to GAPDH.  
 
1.1.3. Oligomeric states of GAPDH 
GAPDH is translated as 37 kDa monomer but mainly exists as the tetramer.2 However, PTMs 
could give rise to dimers or monomers.14,77–79 It has been shown that cellular localization and 
oligomeric states of GAPDH lead to many of its different functions.80,81 For example, GAPDH 
exhibits dehydrogenase activity in the cytoplasm as the tetramer. Some literature reports indicate 
that the tetramer is the only active form of GAPDH,71  but a few reports suggest that the dimer is 
also active.82,83 The tetramer dissociates into monomers at extreme pH or in the presence of 
chemical denaturants such as guanidine or urea.72,84,85 The monomers and dimers of GAPDH are 
7 
 
implicated in the aggregation that contributes to neurodegenerative diseases such as Alzheimer’s 
disease.86 GAPDH monomer is found in cells that are undergoing apoptosis,14 and monomeric 
nuclear GAPDH is implicated in DNA repair.10,87  
Such literature reports raise various questions about GAPDH’s structure and function. What 
are the structural differences between the GAPDH oligomers? How do the different oligomeric 
states possess different functions? There is no detailed understanding of the mechanism of GAPDH 
oligomerization/deoligomerization. Understanding the GAPDH oligomerization process and 
identifying the amino acids that contribute to the different oligomeric states will provide insight 
into the important physiological and pathological phenomena, including apoptosis and 
neurodegenerative diseases involving GAPDH. 
Cofactor removal from GAPDH (apo-GAPDH) increases internal solvation, which signals the 
instability of apo-GAPDH. Thus, examining the effects of cofactor binding or removal on tetramer 
GAPDH would reveal the importance of the cofactor in the formation of GAPDH tetramer. 
Ionic interactions between the positively charged NAD+ cofactor and the negatively charged 
thiolate of the catalytic Cys152, with a pKa of 6.03,
88 contribute to the stability of tetrameric 
GAPDH. Hence, modification of Cys152 can decrease the stability of the tetramer, giving rise to 
monomers, dimers and other denatured GAPDH products 89,90 that affect glycolytic function.91 
Elucidating precisely how these electrostatic interactions influence the stability of each oligomeric 
state is critical to understanding GAPDH’s diverse functions. It is important to establish how 
changes in the active-site control the formation of different oligomers. For example, what regions 
of GAPDH are the most flexible, and what interactions are involved in the stabilization of the 
dimer or tetramer compared to the monomer? 
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1.2. Objectives and outline 
The goal of this thesis is to gain molecular and structural insights into GAPDH’s role in NO 
biochemistry and other functions. To understand GAPDH’s involvement in GTN bioactivation at 
the molecular level, we investigated pathways proposed for decomposition of E-Cys-NO2, the 
intermediate formed upon GTN reaction with GAPDH. We show that GTN turnover is doubled in 
presence of NAD+,48 thus we carried out molecular dynamics (MD) simulations of GAPDH-NAD+ 
and  GAPDH-NADH to investigate effects of the cofactor on the dynamics of the active-site. We 
compare the dynamics of holo- and apo-GAPDH to identify cofactor-induced dynamic changes. 
The removal of NAD+ from the tetramer promote monomer formation, so we examined the 
dynamics of the GAPDH tetramer, dimer, and monomer. These oligomeric states could play 
important roles in the moonlighting functions of GAPDH. The role of GAPDH in one 
moonlighting function, apoptosis, is investigated to understand complex formation between 
GAPDH and Siah1.  
In Chapter 2 of this thesis, we use CH3SNO2 as a model compound for E-Cys-NO2 to 
investigate its decomposition with state-of-the-art quantum mechanics (QM) calculations. We 
investigated all the proposed pathways 52,56–58 for thionitrate decomposition using 
CCSD(T)//MP2/aug-cc-pVTZ model chemistry 92–96 in the gas phase and solvent effects were 
included implicitly with the Polarized Continuum Model (PCM).97,98 We specifically investigated 
E-Cys-NO2 decomposition by reaction with the anionic nucleophiles, OH
– and CH3S
–, which 
represent activated water molecules and activated thiols, respectively. Geometries and the 
activation barriers for CH3SNO2 decomposition are compared with CH3SNO as a model S-
nitrosothiol because S-nitrosothiols are well-known NO donors. We also carried out benchmark 
calculations for CH3SNO2 decomposition with density functional theory (DFT) methods such as 
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BLYP and B3LYP and a different basis sets, which are relatively fast, to find the best model 
chemistry to use in quantum mechanics / molecular mechanics (QM/MM) calculations of E-Cys-
NO2 decomposition.  
In Chapter 3 of this thesis, we investigate the effect of protonation on the stability and 
electronic structure of CH3SNO2. We used CCSD(T)//MP2/aug-cc-pVTZ model chemistry to 
investigate the geometry and decomposition of the protonated isomers of CH3SNO2 and the 
electronic structures of the isomers were evaluated using natural bond orbital (NBO), and natural 
resonance theory (NRT), as well as AIMALL and QTAIM analysis. The results are compared with 
those for CH3SNO2 to explain the increase/decrease in the stability of the protonated isomers.  
In Chapter 4 of this thesis, cofactor-dependent structural dynamics of GAPDH are investigated. 
We carried out molecular dynamics (MD) simulations of GAPDH tetramer with bound NAD+ or 
NADH (GAPDH-NAD+ or GAPDH-NADH) and apo-GAPDH. We used the CHARMM27 force-
field and NAMD2.9 99 to carry out the MD simulations. Multivariate statistical analysis, principal 
component analysis (PCA) 100,101 and cross-correlation analysis (CCA) was used to evaluate the 
large MD simulations data. Further, normal mode analysis (NMA) 102–104 was carried out using the 
crystal structure of human GAPDH (PDB 1U8F) 105 to investigate the global motions of GAPDH 
and compared with the MD simulations trajectories.  
In Chapter 5, we investigate the dynamics of the three oligomeric states of GAPDH, the 
tetramer, dimer and monomer, to understand the conformational changes induced by 
oligomerization or deoligomerization of the tetramer. We carried out these simulations in presence 
of NAD+ and evaluated subdomain and subunit dynamics of the oligomeric states. We also 




In Chapter 6, we investigated the binding of GAPDH with Siah1 using molecular docking. The 
study evaluates complex formation between the oligomeric states of GAPDH and Siah1. Molecular 
docking was carried out using web servers and possible docking poses were predicted for the 
tetramer, dimer and monomer of GAPDH with the Siah1 dimer and monomer.  
In Chapter 7, QM/MM calculations were performed to investigate the activation barrier for E-Cys-
NO2 decomposition by hydrolysis at the active-site of GAPDH. The active-site residues within 4 
Å of catalytic Cys152, including His179 and Glu317, were treated in the QM part using 
BLYP/TZV2P-GTH, while the remaining residues of the protein and the solvent molecules were 



















Chapter 2. Barrierless nitrite release from thionitrates exposed on modeling 

























Organic thionitrates (RSNO2) release vasoactive nitrite and nitric oxide and are key intermediates 
in the biotransformation of organic nitrates like glyceryl trinitrate (GTN). However, mechanisms 
of NO2
–
 and NO release from RSNO2 are controversial. To address this, we performed a 
comprehensive high-level quantum chemistry investigation of RSNO2 decomposition using 
CH3SNO2 as a model compound. We find prohibitively high activation enthalpy (H‡calc) for S–N 
bond homolysis (> 40 kcal/mol) or CH3SNO2 concerted rearrangement (> 50 kcal/mol) although 
the CH3S(O)NO and CH3SONO products of these reactions undergo facile homolysis to release 
NO (H‡calc ~ 6 kcal/mol). Gas-phase hydrolysis of CH3SNO2 by three water molecules to release 
NO2
– is substantially more favorable (H‡calc ~ 21 kcal/mol). The most favorable pathways, 
however, involve an attack by OH– or CH3S
– perpendicular to the S–N bond (H‡calc ~ 17 kcal/mol) 
or barrierless attack (H‡calc ~ 0 kcal/mol) along the S–N bond to release NO2–.  Reactions with 
the anionic nucleophiles model attack by an activated water or a neighboring cysteinate on an 
enzyme-bound RSNO2 (E–Cys–NO2), the intermediate implicated in GTN enzymatic 
bioactivation. In sum, our calculations predict biologically viable pathways for RSNO2 
decomposition with NO2




2.2. Introduction  
Organic nitrates are used in the treatment of heart diseases,53 cancer pain management,108 
osteoporosis,109 neuropathic pain110 and as NO-NSAIDs (nitric oxide-donating nonsteroidal anti-
inflammatory drugs).111 Nitroglycerin (or glyceryl trinitrate; GTN) has been widely used as a 
vasodilator for over 130 years. GTN acts as a prodrug and undergoes biotransformation to release 
nitrite (NO2
–) and/or nitric oxide (NO) to rapidly trigger vasodilation.53 The extent of NO2
– or NO 
release from GTN remains the subject of much debate as does the relative contribution of these 
two metabolites to the vasodilatory effect of GTN. Thatcher et al.112 reviewed evidence for NO or 
NO2
– release from GTN and discussed the reactions of organic nitrates with thiols. They suggested 
mechanisms for NO generation in these reactions, including the formation of an organic thionitrate 
intermediate, which was proposed over 30 years ago by Yeates et al.113 GTN decomposition by 
various enzymes with catalytic Cys residues, including mitochondrial aldehyde dehydrogenase 
(ALDH2) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), gives NO2
– plus 1,2- or 1,3-
glyceryl dinitrate (GDN) as products.48,52,114 For example, we reported that in the presence of 
dithiothreitol (DTT) to regenerate the thiol form of its catalytic Cys, GAPDH catalyzes the release 
of NO2
– and 1,2-GDN from GTN.48 Based on the observed products, a consensus emerges that an 
enzyme bound thionitrate (E–Cys–NO2) is an intermediate in organic nitrate decomposition by 
cysteine nitrate reductases such as GAPDH.54 
From their synthesis of various low-molecular-weight aromatic and aliphatic thionitrates 
(RSNO2), Oae et al. reported that only t-alkyl thionitrates are stable at room temperature.
61,62 
However, the crystal structure of an aromatic RSNO2 was recently reported
115 and the E-Cys-NO2 
group also was observed in the crystal structure of an ALDH2 variant.55 These findings suggest 
that RSNO2 are viable intermediates in nitrate biotransformation. 
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Figure 2.1: Proposed pathways for thionitrate (RSNO2) decomposition to NO2– and •NO.52,56–58,113,116 
Hydrolysis by H2O or OH– (activated water) as well as thiolysis by R–S– (small-molecule thiolate or a 
protein-based cysteinate) release NO2–. S–N bond homolysis in RSNO2 produces highly reactive radicals 
that recombine to give RSONO (sulfenyl nitrite) or RS(O)NO (sulfinyl nitrite) and O–N or S–N bond 
homolysis, respectively, release NO. Alternatively, concerted rearrangement of RSNO2 could generate 
RSONO. In this work, we examine these pathways for R = CH3.  
Several mechanisms for RSNO2 decomposition have been proposed,
52,56–58,113,116 including 
homolysis, hydrolysis, and thiolysis (Figure 2.1). For instance, homolysis of the S–N bond is 
implicated in the rapid decomposition of t-butylthionitrate (RSNO2; R= t-Bu) to RS(O)SR, 
RS(O2)SR and NO.
65 The mechanism of HSNO2 and CH3SNO2 decomposition also was 
investigated with quantum chemistry calculations. The MP4SDQ//6-31G*//MP2/6-31G* 
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kcal/mol,56 while the MP2/6-311+G** activation enthalpy barrier (H‡calc) for homolytic cleavage 
of CH3SNO2 to CH3S
 + NO2 is reported to be 33.3 kcal/mol.
112 Another computational 
investigation of CH3SNO2 decomposition with ROCCSD(T)//HF/6-311+G* yielded similar 
results for the homolysis and rearrangement pathways.117 Thus, the reported computational studies 
suggest that RSNO2 decomposition via homolysis is not favorable.  
Although NO release from RSNO2 has been the focus of theoretical work to date, various 
experimental reports suggest that NO2
– is the main product formed upon the decomposition of 
organic nitrates by protein-based thiols as seen in the catalysis of GTN decomposition by 
ALDH252,58 and GAPDH.48 A study on the hydrolysis in an alkaline solution of an aromatic 
thionitrate within a bowl-shaped steric protection group (Bpq-SNO2) produced a stable sulfenic 
acid,64 consistent with the release of NO2
– (Figure 2.1). Also, the reaction of glutathione (GSH) 
with peroxynitrite (ONOO–) is reported to give GSNO2, which forms NO2
– and GSSG on further 
reaction with GSH, pointing to thiolysis as a viable pathway for RSNO2 decomposition.
118 
Interestingly, the GSNO2H
+ ion is found to be stable to fragmentation in ESI/MS/MS 
experiments,118 which suggests that some RSNO2 might be more stable than assumed.
56,113  
In order to rigorously examine the proposed mechanisms of NO and NO2
– release from RSNO2 
and to address the confounding issue of RSNO2 stability, here we report a comprehensive quantum 
chemical investigation of CH3SNO2 decomposition to NO2
– or NO via homolysis, hydrolysis, and 
thiolysis (Figure 2.1). We also consider the reaction of CH3SNO2 with OH
– to approximate a water 
activated by H-bonding in the active-site of an enzyme such as GAPDH, whereas the attack on 
CH3SNO2 by CH3S
– serves to model thiolysis by an activated Cys residue, which likely occurs in 
ALDH2. Throughout, we contrast CH3SNO2 and CH3SNO decomposition since S-nitrosothiols 
are well-characterized NO donors. 
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2.3. Computational Methods   
Molecular geometries of the reactants, products and transition states (TS) were optimized with 
second-order Møller-Plesset perturbation theory (MP2)92,119 and the aug-cc-pVTZ augmented 
correlation-consistent basis set.94 Vibrational analysis was performed to confirm the nature of the 
stationary points (energy minima, TS) and to estimate thermodynamic properties under the rigid 
rotor-harmonic oscillator approximation,120 while Intrinsic Reaction Coordinate (IRC)121,122 
calculations were performed to unambiguously connect the TS to reactants and products. Hartree-
Fock wavefunction stability tests were performed for all intermediates and transition states and 
confirmed the absence of open-shell character. Electronic energies were further refined at the 
Coupled Cluster with Single, Double and perturbative linearized Triple excitations [CCSD(T)] 
level of theory.95,96 Calculations were carried out within the restricted wavefunction formalism, 
except in the case of (open–shell) radicals where the unrestricted formalism was employed (spin 
contamination was checked for and found to be insignificant). Solvent effects were included 
implicitly with the Polarized Continuum Model (PCM)97,98 using dielectric constants of 4, 30 and 
78.4 to represent diethyl ether, methanol, and water as solvents. The Gaussian09123 program was 
used for all calculations. 
2.4. Results 
2.4.1. Model compound selection  
HSNO2, CH3SNO2, and t-BuSNO2 were considered as model compounds for Cys–NO2, which 
itself is deemed representative of the thionitrate intermediate in an enzyme (E–Cys–NO2) such as 
GAPDH and ALDH2. The calculated geometries of HSNO2, CH3SNO2, t-BuSNO2, and Cys–NO2 
are shown in Figure 2.2 while selected geometric parameters and charge distributions are collected 
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in Table 2.1. The geometries of all four compounds exhibit similar S–N bond lengths (1.776-1.785 
Å), which are in good agreement with the observed S–N bond lengths (1.780-1.790 Å) in the 
recently published crystal structures of bowl-shaped aromatic thionitrates.115,124 However, the H–
S–N angle of HSNO2 (92.79 °) is 612 ° smaller than the R–S–N angle in RSNO2 (98.87-105.15 
°), which is close to the angle (100.47-107.9 °) observed in the Bpq-SNO2 crystal structures.
115,124 
Also, the partial charge of sulfur is significantly less positive in HSNO2 (0.247) than in RSNO2 
(0.432  0.470). Furthermore, we observed in the gas phase that HSNO2 easily transfers a proton 
from sulfur to a nearby nucleophile (data not shown), which is not possible for RSNO2. Hence, 
based on geometry, charge distribution and reactivity, HSNO2 is not a good model for the larger 
RSNO2. CH3SNO2, t-BuSNO2, and Cys–NO2 exhibit similar structural properties, so we selected 
CH3SNO2 as the smallest model compound to investigate the stability and decomposition of 
RSNO2, including E–Cys–NO2. 
 
Figure 2.2: HSNO2, CH3SNO2, t-BuSNO2, and Cys–NO2 gas-phase molecular geometries optimized with 
MP2/aug-cc-pVTZ. The H/R–S–N angle (degrees, ͦ ) and the partial charge on the sulfur atom are indicated. 
Note that in each structure the H/C–S–NO2 atoms are in the same plane and the barrier for rotation around 
the S–N bond is ~8 kcal/mol (see text). In the plane of the molecule, nucleophiles can attack the sulfur atom 
along the S–N bond or perpendicular to this bond either trans (top attack) or cis (bottom attack) to the R-
group. Attack perpendicular to the molecular plane is not favored due to electrostatic repulsion with the 
sulfur lone pairs (Figure S2.1). O1 and O2 refer to oxygen atoms trans and cis to R-group, respectively. 
18 
 
The C–S–NO2 atoms of CH3SNO2 in Figure 2.2 are in the same plane, which also has been 
observed in the crystal structures of bowl-shaped aromatic thionitrates.63,115,124 The barrier for 
rotation around the S–N bond is calculated to be 8 kcal/mol, which restricts rotation of the nitro 
group out of the plane. Also, the electrostatic potential map for CH3SNO2 (Supporting Information 
Figure S2.1) reveals that nucleophilic attack on the sulfur atom occurs in the C–S–NO2 plane to 
minimize electrostatic repulsion between the nucleophile and the sulfur lone pairs perpendicular 
to this plane. 
Table 2.1. Geometric parameters and charge distribution for RSNO2a
RSNO2 
Bond lengths (Å) Angle (°) Atomic partial charges 
S–N N–O1b N–O2b H/C–S–N S N O1 b O2 b 
HSNO2 1.785 1.222 1.220 92.79 0.247 0.497 -0.429 -0.433 
CH3SNO2 1.776 1.225 1.223 98.87 0.444 0.482 -0.438 -0.448 
t-BuSNO2 1.776 1.226 1.224 105.15 0.432 0.487 -0.439 -0.458 
Cys–NO2 1.779 1.225 1.224 99.83 0.470 0.490 -0.433 -0.470 
a Geometries are optimized with MP2/aug-cc-pVTZ in the gas phase and partial charges calculated with the Natural 
Bond Orbital (NBO) module as implemented in Gaussian09. 
b See Figure 2.2 for the definition of O1 and O2. 
2.4.2. Decomposition of CH3SNO2 by homolysis 
The two pathways investigated for CH3SNO2 decomposition by homolysis are shown in Figure 
2.1. Direct homolytic cleavage of the CH3SNO2 S–N bond gives the highly reactive nitrogen 
dioxide (•NO2) and thiyl (CH3S
•) radicals, which would recombine to form sulfenyl (CH3SONO) 
or sulfinyl (CH3S(O)NO) nitrite. Homolytic cleavage of the (S)O–N bond in CH3SONO or the S–
N bond in CH3S(O)NO would then generate the nitric oxide (
•NO) and sulfenyl (CH3SO
•) radicals. 
Alternatively, CH3SNO2 may rearrange to CH3SONO via a concerted mechanism.
56 The profile 
for these reactions is shown in Figure 2.3 along with selected molecular geometries. The calculated 
S–N bond length in CH3SNO2 (1.776 Å) matches the experimental value of 1.7801.790 Å 
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observed for aromatic RSNO2 by X-ray crystallography,
115,124 and H‡calc for CH3SNO2 homolytic 
cleavage to •NO2 and CH3S
• is 42.6 kcal/mol in the gas phase. The concerted rearrangement of 
CH3SNO2 to CH3SONO is less favorable, with H‡calc = 51.7 kcal/mol. Our transition state (TS1) 
and reaction profile for this rearrangement are consistent with previously published reports.56,117 
We performed further energy refinement with CCSD(T)/aug-cc-pVQZ//MP2/aug-cc-pVTZ but 
the activation barriers for S–N bond homolysis or rearrangement to CH3SONO (Supporting 
Information Table S2.1) change by only ~1 kcal/mol upon extension of the basis set to quadruple 
zeta quality. Hence, energy refinement is carried out with a triple zeta basis set hereafter for the 
sake of computational efficiency.  
 
 
Figure 2.3. Modeling CH3SNO2 homolysis and its rearrangement to CH3SONO and CH3S(O)NO. 
Geometries are optimized with MP2/aug-cc-pVTZ in the gas phase. The vertical axis represents MP2/aug-
cc-pVTZ relative energies with respect to the reactants. Indicated on the graph are the Hcalc (or H‡calc for 
TS) values calculated with CCSD(T)//MP2/aug-cc-pVTZ in the gas phase and the Hcalc that further include 
solvent effects with PCM-water are in parentheses. Energies/enthalpies in kcal/mol, distances in Å and 
angles in degrees ( ͦ ). 
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The most stable conformations of CH3SONO and CH3S(O)NO lie 7–8 kcal/mol higher in 
enthalpy than their CH3SNO2 precursor. Their weak elongated (S)O–N (2.10 Å) and S–N (2.43 Å) 
bonds can undergo homolytic cleavage to release CH3SO
• and •NO with a modest H‡calc = 6 
kcal/mol. Note that the CH3SO
• + •NO products lie 13.8 kcal/mol higher in enthalpy than the 
CH3SNO2 reactant, indicating that 
•NO release is endothermic but significantly less so than direct 
•NO2 release (42.6 kcal/mol) from CH3SNO2. 
Table 2.2. Activation barriers (H‡calc; kcal/mol) of CH3SNO2 decomposition by SN bond homolysis, 
hydrolysis, reaction with OH– and CH3S–  





(3 H2O top) 
Reaction with 
OH–  (top) 
Reaction with 
OH– (bottom) 
Reaction with  
CH3S– (top) 
Gas phase 42.6 20.9 ~ 0c ~ 0c ~ 0c 
PCM Ɛ=4 43.6 20.7 9.0 22.3 12.9 
PCM Ɛ=30 44.2 20.6 16.1 28.4 17.0 
PCM Ɛ=78.4 44.2 20.6 16.7 28.9 17.3 
a Gas-phase molecular geometries are used to calculate H‡calc values for homolysis (Figure 2.3) and hydrolysis 
(Figure 2.4a,b and Figure 2.5). Solvent effects are included using PCM with dielectric constants (ε) corresponding to 
diethyl ether (4), methanol (30) and water (78.4).  
b Molecular geometries for reactions with OH– (Figure 2.6a,b) and CH3S– (Figure 2.7) are calculated in PCM-water. 
d H‡calc ~ 0 for the reaction of CH3SNO2 with OH– and CH3S– because the ions are unstable in the gas phase. 
 
The Hcalc values of the reactants, intermediates, and products with the inclusion of implicit 
solvent are reported in Figure 2.3 for PCM-water and those evaluated with varying dielectric 
constants are collected in Table 2.2. The Hcalc values change by < 1 kcal/mol when solvent effects 
are considered and H‡calc for direct S–N bond homolytic cleavage or rearrangement to CH3SONO 
or CH3S(O)NO increases by ~1.5 kcal/mol. Thus, solvent effects are negligible despite the large 
increase in the dipole moment of CH3SNO2 from 4.44 D in the gas phase to 5.61 D in PCM-water 
since a similar trend is observed for all chemical species (Supporting Information Table S2.2). In 
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summary, NO release from CH3SNO2 via homolysis is unfavorable since it requires steps with 
prohibitory high activation barriers in the gas phase and in solvent. 
2.4.3. Decomposition of CH3SNO2 by hydrolysis 
The products of CH3SNO2 hydrolysis are HONO and CH3SOH (Figure 2.1). The calculated 
profiles for the reaction of CH3SNO2 with a single water molecule are displayed in Figure 2.4a,b 
along with selected molecular geometries, while activation barriers are collected in Table 2.3. 
Water can attack the sulfur atom from the top of the C–S–NO2 plane (Figure 2.2) to give TS2-t 
(Figure 2.4a) or from the bottom of this plane to give TS2-b (Figure 2.4b). Both pathways are 
characterized by pre- and post-reaction complexes lying 15 kcal/mol lower in enthalpy than the 
reactants and products. Both TS2-t and TS2-b exhibit an elongated S–N bond (2.32 and 2.12 Å), 
a relatively short S–O(water) separation (1.96 and 2.03 Å), and an elongated water O–H bond, 
consistent with their role as precursors to the CH3SOH and HONO products. The reaction is 
endothermic by ~8 kcal/mol and H‡calc is large, 50.0 and 45.2 kcal/mol for the top and bottom 
attack, respectively. As observed for homolysis, the inclusion of implicit solvent effects has a 
negligible impact on the H‡calc values (Table 2.3). 
Hydrolysis and water-mediated reactions often involve proton shuttle between multiple water 
molecules. Thus, the inclusion of additional explicit water molecules can significantly alter a 
reaction profile by forming stabilizing hydrogen bonds,125–130 so CH3SNO2 hydrolysis also was 
investigated with two to four water molecules. Interestingly, two water molecules form a ring with 
CH3SNO2 in top attack (TS3-t, Figure 2.5, Figure S2.2a,b) but, due to steric constraints enforced 
by the methyl group, the second water acts as a spectator in bottom attack (TS3-b, Figure S2.2b). 
Similarly, due to steric constraints imposed by the methyl group, the reaction of CH3SNO2 with 
three and four water molecules occur from the top of the C–S–NO2 plane only. TS geometries with 
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one to three water molecules are all consistent with the formation of CH3SOH and HONO as 
reaction products (Figure 2.4a,b and Figure 2.5) but H‡calc drops by 16 kcal/mol on going from 
two (37.2 kcal/mol) to three water molecules (20.9 kcal/mol, Table 2.3). A slight increase occurs 
when a fourth water (estimatedH‡calc of 22 kcal/mol, Supporting Information Table S2.3) is 




Figure 2.4: Modeling CH3SNO2 hydrolysis by one water molecule. Water attack from the (a) top and (b) 
bottom of the C–S–NO2 plane of CH3SNO2. See captions to Figure 2.2 and Figure 2.3 for details. 
23 
 
Table 2.3. Activation barriers (H‡calc, kcal/mol) for CH3SNO2 hydrolysis a 










Gas phase 50.0 45.2 37.2 39.9 20.9 
PCM Ɛ=4 52.8 46.3 38.4 42.4 20.7 
PCM Ɛ=30 54.1 46.7 38.9 43.3 20.6 
PCM Ɛ=78.4 54.3 46.7 38.9 43.4 20.6 
a H‡calc calculated with CCSD(T)//MP2/aug-cc-pVTZ for gas-phase geometries. Solvent effects are included with 
the PCM model and dielectric constants (ε) for diethyl ether (4) methanol (30) and water (78.4). 
 
 
Figure 2.5: Transition state in modeling CH3SNO2 hydrolysis by two and three water molecules. Water 
attack from the top of the C–S–NO2 plane. See captions to Figure 2.2 and Figure 2.3 for details. The ΔH‡calc 
values (kcal/mol) indicated under each transition state structure are calculated with CCSD(T)//MP2/aug-
cc-pVTZ in the gas phase. 
2.4.4. Decomposition of CH3SNO2 by reaction with OH– 
As mentioned above, water can be activated for the nucleophilic attack in enzyme active-sites 
by hydrogen-bond donation to neighboring residues. Thus, to mimic hydrolysis with a highly 
activated water, we examined the OH–/CH3SNO2 reaction. Due to the questionable relevance of 
the results from gas-phase calculations for anionic species (Figure S2.3a), the reaction profiles for 
OH– attack from the top and bottom of the C–S–NO2 plane are characterized in PCM-water (Figure 
2.6a,b). OH– attack from the top (Figure 2.6a) or bottom (Figure 2.6b) of the C–S–NO2 plane is 
highly exothermic (Hcalc = -25.4 kcal/mol), but not as much as in the gas phase. Attack from the 
bottom (TS5-b) or top (TS5-t) of the C–S–NO2 plane gives a transition state with an elongated S–
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N bond and a nascent S–O bond that is a precursor for CH3SOH and NO2– formation (Figure 
2.6a,b). However, the barrier for attack from the top (H‡calc = 16.7 kcal/mol) is remarkably lower 
than that from the bottom (H‡calc = 28.9 kcal/mol; Figure 2.6a,b and Table 2.2), which we attribute 
in part to distortion of the C–S–N angle. Relative to the CH3SNO2 reactant (Figure 2.2), the C–S–
N angle is compressed by only 20 ° in TS5-t but expanded by 37 ° in TS5-b. Additionally, TS5-t 
has a stabilizing OH–ONO bond which is absent in TS5-b. Since OH– attack from the top is 4 
kcal/mol more favorable than hydrolysis with three water molecules (Table 2.2), RSNO2 is 
predicted to be less stable with increasing pH or in an enzyme’s active-site close to an activated 
water molecule. 
Attempts to locate a TS for the attack of OH– along the S–N bond with an O(OH_)--- S–N angle 
of ~180 ° were unsuccessful. Thus, we calculated the potential energy curve (PEC) by scanning 
the distance between O(OH–)---S, while relaxing the geometry. The relaxed PEC reveals barrierless 
attack along the S–N bond (Figure 2.6c), which explains why we failed to locate a TS. The O(OH–
)---S distances are 1.6, 2.3 and 3.8 Å in A5-l, B5-l and C5-l complexes, respectively. The NBO 
charges of these structures show a charge transfer from OH– (-0.984 to -0.433) to NO2
– (-0.483 to 
-0.986) going from C5-l to A5-l (Table S4). NBO analysis reveals an NBO interaction between a 
lone pair of OOH
– and σ*(S–N) with stabilization energy of 50 kcal/mol for structure B5-l (Table 
S2.5 and Figure S2.4), which destabilizes the S–N bond. This NBO interaction is absent in A5-l 
and C5-l. Thus, the charge transfer from OH– to NO2
– with S–N bond breaking favored due to 
strong interactions between a lone pair of OH– and sulfur makes the attack of OH– along the S–N 
bond barrierless. Also, the electrostatic surface shows a positive charge (σ-hole) on the sulfur atom 




The barrierless attack of OH– along the S–N bond was further confirmed by QM simulation of 
CH3SNO2 and OH
– complex. We started QM simulation with O(OH
–
)---S distance of 3.8 Å and 
relaxed geometry of the complex by following the negative energy gradient using our own code, 
which uses Gaussian09 for geometry optimization (Figure S2.5). The calculation was carried out 
using MP2/6-311+G(d,p)(PCM-water) and further energies were corrected for selected geometries 
with CCSD(T)/aug-cc-pVTZ(PCM-water) (Figure S2.5a). It reveals similar reaction coordinates 
as seen with relaxed PEC (Figure S2.5b-d vs Figure 2.6c). 
2.4.5. Decomposition of CH3SNO2 by reaction with CH3S–  
Protein-based thiols, particularly those involved in enzyme catalysis, are frequently in an activated 
thiolate form.131–133 Accordingly, the reaction of CH3SNO2 with CH3S
– was investigated (Figure 
2.1). Because this reaction also involves anionic species, the gas-phase profile reveals a highly 
exothermic reaction (Hcalc -29.5 kcal/mol) along with the pronounced stability of the pre- and 
post-reaction complexes and no activation barrier (Figure S2.3b). Therefore, we also characterized 
the CH3S
–/CH3SNO2 reaction profile and stationary points with PCM-water (Figure 2.7). S–N 
bond elongation and partial disulfide bond formation characterize TS6-t as a precursor of the 
products, CH3SSCH3 and NO2
–. Notably, H‡calc in PCM-water for attack from the top of the C–
S–NO2 plane by CH3S– and OH– are very similar (~17 kcal/mol; Table 2.2).  Although CH3S– is a 
stronger nucleophile than OH–, presumably TS5-t is stabilized by the H-bond interaction between 
OH– and the ONO moiety (Figure 2.6a). As seen for OH–, attack of CH3S
– along the S–N with an 
S---S-N angle of ~180 ° is barrierless (Figure 2.7b). The S(CH3S
–
)---S distances are 2.0, 2.8 and 3.5 
Å in structures A6-l, B6-l and C6-l, respectively. As similar to OH–, this barrierless attack also 
involves a charge transfer from CH3S
– (-0.975 to -0.018) to NO2
– (-0.493 to -0.990) going from 
C6-l to A6-l (Table S6). The NBO interaction between a lone pair of SCH3S
– and σ*(S–N) has 
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stabilization energy of 42 kcal/mol for structure B6-l, which favors the barrierless attack (Figure 
S2.6).  
 
Figure 2.6: Modeling the reaction of CH3SNO2 with OH– where the nucleophile attacks from the (a) top or 
(b) bottom of the C–S–NO2 plane and (c) along the S–N bond (see Figure 2.2). Panels (a,b) show IRCs, 
whereas panel (c) shows the relaxed potential energy curve (PEC) calculated for the O(OH-)---S distance 
scan. Geometries are optimized with MP2/aug-cc-pVTZ(PCM-water). The vertical axis represents 
MP2/aug-cc-pVTZ(PCM-water) relative energies with respect to the reactants. Indicated on the graph are 
the Hcalc (or H‡calc for TS) values calculated with CCSD(T)// MP2/aug-cc-pVTZ(PCM-water). 




Figure 2.7: Modeling the reaction of CH3SNO2 with CH3S– where the nucleophile attacks from (a) top of 
the C–S–NO2 plane (b) along the S–N bond. Note that panel (a) shows the IRC whereas panel (b) shows 
the relaxed PEC calculated for the S---S distance scan. See captions to Figure 2.2 and Figure 2.6 for details. 
2.5. Discussion 
2.5.1. S–N bond homolysis and concerted rearrangement in RSNO2 
Homolytic cleavage of the S–N bond in CH3SNO2 is unfavorable (H‡calc = 42.6 kcal/mol). The 
previously reported MP2/6-311+G** H‡calc values (33.3 kcal/mol)112 and ROCCSD(T)//HF/6-
311+G* (38.3 kcal/mol)117 underestimate the stability of the S–N bond in CH3SNO2 as higher-
level model chemistries predict higher activation enthalpies. The present gas-phase 
CCSD(T)//MP2/aug-cc-pVTZ calculations provide one of the best estimates of this barrier, which 
increases only slightly (H‡calc = 43.9 kcal/mol, Supporting Information Table S2.1) upon 
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extension of the basis set to quadruple zeta quality. Hence the prohibitive computational cost of 
such calculations is not warranted. Notably, our H‡calc for S–N bond homolysis in CH3SNO2 is 
10 kcal/mol higher than that calculated with CCSD(T)-F12/CBS for the corresponding 
nitrosothiol, CH3SNO (H‡calc = 32.4 kcal/mol).134 Also, an experimental H‡ of ~ 25 kcal/mol 
has been reported for S–N homolysis in t-BuSNO,135 suggesting that RSNO are considerably more 
labile than RSNO2, but a comprehensive experimental examination of their relative stabilities is 
lacking.  
As reported previously,56  the barrier for concerted rearrangement of CH3SNO2 (H‡calc = 51.7 
kcal/mol, Figure 2.3 and Supporting Information Table S2.1) is too high to be of biological 
significance. Hence, given the high barrier for CH3SNO2 homolysis, the biological relevance of 
CH3SONO and CH3S(O)NO formation (Figure 2.1) also is questionable. Nonetheless, our Hcalc 
for the CH3SONO intermediate (8.2 kcal/mol, Figure 2.3 and Supporting Information Table S2.1) 
is comparable to the MP2/6-311+G** value (7.5 kcal/mol).112 CH3SONO and CH3S(O)NO were 
previously found to be isoenergetic,112 and we find a difference of ≤1.5 kcal/mol in their Hcalc 
values. For homolysis of the O–N or S–N bond to release •NO and CH3S• (Figure 2.1), the reported 
MP2/6-311+G** H‡calc is ~13 kcal/mol,112 while we estimate H‡calc ~ 6 kcal/mol (Figure 2.3), 
suggesting that NO release is energetically more favorable than previously reported. Thus, the high 
barriers for their formation combined with their low stability would explain why RSONO and 
RS(O)NO have not been isolated during RSNO2 decomposition.
65,118 Overall, the high H‡calc for 
homolysis and rearrangement suggest that RSNO2 are stable at room temperature as reported for 





2.5.2. Hydrolysis and thiolysis of RSNO2 
H‡calc for gas-phase CH3SNO2 hydrolysis by one water (45.2 kcal/mol, Figure 2.4b) is ~3 
kcal/mol higher than that for S–N bond homolysis (42.6 kcal/mol, Figure 2.3). However, adding 
three water molecules lowers the barrier to ~21 kcal/mol (Figure 2.5 and Table 2.3), making 
hydrolysis considerably more favorable than homolysis, and more in keeping with the 
experimentally observed half-life of ~10 min for t-BuSNO2 in aqueous solution at neutral pH,
65 
and alkaline hydrolysis of sterically protected Bpq-SNO2 to the sulfenic acid within 10 min.
64 
Examining the structures in Figures 2.4a,b and Figure 2.5, we notice that the transition states with 
one and two water molecules are highly strained with large deviations in the S–N bond length (0.5 
and 0.6 Å) and C–S–N angle (-21 and +16 °) from the CH3SNO2 reactant (Figure 2.3), which 
would explain the high activation barriers. In contrast, the S–N bond and C–S–N angle in the 
transition state structures with 3 water molecules (Figure 2.5) deviate much less from their values 
in the CH3SNO2 reactant. Thus, reduced strain and reorganization significantly lower the H‡calc 
for hydrolysis (Table 2.3). 
Notably, H‡calc (45 kcal/mol) for hydrolysis of the corresponding S-nitrosothiol, CH3SNO, to 
HNO and CH3SOH by two water molecules is ~8 kcal/mol 
127 higher than that for CH3SNO2 
hydrolysis (37 kcal/mol). Thus, the proposed sulfhydryl pathway for NO generation involving 
RSNO2 reduction to RSNO
113,136 would be energetically more favorable if RSNO undergoes 
homolysis but not hydrolysis. Also, the experimentally observed depression of NO release from 
GSNO2 in the presence of GSH




Figure 2.8: Active-site of GAPDH and ALDH2. (a) Catalytic Cys152 is converted to Cys–NO2 on the 
reaction of GAPDH with GTN.48 Glu317 is positioned to activate a water molecule for nucleophilic attack 
on Cys–NO2 but Cys156 is too far away to attack Cys152. (b) Catalytic Cys302 is converted to Cys–NO2 
on the reaction of ALDH2 with GTN.55 Either Cys301 or Cys303 is positioned to attack Cys–NO2 and 
Glu268 also activates a water molecule for possible hydrolysis. Distances (black font) in Å. 
The barrier is lowered further by top attack of OH– or CH3S
– on CH3SNO2 (H‡calc ~17 
kcal/mol, Table 2.2). However, when the nucleophile attacks along the S–N bond, the activation 
energy dramatically decreases to 0 kcal/mol (Figure 2.6c and Figure 2.7b). Favorable electrostatic 
interaction between the nucleophile and the -hole on the CH3SNO2 sulfur atom gives rise to this 
somewhat unexpected barrierless pathway. Notably, the rapid decomposition of Bpq-SNO2 in 
alkaline solution and its stability in aqueous acetic acid 64 corroborate barrierless hydrolysis by 
OH– but not H2O. The sulfenic acid produced on RSNO2 hydrolysis is unstable and may undergo 
further reaction depending on the experimental conditions.137 
2.5.3. Decomposition of E–Cys–NO2 in GAPDH and ALDH2 
NO2
– release from E–Cys–NO2 in GAPDH is likely catalyzed by a water molecule activated by 
conserved Glu317 at ~6 Å from the catalytic Cys152 (Figure 2.8a). Hence, based on our 
31 
 
calculations, the barrier for NO2
– release from E–Cys–NO2 should fall within 0-21 kcal/mol 
depending on the extent of activation of the water molecule as well as its line of attack on the 
sulfur atom. The efficacy of GTN turnover by the Glu317Gln variant of GAPDH, which remains 
to be investigated, should indicate the importance of water activation.  
The active-site of ALDH2 possesses three potential nucleophiles, Cys301, Cys303 and a water 
molecule activated by Glu268 (Figure 2.8b). ALDH2 variants with these residues singly, doubly 
or triply mutated exhibit significant loss of GTN denitrating activity,58 indicating that all three 
residues are somehow involved in catalyzing NO2
– release from GTN.   
Both GAPDH and ALDH2 catalytically denitrate GTN in the presence of a reducing substrate 
(e.g., dithiothreitol). This will reduce the sulfenic acid or disulfide formed on nucleophilic attack 
on E–Cys–NO2 (Figure 2.1) back to the thiol. Since ALDH2 turns over GTN (38 nmol min–1 mg–
1)138 10-fold faster than GAPDH (2.6 nmol min–1 mg–1)48 and our calculations uncover a barrierless 
pathway for NO2
– release (Figure 2.6c and Figure 2.7b), we speculate that E–Cys–NO2 formation 
may be rate limiting in the enzymes.   
Rearrangement of E–Cys–NO2 to sulfenyl nitrate with subsequent NO release (Figure 2.1) also 
has been proposed for ALDH2.58 However, given the high barrier we find here for CH3SNO2 
rearrangement (H‡calc ~52 kcal/mol, Figure 2.3), any ALDH2-catalyzed NO release, which is a 
minor pathway of GTN decomposition,58 likely occurs via some undefined mechanism that 
remains to be unveiled by further investigation. 
2.5.4. Benchmarking DFT for future QM/MM calculations. 
The present quantum chemistry calculations provide insight into the RSNO2 reactivity in the gas 
phase and in solvent. Since the protein environment at the active-site influences the activation 
barrier for E–Cys–NO2 decomposition, quantum mechanics / molecular mechanics (QM/MM) 
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calculations are underway to include neighboring residues in GAPDH (Figure 2.8a). To that effect, 
we compared the performance of computationally efficient density-functional theory in 
reproducing the geometry of CH3SNO2 calculated with MP2/aug-cc-pVTZ (Table 2.4). The S–N 
bond lengths calculated with B3LYP/6-311+G(d,p) and BLYP/6-311+G(2df,2pd) are close to its 
MP2/aug-cc-pVTZ counterpart but a smaller basis set tends to predict slightly longer S–N bonds. 
Comparison of the activation barriers for S–N bond homolysis, hydrolysis, reaction with OH– and 
CH3S
– with CCSD(T)//MP2/aug-cc-pVTZ values as reference data indicates that B3LYP/6-
311+G(d,p) and BLYP/6-311+G(2df,2pd) reproduce acceptable activation barriers for these 
reaction pathways (Table 2.5). Thus, as the hybrid B3LYP model is computationally more 
intensive than BLYP, we consider BLYP/6-311+G(2df,2pd) to be the best compromise in terms 
of reliability and computational cost for further QM/MM investigations with large QM zones 
centered on the active-site and including relevant nearby residues. 
Table 2.4. Selected gas-phase geometric parameters for CH3SNO2 calculated with different model 
chemistries  
Model chemistry 
Bond lengths (Å) Angle (°) 
S–N N–O1a N–O2a C–S–N 
MP2/aug-cc-pVTZ 1.776 1.225 1.223 98.87 
BLYP/6-311+G(2df,2pd) 1.860 1.229 1.229 100.1 
BLYP/6-31+G(d,p) 1.877 1.238 1.239 99.75 
B3LYP/6-311+G(d,p) 1.831 1.214 1.213 99.58 






Table 2.5. Activation barrier (H‡calc, kcal/mol) for CH3SNO2 decomposition by homolysis, hydrolysis, 
reaction with OH– and CH3S– calculated with different model chemistries 
 Homolysisa 
Hydrolysis by 
3 H2O (top)a,b 
Attack by OH– 






CCSD(T)//MP2/aug-cc-pVTZ  42.6 20.9 16.7 (0)d 17.3 
BLYP/6-311G+(2df,2pd) 35.0 18.2 13.5 12.5 
BLYP/6-31+G(d,p) 33.9 14.9 12.3 11.4 
B3LYP/6-311+G(d,p) 32.7 20.8 17.2 (0)d 17.4 
a Activation barriers calculated in the gas phase. 
b Attack from the top of the C-S-NO2 plane (see caption to Figure 2.2). 
c Activation barriers calculated in PCM-water. 
d Attack along S–N bond is barrierless (0 kcal/mol) 
2.6. Conclusions 
CH3SNO2 is the smallest model compound representative of larger RSNO2 such as protein-bound 
E–Cys–NO2. From our investigations using high-level quantum chemistry calculations, we find 
that direct CH3SNO2 homolysis or its concerted rearrangement have prohibitively high barriers 
(H‡calc ~ 43 and 52 and kcal/mol, respectively, Figure 2.3). Hence, while facile S–O bond 
homolysis in CH3SONO or S–N bond homolysis in CH3S(O)NO yield NO (H‡calc ~ 6 kcal/mol), 
the formation of these intermediates from CH3SNO2 is highly unfavorable. Therefore, NO release 
from RSNO2 by mechanisms proposed in the literature (Figure 2.1)52,56–58,113,116 is highly unlikely.  
In contrast, hydrolysis or thiolysis of CH3SNO2 to release NO2
– can be barrierless on attack by 
OH– or CH3S
–. This explains the aqueous instability of Bpq-SNO2 at high but not low pH 
64 and 
the experimental half-life (~10 min) of t-BuSNO2 in neutral aqueous solution.
65 In sum, our 
findings from high-level quantum chemistry calculations are consistent with the low aqueous 
stability of thionitrates observed experimentally. 
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Decomposition of an enzyme-bound thionitrate, E-Cys-NO2, may be close to barrierless if an 
activated water molecule and/or an activated cysteine is suitably positioned to attack the thionitrate 
sulfur atom. Thus, we speculate that the rate-limiting step in the catalysis of GTN denitration by 
GAPDH and ALDH2 is E-Cys-NO2 formation. Our high-level quantum chemistry calculations 
will serve as a benchmark for QM/MM investigations of NO2
– release from this intermediate, 
which will provide critical information on the biotransformation of GTN and other organic nitrates. 
2.7. Supporting Information 
 
Figure S2.1: Electrostatic potential map of CH3SNO2 calculated with MP2/aug-cc-pVTZ. The grey arrows 
indicate rotation of the structure by 90 to give the top and bottom representations or by 180  to show the 
two orientations with the C–S–NO2 plane in the page. The sulfur lone pairs (short black arrows) force 
nucleophilic attack in the C–S–NO2 plane rather than perpendicular to this plane while the σ-hole on the 
sulfur atom (short blue arrow) favors attack by ionic nucleophiles along the S–N bond (Figure 2.6c and 




Figure S2.2: Modeling CH3SNO2 hydrolysis by two water molecules. Water attack from the (a) top and (b) 







Figure S2.3: Modeling the gas-phase reaction of CH3SNO2 with OH- and CH3S-. (a) The OH– nucleophile 
attacks from the bottom* and (b) the CH3S– nucleophile attacks from the top.**  See captions to Figure 2.2 
and Figure 2.3 of the main text for details. 
 
* The reaction profile for OH– attack from the bottom of the C–S–NO2 plane is shown along with selected 
molecular geometries.  Panel (a) shows that this reaction is highly exothermic in the gas phase (Hcalc = -
41.6 kcal/mol) and the pre- and post-reaction complexes separated by the transition state are dramatically 
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more stable in the gas-phase than in PCM-water (Figure 2.6b). A methyl hydrogen has been transferred to 
OH– in pre-reaction complex A7-b, which is connected to TS7-b via a second intermediate complex (C7-
b) where OH– is now bound to a methyl hydrogen. OH– has shifted to the sulfur atom in TS7-b, which 
promotes cleavage of the S–N bond to give the NO2– – CH3SOH ion-molecule post-reaction complex, B7-
b. While the gas-phase OH–/CH3SNO2 reaction has a negligible H‡calc relative to the reactants (Table 2.2), 
the large H‡calc of 55.1 kcal/mol from the stable pre-reaction complex renders it unfavorable. The inclusion 
of implicit solvent shifts the entire reaction profile by ~20 kcal/mol, essentially the difference in the 
solvation free energy (Gsolv,calc) of OH– (–80.5 kcal/mol) and NO2– (–64.4 kcal/mol) in PCM-water (Table 
S2.7). 
** Similar to the OH–/CH3SNO2 reaction, the CH3S–/CH3SNO2 reaction in panel (b) also involves ionic 
species. Thus, the gas-phase profile reveals a highly exothermic reaction (ΔHcalc -29.5 kcal/mol) along with 
the pronounced stability of the pre- and post-reaction complexes and no activation barrier (ΔHcalc ~0 
kcal/mol). 
 
Figure S2.4: NBO interactions showing (a) donor orbital (n(O
OH
–)) and (b) acceptor orbital (σ*(S–N)) of 
structure B5-l. n(O
OH
–) → σ*(S–N) NBO interaction with stabilization energy of 50 kcal/mol, which is 
absent in complexes A5-l and C5-l. Chemcraft was used to visualize the orbitals and NBO module was used 




Figure S2.5: Reaction profile for the attack of OH– along the S–N bond. (a) Potential energy curve 
calculated for OH– attack along the S–N bond calculated with MP2/6-311+G(d,)(PCM-water) (red line) 
and selected constrained O(OH–)---S distance with MP2/aug-cc-pVTZ(PCM-water) (black line). Indicated 
on the graph are Hcalc values calculated with CCSD(T)/aug-cc-pVTZ//MP2/6-311+G(d,p)(PCM-water) 
(red) and CCSD(T)//MP2/aug-cc-pVTZ(PCM-water) (black). The reaction profile shows the barrierless 
attack of OH– along the S–N bond. The structures (b-d) represent the geometry of reaction coordinates with 




Figure S2.6: NBO interactions showing (a) donor orbital (n(S
CH3S
–)) and (b) acceptor orbital (σ*(S–N)) of 
structure B6-l. n(S
CH3S
–) → σ*(S–N) NBO interaction with stabilization energy of 42 kcal/mol, which is 
absent in complexes A6-l and C6-l. See caption to Figure S2.4. 
 
Table S2.1. Relative enthalpies (Hcalc or H‡calc kcal/mol) for CH3SNO2 homolysis and concerted 
rearrangement a  
 CH3SNO2 CH3S• + •NO2 TS1 CH3SONO CH3S(O)NO CH3SO• + •NO 
Gas phaseb 0 42.6 51.7 8.2 7.0 13.8 
PCM Ɛ=4c 0 43.6 52.6 8.7 7.0 13.7 
PCM Ɛ=30c 0 44.2 53.0 9.0 6.8 13.6 
PCM Ɛ=78.4c 0 44.2 53.1 9.0 6.8 13.6 
Gas phased 0 43.9 52.0 8.0 6.8 12.4 
a See Figure 2.3 of the main text for the reaction profile for CH3SNO2 homolysis and rearrangement to CH3SONO 
and CH3S(O)NO. Geometries are optimized with MP2/aug-cc-pVTZ in the gas phase. The Hcalc (or H‡calc for TS) 
values are calculated with CCSD(T)//MP2/aug-cc-pVTZ except where indicated.   
b Hcalc /H‡calc in the gas phase.  
c Hcalc /H‡calc for the gas-phase optimized geometries in PCM solvent with dielectric constants () for diethyl ether 
(4), methanol (30) and water (78.4).  




Table S2.2.  Dipole moments (D) of all reactants, products, and complexes 







CH3SNO2 2.3 4.44 5.21 5.57 5.61 
CH3SONO 2.3 2.87 3.56 3.98 4.00 
CH3S(O)NO 2.3 3.55 4.28 4.67 4.96 
CH3S• 2.3 1.73 2.04 2.19 2.21 
NO2• 2.3 0.66 0.74 0.79 0.79 
H2O 2.4 1.99 2.18 2.27 2.28 
HONO 2.4 2.30 2.60 2.74 2.76 
CH3SOH 2.4 2.15 2.51 2.71 2.73 
2H2O 2.5 2.65 2.81 2.87 2.88 
OH– 2.6 1.50 1.77 1.90 1.91 
NO2– 2.6 0.67 0.78 0.85 0.85 
CH3S– 2.7 3.53 4.38 4.82 4.87 
CH3SSCH3 2.7 2.25 2.74 3.00 3.03 
CH3SNO2–H2O top TS2-t 2.2a 3.07 3.55 3.79 3.82 
CH3SNO2–H2O bottom TS2-b 2.2b 6.28 7.43 7.94 8.00 
CH3SNO2–2H2O top TS3-t 2.5 4.95 5.81 6.20 6.24 
CH3SNO2–2H2O bottom TS3-b S2.2b 6.02 6.97 7.38 7.42 
CH3SNO2–OH– top TS5-t 2.6a 4.32 4.32 4.76 4.80 
CH3SNO2–OH– bottom TS5-b 2.6b 4.45 5.65 6.21 6.27 
CH3SNO2–CH3S– top TS6-t 2.7 5.66 7.13 7.81 7.88 
CH3SNO2–OH– bottom TS7-b  S2.3a 4.47 5.54 6.07 6.13 
CH3SNO2–CH3S– top TS8-t S2.3b 5.90 7.30 7.96 8.04 
a Figure in the main text that displays the structure of the chemical species. 
b Dipole moments calculated with CCSD(T)//MP2/aug-cc-pVTZ in the gas phase. 
c Dipole moments calculated with CCSD(T)//MP2/aug-cc-pVTZ for gas-phase geometries with solvent effects 




Table S2.3. MP2/6-311+G** activation barriers (H‡calc, kcal/mol) for CH3SNO2 hydrolysis a 












Gas phase 56.6 51.3 45.7 46.0 26.7 28.0 
PCM Ɛ=4 59.7 52.5 46.2 48.2 26.4 26.9 
PCM Ɛ=30 60.9 52.9 46.3 49.0 26.3 26.6 
PCM Ɛ=78.4 61.0 52.9 46.3 49.1 26.3 26.6 
a H‡calc calculated with MP2/6-311+G** for gas-phase geometries (less than 8% deviation in bond lengths compared 
to MP2/aug-cc-pVTZ). Solvent effects are included with the PCM model and the dielectric constants (ε) of diethyl 
ether (4), methanol (30), and water (78.4). The MP2/6-311+G** barriers overestimate their  CCSD(T)//MP2/aug-cc-
pVTZ counterparts by 6-7 kcal/mol; i.e., by 12, 16 and 20% for hydrolysis by 1, 2 and 3 water molecules, respectively. 
The CCSD(T)//MP2/aug-cc-pVTZ barriers for hydrolysis by 4 water molecules are thus estimated as 21-22 kcal/mol 
by scaling the MP2/6-311+G** data by 20%. 
 
Table S2.4. Charge distribution in the CH3SNO2---OH– complexes.a 
 A5-l b B5-l b C5-l b 
-S  0.522  0.503  0.472 
-NO2
– -0.986 -0.610 -0.483 
-CH3 -0.099 -0.037 -0.005 
-OH– -0.433 -0.857 -0.984 
a The structures A5-l, B5-l, and C5-l are from the PEC calculated with MP2/aug-cc-pVTZ(PCM-water). The charges 
are calculated with the Natural Bond Orbital (NBO) module as implemented in Gaussian09.  




















A5-l b B5-l b C5-l b 
n(OOH–)   → σ*(S–N) - 50 - - 
n(O1)      → σ*(S–N) - 14 20 24 
n(O2)      → σ*(S–N) - 18 25 29 
n(O2)      → σ*(N–O1) - - - 28 
n(O2)      → σ*(N–O1) 192 28 29 - 
n(O2)      → π*(N–O1) 23 - - 261 
n(S)         → π*(N–O1) - - - 30 
n(O1)      → σ*(N–O2) 24 29 29 29 
n(S)         → σ*(N–O2) - 06 05 04 
n(O1)      → π*(N–O2) - 230 244 - 
n(S)         → π*(N–O2) - 31 40 - 
n(OOH–)   → σ*(C–H) - - 10 - 
n(OOH–)   → σ*(S–C) 06 - - - 
n(N)        → σ*(S–OOH–) 05 - - - 
a NBO interactions calculated using geometries optimized with MP2/aug-cc-pVTZ. We report the stabilization 
energies, E(2), of the NBO donor orbital → acceptor orbital pair with > 5 kcal/mol. 
b The O(OH–)---S distances are 1.6, 2.3 and 3.8 Å in the A5-l, B5-l and C5-l structures, respectively. See Figure 2.6c 
for the structures. 
 
Table S2.6. Charge distribution on CH3SNO2---CH3S– complexes a 
 A6-l b B6-l b C6-l b 
-S  0.054  0.402  0.488 
-NO2
– -0.990 -0.593 -0.493 
-CH3 -0.047 -0.039 -0.020 
- CH3S
– -0.018 -0.770 -0.975 
a The structures A6-l, B6-l, and C6-l are from the PEC calculated with MP2/aug-cc-pVTZ(PCM-water) (Figure 2.7b). 
The charges are calculated with the NBO module as implemented in Gaussian09.  




Table S2.7. Solvation free energy (Gsolv,calc, kcal/mol) for CH3SNO2 homolysis, hydrolysis, and thiolysisa 
Homolysis   
CH3SNO2 CH3S• •NO2 TS1 CH3SONO CH3S(O)NO CH3SO• •NO 
PCM Ɛ=4 -2.5 -1.1 -0.4 -1.6 -2.0 -2.6 -2.5 -0.2 
PCM Ɛ=30 -3.7 -1.6 -0.6 -2.3 -2.9 -3.9 -3.6 -0.2 
PCM Ɛ=78.4 -3.9 -1.7 -0.6 -2.4 -3.0 -4.0 -3.8 -0.2 
 
Hydrolysis  
 H2O 2 H2O CH3SOH HONO TS2-t TS2-b TS3-t TS3-b 
PCM Ɛ=4 -2.7 -4.8 -2.3 -1.9 -2.3 -4.1 -6.1 -4.8 
PCM Ɛ=30 -3.9 -6.8 -3.4 -2.8 -3.5 -6.2 -8.8 -7.0 
PCM Ɛ=78.4 -4.0 -7.0 -3.6 -2.9 -3.6 -6.4 -9.1 -7.3 
 
Reaction with OH– 




PCM Ɛ=4 -60.5 -48.8 -42.4 -40.2 -41.9 
PCM Ɛ=30 -78.8 -63.1 -56.2 -51.7 -54.4 
PCM Ɛ=78.4 -80.5 -64.4 -57.6 -52.7 -55.5 
 
Reaction with CH3S– 
 CH3S– CH3SSCH3 TS6-t TS7-t 
PCM Ɛ=4 -48.9 -1.5 -38.5 -38.9 
PCM Ɛ=30 -64.7 -2.3 -51.1 -50.7 
PCM Ɛ=78.4 -65.8 -2.4 -52.3 -51.8 
a Calculated with CCSD(T)//MP2/aug-cc-pVTZ using the PCM model with the dielectric constants () for diethyl 

















Chapter 3. Effects of Protonation on the Electronic Structure and Reactivity 























Thionitrates (RSNO2), active intermediates in nitrate biochemistry, are shown to be stable in the 
presence of an acidic environment. Thus, we investigated the effect of protonation on the electronic 
structure and reactivity of CH3SNO2 as a model thionitrate. We show that the complex electronic 
structure of CH3SNO2 calculated with natural resonance theory (NRT) can be explained by three 
resonance structures with characteristics with a single S–N bond, a double S=N bond and S–---N+ 
ionic structure. The contribution of the resonance structure with double S=N bond character (3 %) 
increases upon O-protonation (13 %), whereas the S–---N+ structure (6 %) increases upon S-
protonation (42 %). This explains the altered S–N bond stability of to homolysis (~ 43 kcal/mol) 
upon O-protonation (~ 90 kcal/mol) and S-protonation (~ 30 kcal/mol). Also, our study shows that 




The interest in understanding the reactivity and stability of thionitrates (RSNO2) spiked recently 
after they were proposed as active intermediates in organic nitrate decomposition.54,113 Crystal 
structures of small aromatic thionitrates 63,64,115,124 and cysteine thionitrate (E-Cys-NO2) in the 
triple variant of mitochondrial aldehyde-dehydrogenase (ALDH2) 55 indicate that RSNO2 are 
stable. However, tert-butyl thionitrate (t-BuSNO2) readily decomposes in neutral aqueous 
solution.65 Hydrolysis in aqueous alkaline solution of the bowl-shaped aromatic thionitrate, Bpq-
SNO2, produces the sulfenic acid in 10 min at room temperature, whereas the reaction does not 
proceed even after 4 h with aqueous acetic acid in CDCl3, or with aqueous tetrahydrofuran at room 
temperature.64 Additionally, protonated glutathione thionitrate (GSNO2) is resistant to 
decomposition at a collision energy of 25 eV in the electrospray ionization source of a mass 
spectrometer.118 These reports suggest that the stability and reactivity of thionitrates change in 
different environments.  
Protonation and deprotonation are fundamental steps in many chemical and biochemical 
reactions. Especially, the microenvironment provided by acidic or basic residues within a protein’s 
active-site can change the pKa to protonate or deprotonate another residue. Moreover, the 
reactivity and stability of reaction intermediates are influenced by protonation or deprotonation. 
For example, the reactivity of E-Cys152-NO2 in the active-site of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 48 could be altered if neighbouring His179 becomes protonated (See 
Chapter 2, Figure 2.8). Thus, studying the effects of protonation on RSNO2 reactivity could 
provide insight into the stability of RSNO2 in an acidic environment. The gas-phase proton affinity 
(PA), represented as a negative enthalpy change upon protonation, is used to express the ability of 
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a molecule to accept a proton. Ab initio calculations are often used to predict gas-phase proton 
affinities due to difficulties in experimental measurement.139–141 
The energetics of RSNO2 decomposition pathways (Figure 2.1) indicate a very high activation 
barrier for homolysis,65,112,117 but small activation barriers for hydrolysis and thiolysis are predicted 
by our computational study (Chapter 2). The reactivity of RSNO2 are reported in various 
computational 56,112,117 and experimental 61,65,115,142 studies. However, there are no reports on the 
electronic structure of RSNO2. Thus, we investigated their resonance structures using CH3SNO2 
as a model compound. The effect of CH3SNO2 protonation on its resonance description is 
evaluated to reveal how an acidic environment might alter its reactivity. We further looked at the 
homolysis and hydrolysis of protonated isomers of CH3SNO2 to predict the changes in RSNO2 
decomposition at low pH. 
3.3. Computational Methods 
Molecular geometries of the reactants, products and transition states (TS) were optimized using 
second-order Møller-Plesset perturbation theory (MP2) 92,93,119,143,144 and the aug-cc-pVTZ 
augmented correlation-consistent basis set. 94 Vibrational analyses were performed to confirm the 
nature of the stationary points (energy minima, TS) and to estimate thermodynamic properties 
under the rigid rotor-harmonic oscillator approximation, 120 while Intrinsic Reaction Coordinate 
(IRC) 121,122 calculations were performed to unambiguously connect the TS to reactants and 
products. Electronic energies were further refined at the Coupled Cluster with Single, Double and 
perturbative linearized Triple excitations [CCSD(T)] 95,96 level of theory. Solvent effects were 
included implicitly with the Polarized Continuum Model (PCM) 97,98 and dielectric constants of 4, 
30 and 78, representative of diethylether, methanol and water as solvents. The Gaussian09 123 
program was used for all calculations. Natural bond orbital (NBO) 145 and natural resonance theory 
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(NRT) 146–148 analyses were carried out using the NBO 5.0 program. 149,150 Wavefunctions for the 
optimized reactants, products, and TS were obtained using the MP2/aug-cc-pVTZ method. 
Bonding interactions were determined from computed electron densities, (r), using the AIMAll 
program 151 within the Quantum Theory of Atoms in Molecules (QTAIM).  152,153 Atomic charges 
were determined using the NBO approach and AIMAll as implemented in Gaussian09. 
3.4. Results 
Our previous investigations into HSNO2, CH3SNO2, t-BuSNO2 and Cys-NO2 indicate that sulfur 
is significantly less positive in HSNO2 compared to RSNO2 (R= Methyl, tert-Butyl, and Cysteine). 
Additionally, the H–S–N angle is 6-12 ° smaller than the R–S–N angle. Thus, CH3SNO2 is a 
minimal model compound to represent E-Cys-NO2 (See Chapter 2).
  
There are three protonation sites in CH3SNO2, the two oxygen atoms (CH3SNO2H
+-1, 
CH3SNO2H
+-2) and the sulfur atom (CH3S(H)NO2
+) (Figure 3.1).  The C-S-NO2 atoms are in the 
same plane in CH3SNO2 (Figure 2.2) and its three-protonated forms. The H-atom in the O-
protonated isomer is also in the same plane, whereas it is out of the plane in the S-protonated 
isomer. We have shown in Chapter 2, that the S–N, N–O1 and N–O2 bond lengths (Table 3.1) of 
CH3SNO2 calculated with MP2/aug-cc-pVTZ are in good agreement with the recently published 
crystal structure of bowl-shaped aromatic thionitrates. 64,124 O-protonation shortens the S–N bond 
to 1.676 Å (CH3SNO2H
+-1) and 1.678 Å (CH3SNO2H
+-2), which is close to the S=N bond length 
of ~1.5 Å,154 whereas S-protonation lengthens the S–N bond to 2.298 Å. The lengthening of the 
S–N bond is consistent with the calculated NBO charges in CH3S(H)NO2+ (Table 3.1), where the 
CH3SH moiety has +0.7 charge, whereas NO2 moiety has +0.3. Thus, it might partially behave as 
a CH3SH
+ and NO2. The charges on the sulfur atom become more positive in the O-protonated 
isomers (+0.690 and +0.678 in CH3SNO2H
+-1 and CH3SNO2H
+-2, respectively), whereas it does 
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not change significantly upon S-protonation (Table 3.1). The changes in S–N bond length and 
charges on the sulfur and nitrogen atoms point towards different reactivities for the protonated 
isomers compared to CH3SNO2. The calculated proton affinities (PA) indicate that O2 
(CH3SNO2H
+-2; PA=180.6 kcal/mol) possess the highest PA than CH3SNO2H
+-1 and 
CH3S(H)NO2
+ (Figure 3.1).  
 
Figure 3.1. Geometries of CH3SNO2 and its protonated isomers. Optimized geometries for protonation of 
oxygen (O1) trans to the carbon atom (CH3SNO2H+-1), oxygen (O2) cis to the carbon atom (CH3SNO2H+-
2) and sulfur (CH3S(H)NO2+) are shown. Geometries were optimized with MP2/aug-cc-pVTZ in the gas 
phase. The proton affinities (PA; kcal/mol) calculated with CCSD(T)//MP2/aug-cc-pVTZ are reported 
under each protonated isomer. 
Table 3.1. Geometric parameters and charge distribution for CH3SNO2 and its protonated isomers a 
 
Bond lengths (Å) Angle (°) Atomic partial charges 
S–N N–O1b N–O2b C–S–N S N O1b O2b 
CH3SNO2 1.776 1.225 1.223 98.87 0.444 0.482 -0.438 -0.448 
CH3SNO2H+-1 1.676 1.339 1.206 97.39 0.690 0.407 -0.447 -0.234 
CH3SNO2H+-2 1.678 1.206 1.341 102.16 0.678 0.408 -0.216 -0.461 
CH3S(H)NO2+ 2.298 1.175 1.176 97.42 0.491 0.743 -0.207 -0.233 
a Geometries are optimized with MP2/aug-cc-pVTZ in the gas phase and partial charges calculated with the Natural 
Bond Orbital (NBO) module as implemented in Gaussian09. 





Figure 3.2. Resonance structures of CH3SNO2, CH3SNO2H+-1, CH3SNO2H+-2 and CH3S(H)NO2+ 
calculated using NBO and NRT analyses with their associated resonance weights in percent. See Figure 
S3.2 for all resonance structures. 
The most stable conformers of the O- and S-protonated isomers have the C–S–NO2 atoms in 
the same plane as CH3SNO2. The activation barrier for rotation around the S–N bond of CH3SNO2 
is 8 kcal/mol (See Chapter 2), which is smaller than the barrier for S–N bond rotation (≥ 10 
kcal/mol) in RSNOs.155 However, it is 13 and 10 kcal/mol for CH3SNO2H
+-1 and CH3SNO2H
+-2, 
respectively (Structure TN3 in Figure S3.1a). The less stable conformers of the O-protonated 
isomers are 4 (TN1) and 7 (TN2) kcal/mol higher in enthalpy than their respective stable 
conformers. The rotation barrier of 10 kcal/mol for the S–N bond of TN1 is expected due to S–N 
bond strengthening upon O-protonation. The high rotation barrier for the O-protonated isomers 
can force nucleophilic attack on the stable conformers but not in TN3. In contrast, the S-protonated 
51 
 
isomer has a very small rotation barrier due to it weak S–N bond. Thus, nucleophilic attack could 
occur in either conformation shown in Figure S3.1b.   
The S–N bond length changes significantly upon O- or S-protonation, influencing the 
resonance between the S–N, N–O1 and N–O2 bonds. NRT analysis of CH3SNO2 reveals three 
major resonance structures (a1, a2 and a3; Figure 3.2) based on the nature of the S–N bond. 
Resonance structure a1 (85% resonance weight) has a single S–N bond, a2 (3% resonance weight) 
with a double S=N bond and a3 (6% resonance weight) with no S----N bond.  Structure a1 is a 
combination of a1-1 and a1-2 resonance structures (Figure S3.2) with a resonance weight of 43% 
and 42%. The resonance structures a1-1 and a1-2 arise from the NBO interaction between the lone 
pair of atom O2 to the π-antibonding orbital of N–O1 (nO2→π*NO1 interaction), giving rise to a 
strong stabilization of 261 kcal/mol that weakens N=O1 (Figure S3.2 and Table 3.2) and promotes 
N=O2 formation. In contrast, a2 (S=N, 3% resonance weight) arises from the nS→π*NO1 
interactions with a stabilization energy of 30 kcal/mol. Similarly, nO1→σ*SN (24 kcal/mol) and 
nO2→σ*SN (29 kcal/mol) interactions weaken the S–N bond by contributing to a3 (S----N bond, 
6% resonance weight) formation. 
CH3SNO2 O-protonation to CH3SNO2H
+-1 and CH3SNO2H
+-2 leads to decreased resonance 
weight for the S–N bond structures with resonance weights of 76% (b1) and 75% (c1) (Figure 3.2), 
respectively from 85% in CH3SNO2. As expected, the resonance weight of the S=N bond increases 
to 14% (b2) and 13% (c2) due to strong stabilization of the nS→π*NO2 (90 kcal/mol, CH3SNO2H+-
1) and nS→π*NO1 interaction (86 kcal/mol, CH3SNO2H+-2) compared to the CH3SNO2 (30 
kcal/mol for nS→π*NO1) (Table 3.2). The increased resonance contribution of the S=N bond agrees 
well with the shorter S–N bond length in CH3SNO2H+-1 and CH3SNO2H+-2 compared to 




+  compared to 13% for CH3SNO.
156 The decreased resonance weight of b3 and c3 to 
3% compared to a3 (6%, CH3SNO2) is due to loss of the nO1→σ*SN and nO1→σ*SN interactions, 
respectively. 
Table 3.2.  Stabilization energies (kcal/mol) for NBO interactions in CH3SNO2, CH3SNO2H+-1, 
CH3SNO2H+-2, and CH3S(H)NO2+ a  
NBO interactions CH3SNO2 CH3SNO2H+-1 CH3SNO2H+-2 CH3S(H)NO2+ 
n(O1)      → σ*(S–N) 24 - 21 126 
n(O2)      → σ*(S–N) 29 23 - 135 
n(O2)      → σ*(N–O1) 28 40 09 23 
σ(S–N)    → σ*(N–O1) 02 01 - 05 
n(O2)      → π*(N–O1) 261 - 57 281 
n(S)         → π*(N–O1) 30 - 86 - 
n(O1)      → σ*(N–O2) 29 10 42 24 
n(S)         → σ*(N–O2) 04 08 06 - 
σ(S–N)    → σ*(N–O2) 01 - 01 05 
n(O1)      → π*(N–O2) - 58 - - 
n(S)         → π*(N–O2) - 90 - - 
a NBO interactions are calculated by NRT analysis on geometries optimized with MP2/aug-cc-pVTZ.  
 
The resonance structure with a S–N bond (d1) decreases to 44% in CH3S(H)NO2+ from 85% 
(a1) in CH3SNO2. Whereas, the resonance structure with no S----N bond (d3) increases to 42% 
from 6% (a3) in CH3SNO2 due to strong stabilization of NBO interactions like nO1→σ*SN (126 
kcal/mol) and nO2→σ*SN (135 kcal/mol). Similarly, the resonance contribution for S----N increases 
for CH3S(H)NO
+ (51%) compared to CH3SNO (10%).
156 The dramatic increase in the resonance 
weight of d3 and a lack of resonance structures with S=N bond are consistent with the large S–N 
bond length in CH3S(H)NO2
+.  
An analysis of the topology of the electron density of CH3SNO2 and its protonated isomers 
(Figure S3.3) supports the NBO findings. While the calculated QTAIM charges vary from the 
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NBO charges, they maintain a similar trend (Table 3.1 and Table 3.3). Upon O-protonation, the 
partial positive charge on the sulfur atom increases (i.e., this atom becomes more positive) by 
+0.430 and +0.423 for CH3SNO2H
+-1 and CH3SNO2H
+-2, respectively, with no significant 
changes observed upon S-protonation (Table S3.1). 
Table 3.3. Electronic properties including electron density (S-N, e∙Å–3), bond ellipticity (S-N), atomic partial 
charges (q, au) at the S-N bond critical point of CH3SNO2 and its protonated isomers a, b 
 Electronic properties 
S-N c S-N d qS qN 
CH3SNO2 1.238 0.471 0.372 0.418 
CH3SNO2H+-1 1.357 0.955 0.802 0.181 
CH3SNO2H+-2 1.345 1.000 0.795 0.185 
CH3S(H)NO2+ 0.480 0.111 0.346 0.753 
a See Figure 3.1 for structures. 
b Values are calculated with MP2/aug-cc-pVTZ using QTAIM. 
c Electron density at the SN bond critical point (S-N).  
d Bond ellipticity at the S–N bond (S-N). 
 
Table 3.4. Activation barriers (kcal/mol) for homolysis and hydrolysis of the protonated isomers of 
CH3SNO2 a  
 Homolytic cleavage of S–N bond Hydrolysis of 
CH3SNO2H+-2 CH3SNO2H+-1 CH3SNO2H+-2 CH3S(H)NO2+ 
Gas phase 91.1 88.7 29.6 29.9 
PCM Ɛ=4 73.1 71.1 24.3 – 
PCM Ɛ=30 69.7 67.8 23.1 – 
PCM Ɛ=78.4 69.3 67.4 23.0 38.3, 38.7b 
Gas phase 92.5c 90.1c 29.8c – 
a Activation barriers calculated with CCSD(T)//MP2/aug-cc-pVTZ (except where indicated) for the gas-phase 
geometries and solvent effects are included with PCM model and dielectric constants (ε) listed.   
b Activation barrier calculated with CCSD(T)//MP/aug-cc-pVTZ(PCM-water). 
c Activation barriers calculated with CCSD(T)/aug-cc-pVQZ//MP2/aug-cc-pVTZ in the gas phase. 
 
As previously indicated, S-protonation weakens the S–N bond. This can be confirmed through 
electron density ( as there is a known power law relationship between  and bond length. 
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Therefore,  provides a measure of the bond strength.157,158 As expected, the short S–N bond upon 
O-protonation (Table 3.1) results in an increase in electron density at the S-N bond critical point 
(S-N) of 0.119 e·Å–3 and 0.107 e·Å–3 for CH3SNO2H+-1 and CH3SNO2H+-2, respectively. In 
contrast, the longer S–N bond upon S-protonation yields a lower S-N of 0.480 e·Å–3 (Table S3.2). 
As later discussed, S-protonation sees a lowering of the activation energy for S–N cleavage (Table 
3.4), which can be represented in a lowering of S-N. 
Further electronic details can be obtained by examining the Hessian of . The ellipticity at the 
bond critical point (BCP), as denoted through the following equation BCP= [1/2 – 1], provides a 
measure of the accumulation of in a given plane where 1 and 2 represent the negative curvature 
along the interatomic surface,152 which indicates whether bonding has  or character (single 
or double bond). As such, it provides valuable insight into validating the -character found from 
the NBO calculations and resonance weights from the NRT results. S-N values close to zero 
indicate a more cylindrical bond (single or triple bond character) and values close to one indicate 
a more elliptical bond (double bond character).  CH3SNO2, with a large S-N single bond resonance 
contribution (85%), has a S-N of 0.471 (Table 3.3 and Table S3.2) which still captures the small 
S=N double bond resonance (as S-N is not 0). Upon O-protonation, S-N increases to 0.955 and 
1.000 (CH3SNO2H
+-1 and -2, respectively) which is in line with the increase in the weighted 
resonance of S=N (Figure 3.2), although to varying degrees. Upon S-protonation, the double S=N 
bond resonance is lost and a significant decrease in bond ellipticity is observed (S-N: 0.111).    
Homolytic S–N bond cleavage of CH3SNO2H+-1 and CH3SNO2H+-2 to give CH3S• and 
•HONO+ has an activation barrier (H‡calc) of 91.1 and 88.7 kcal/mol in the gas phase, respectively 
(Table 3.4). Further refinement of energies with quadruple zeta basis sets (aug-cc-pVQZ) changes 
H‡calc by only ~1 kcal/mol, indicating that the energies are converged in the triple zeta basis sets. 
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The H‡calc values change significantly upon the implicit inclusion of solvent effects. In fact, the 
H‡calc values decrease dramatically upon an increase in solvent polarity. This could be due to the 
stabilization of the ionic forms of the reactants, since we have shown for CH3SNO2 (Chapter 2). 
In Chapter 2, we have also observed that the inclusion of solvent effects with the gas-phase 
optimized geometries provides energetics close to those obtained with PCM-water optimized 
geometries (Figure 2.6, 2.7, and S2.3) . The gas-phase H‡calc value for S–N bond homolytic 
cleavage in CH3S(H)NO2
+ to CH3SH
+• and •NO2 is 29.6 kcal/mol. The inclusion of solvent effects 
similarly affects the S-N bond homolytic cleavage in the CH3SNO2H
+ isomers. Overall, CH3SNO2 
O- and S-protonation increases and decrease the activation barrier for S–N bond homolysis, 
respectively, which correlates well with the S–N bond length in the protonated isomers.   
 
Figure 3.3. Reaction profile for hydrolysis of CH3SNO2H+-2. Geometries were optimized with MP2/aug-
cc-pVTZ(PCM-water). The relative enthalpies reported at each stationary point are calculated with 




Scheme 1. Hydrolysis of CH3SNO2H+-2. 
The H‡calc for heterolytic cleavage of CH3S(H)NO2+ to CH3SH + NO2+ is 29.4 kcal/mol in 
the gas phase and 12.3 kcal/mol with implicit inclusion of solvent using PCM-water due to better 
solvent stabilization of NO2
+ compared to CH3S(H)NO2
+ (ΔGsolv,calc = -71.6 vs. -57.0 kcal/mol). 
Thus, heterolytic cleavage of CH3S(H)NO2
+ is energetically more favorable compared to 
homolytic cleavage. The H‡calc for heterolytic cleavage of CH3S(H)NO2+ to CH3SH2+ + NO2– is 
>100 kcal/mol, rendering it to be highly unfavorable. 
Scheme 1 represents the pathway for hydrolysis of CH3SNO2H
+-2. The reaction profile in the 
gas-phase indicates that the TS is not connected to the correct reactants and products due to the 
ionic reactant (OH–) (data not shown). A similar trend is observed in our previous study of 
thionitrate decomposition (Chapter 2, Figure S2.3). Thus, we calculated the reaction profile with 
the implicit inclusion of solvent effects using PCM-water. The reaction profile for the bottom 
attack of water on the sulfur atom (TS1) is characterized by pre- and post-reaction complexes, 
which are 1-5 kcal/mol more stable than the reactants and products, respectively. The TS1 exhibits 
an elongated S–N bond (2.10 Å) as well as initialization of S–O(water) bond formation (2.33 Å) 
(Figure 3.3), indicative of the precursor for the formation of the desired products (CH3SOH + NO
+-
H2O). The reaction is exothermic by ~10 kcal/mol and H‡calc is large at 38.7 kcal/mol (Figure 3.3 
& Table 3.2). Overall, hydrolysis of CH3SNO2H










+ NO+ + H2O
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molecule but additional water molecules could lower the activation barrier as shown in Chapter 2 
for CH3SNO2. 
3.5. Discussion 
O-protonation of CH3SNO2 at O2 (CH3SNO2H
+, 180.6 kcal/mol) leads to a strong S–N bond. 
The O2 atom of CH3SNO2 possesses the highest PA, which is slightly smaller than the PA of the 
O-atom of CH3SNO (185.8 kcal/mol). By contrast, the S-protonation weakens the S–N bond and 
the S-atom has the highest PA in CH3SNO (186.1 kcal/mol) 
127 and the smallest in CH3SNO2 
(166.4 kcal/mol). This properties correlate well with the observed the increase in CH3SNO
127 
decomposition and the increased stability of CH3SNO2 
64 in acidic aqueous environments.  
We are interested in the decomposition of Cys-NO2 formed at the catalytic Cys152 of GAPDH. 
Active-site His179 is protonated in glycolytically active form of GAPDH. Neutral histidine has a 
higher PA (~238 kcal/mol)159 than the O-atom of CH3SNO2. Thus, E-Cys152-NO2 in the GAPDH 
active-site might not extract a proton from His179. However, steric constraints in the active-site 
could force interaction between Cys152-NO2 and protonated His179, which could 
stabilize/destabilize the thionitrate depending on whether the interaction occurs at the Cys152-NO2 
S or O atoms. We have proposed that the slow turnover of glyceryl trinitrate (GTN) by GAPDH 
(2.6 nmol min–1 mg–1) 48 compared to ALDH2 (38 nmol min–1 mg–1) 160 to be the lack of additional 
cysteine residues (Cys301 and Cys303 in ALDH2) to catalyze E-Cys-NO2 (Cys152-NO2 in 
GAPDH, Cys302-NO2 in ALDH2). Although both proteins contain a glutamic residue (Glu317 in 
GAPDH, Glu268 in ALDH2) to catalyze E-Cys-NO2 hydrolysis (Figure 2.8). Our current study 
reveals that protonated His179 may stabilize E-Cys-NO2 in the GAPDH active-site and slowdown 
GTN decomposition by GAPDH.     
58 
 
The increased contribution of resonance structures with S=N (structures b2 and c2, Figure 3.2) 
to 13 % upon O-protonation (Figure 3.2) leads to a strong S–N bond, which increases H‡calc for 
homolytic cleavage in both CH3SNO2H
+-1 and CH3SNO2H
+-2 (~90 kcal/mol, Table 3.2) 
compared to CH3SNO2 (~44 kcal/mol) (Chapter 2). This could explain the reported high stability 
of GSNO2 in ESI–MS if GSNO2H+ forms in the ESI 118 since CH3S(H)NO2+ does not have a 
resonance structure with S=N and the contribution to resonance structure with no S-N bond 
increases significantly (42% resonance weight). Thus, the S–N bond is elongated and enthalpy of 
homolytic cleavage is very small (~29 kcal/mol, Table 3.2).  
Hydrolysis of CH3SNO2H
+-2 by one water molecule has a H‡calc (38.7 kcal/mol) that is 10 
kcal/mol smaller than the hydrolysis of CH3SNO2 by one water molecule (H‡calc ~47 kcal/mol). 
The decrease in H‡calc for CH3SNO2H+-2 hydrolysis is due to the increase in S=N resonance 
contribution, which makes the S atom more positive (Table 3.1) and favors nucleophilic attack on 
this atom. Nonetheless, H‡calc (38.7 kcal/mol) remains high but the addition of more water 
molecules might decrease this barrier as seen for hydrolysis of CH3SNO2 (Table 2.3). The 
resonance structure d1 with a single S–N bond contributes to the positive charge on the N atom of 
CH3S(H)NO2
+, which could favor the nucleophilic attacks at N atom in CH3S(H)NO2
+ compared 
to CH3SNO2. Also, protonation favors nucleophilic attack at S atom due to increase in positive 
chare at this atom. 
3.6. Conclusions 
We conclude that thionitrates (RSNO2) can be represented by three major resonance structures. 
These resonance structures predict and rationalize RSNO2 reactivity in different chemical 
environments. O–protonation of CH3SNO2 to CH3SNO2H+ increases the stability of S–N bond, 
whereas S–protonation to CH3S(H)NO2+ decreases its stability. Additionally, O-protonation and 
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S-protonation increase the positive charge of the S and N atoms, respectively, leading to increased 
reactivity towards nucleophiles. 
3.7. Supporting Information 
 
Figure S3.1. Geometries of conformers of (a) O- and (b) S-protonated CH3SNO2. See captions to Figure 
3.1 of the main text for details. The values in parentheses represent ΔHcalc (H‡calc for TS) in kcal/mol 




Figure S3.2. Resonance structures of CH3SNO2, CH3SNO2H+-1, CH3SNO2H+-2 and CH3S(H)NO2+ with 






Figure S3.3. Molecular graphs of CH3SNO2, CH3SNO2H+-1, CH3SNO2H+-2 and CH3S(H)NO2+. The 
molecular graphs are calculated using AIMAll from MP2/aug-cc-pVTZ optimized geometries. Atoms are 
represented by large spheres: carbon (grey), hydrogen (white), oxygen (red) and nitrogen (blue). Bond 




Table S3.1. QTAIM Atomic partial charges in model systems a, b 
 Atomic partial charges 
qS qN qO1c qO2c 
CH3SNO2 0.372 0.418 -0.432 -0.440 
CH3SNO2H+-1 0.802 0.181 -0.643 -0.293 
TN1 0.694 0.232 -0.626 -0.256 
CH3SNO2H+-2 0.795 0.185 -0.277 -0.655 
TN2 0.733 0.258 -0.236 -0.627 
TN3 0.521 0.405 -0.235 -0.613 
CH3S(H)NO2+ 0.346 0.753 -0.186 -0.203 
TN5 0.329 0.761 -0.184 -0.194 
a See Figure 3.1 and S3.1 for structures.  b Values calculated with MP2/aug-cc-pVTZ using QTAIM. 
c See Figure 3.1 for the definition of O1 and O2.    
Table S3.2. Electronic properties (electron density [BCP, e∙Å–3], bond ellipticity [BCP]) at the bond critical 
point of selected bonds in model systems a, b 
 Bonding 
Electronic properties 
BCP c BCP c 
CH3SNO2 S-N 1.238 0.471 
CH3SNO2H+-1 S-N 1.357 0.955 
 O1-H 2.271  
 N-O1 2.554  
TN1 S-N 1.321 0.968 
 O1-H 2.308  
 N-O1 2.544  
CH3SNO2H+-2 S-N 1.345 0.999 
 O2-H 2.264  
N-O2 2.534  
TN2 S-N 1.295 1.064 
O2-H 2.330  
N-O2 2.557  
TN3 S-N 1.097 0.564 
O-H 2.245  
N-O 2.706  
CH3S(H)NO2+ S-N 0.480 0.111 
TN5 S-N 0.472 0.074 
a See Figure 3.1 and S3.1 for structures. 
b Values are calculated with MP2/aug-cc-pVTZ using QTAIM. 















Chapter 4. NAD Cofactor Binding Alters the Dynamics of Human 
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) as Revealed by 























Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a well-known homotetrameric 
glycolytic enzyme. Each GAPDH subunit binds a nicotinamide adenine dinucleotide (NAD) 
cofactor. The cofactor in the oxidized (NAD+) and reduced form (NADH) exhibits different 
binding affinity but binds with negative cooperativity. Removal of cofactor has been shown to 
affect the structure of the tetramer. Thus, we carried out molecular dynamics simulations of three 
forms of the tetramer GAPDH with NAD+ (GAPDH-NAD+) or NADH (GAPDH-NADH) and 
apo-GAPDH to investigate the effect of cofactor on tetramer dynamics. We show that the NAD-
binding domains (NBDs) are more flexible and the adenine binding groove is open in apo-GAPDH 
compared to GAPDH-NAD+ and GAPDH-NADH.  Principal component analysis (PCA) of MD 
trajectories and normal mode analysis (NMA) of the crystal structure of GAPDH reveal an 
asymmetry in tetramer due to motions of the NBDs interacting across the R-axis, which is 
influenced by the S-loop. We show that interaction across the R-axis is important for negative 
cooperativity and explains how NAD+ binds with negative cooperativity to GAPDH. We also show 
that GAPDH tetramer behaves as a dimer of OP and QR dimers. We also show that the reactivity 
of the catalytic Cys152 is influenced by NAD+ binding. Overall, our findings shed light on the 




Mammalian glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a homotetrameric 
enzyme composed of four 37-kDa subunits, O, P, Q, and R. Each subunit has a nicotinamide 
adenine dinucleotide (NAD) binding domain (NBD; residues 1-151 and 315-335) and a catalytic 
domain (CTD; residues 152-314) (Figure 4.1). Binding of the oxidized cofactor, NAD+, promotes 
GAPDH tetramer formation,71 but exhibits negative cooperativity such that the binding of the first 
NAD+ (K1 = 1.4 × 10
–10 M) is followed by progressively weaker binding for the second (K2 = 3.8 
× 10–9 M), third (K3 = 1.0 × 10
–7 M) and fourth (K4 = 2.8 × 10
–6  M) cofactor.68,69 The reduced 
cofactor, NADH, also binds to GAPDH with negative cooperativity but it binds less tightly (i.e., 
K1,2 < 5.0 × 10
–7; K3 = 2.5 × 10
–6 M and K4 5.0 × 10
–5 M) than NAD+,70 and destabilizes the 
tetramer.72,73 However, oxidation of the catalytic cysteine residue presumably to the 
sulfenic/sulfinic acid weakens GAPDH’s affinity for NAD+ (K1,2,3,4 = 6.4 × 10-5 M) and 
cooperativity is lost.90 In contrast, NADH (K3 = 3.0 × 10
-8 and K4=7.0 × 10
-6 M)  has higher affinity 
than NAD+ for oxidized GAPDH.90 Changes in the affinity of oxidized vs. reduced GAPDH for 
NAD (NAD+ or NADH) are associated with conformational differences in the NBD on oxidation 
of catalytic Cys152.90  
Cofactor removal gives apo-GAPDH, which for the yeast protein has ~ 7 % higher volume due 
to increased internal solvation compared to GAPDH with bound NAD+ (GAPDH-NAD+). This 
signals instability in apo-GAPDH,161 which as demonstrated for  rabbit muscle GAPDH has 
increased tendency to dissociate to the monomer and undergo slow aggregation.71 The interactions 
between the O:R and P:Q subunits across the R-axis (Figure 4.1a) are weakened, and the S-loops 
(residues 181-205), 162,163 which partly cover the active-site and cofactor binding site (Figure 
4.1b,c), are disordered for the apo form of Cryptosporidium parvum and Group B Streptococcus 
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protein. The NBD is rotated by 4.8 ° relative to the CTD and the residues that bind NAD+ are more 
flexible in apo-GAPDH of Palinurus versicolor and Bacillus stearothermophilus.67,164 The crystal 
structure of GAPDH-NAD+ from Kluyveromyces marxianus (radius of gyration 33.5 Å) is more 
compact than its apo-GAPDH (radius of gyration 34.6 Å).165 This is consistent with reports that 
NAD+ binding promotes tetramer formation.71   
No computational studies on human GAPDH focus on the effect of NAD+ or NADH binding 
on the dynamics of its sub-domains (NBDs and CTDs). However, molecular dynamics (MD) 
simulations evaluated changes in tetrameric Trypanosoma cruzi GAPDH after adding NAD+ to 
the crystal structure of apo-GAPDH.166 NAD+ binding switches the apo-GAPDH tetramer to a 
closed conformation as monitored in this study by a decrease in the angle defined by the Cα atoms 
(T. cruzi residue numbering) of Gln91 (close to the adenine moiety), Glu336 (close to the 
nicotinamide ring) and Ser207 (middle of the S-loop).166 This angle defines the movement of the 
S-loop towards and away from the NBD. The simulations also show that the NBD is more flexible 
than the CTD and a single NAD+ fluctuates away from its binding site during 50 ns without causing 
noticeable changes in the dynamics of this subunit.166 It is important to note that this simulation 
reports a single 50 ns MD simulation, without commenting on the reproducibility of the results. 
The goal of this study is to investigate for the human enzyme cofactor-dependent subunit and 
subdomain (NBD and CTD) dynamics of the apo-GAPDH tetramer and the tetramer with NAD+ 
(GAPDH-NAD+) and NADH (GAPDH-NADH) bound. The only MD simulations of human 
GAPDH-NAD+ focused on the active-site, in particular, the oxidation sensitivity of the catalytic 
Cys152. This study implicated Cys156 in controlling Cys152 oxidation indirectly by stabilizing 
H-bond donation from Tyr314 to Thr153, which is close to Cys152.167 Importantly, Thr153 
activates H2O2 for an attack on Cys152. Since the oxidation sensitivity of Cys152 is critical in 
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GAPDH activity, we examine here how NAD binding influences the relative orientations of 
Cys152, Cys156, Thr153, and Tyr314. Protozoan GAPDH has been proposed as a target to treat 
protozoan born disease due to the selectivity of human GAPDH vs. Trypanosomatid GAPDHs.34–
36,40,168 We thus compared the dynamics of a region that provides selectivity in human GAPDH 
with respect to inhibition of Trypanosomatid GAPDHs. 
4.2.1. Overview of GAPDH structure  
The GAPDH homotetramer contains subunit-O, -P, -Q and -R, which interact across the P-, Q- 
and R-axes as shown in Figure 4.1a-b. It has been proposed that the GAPDH homotetramer 
behaves as a dimer of dimers,31,105 where dimers OP and QR (Figure 4.1b)  located across the Q-
axis act as two semi-independent dimers. Note that most inter-subunit interactions occur across 
the P-axis, between O:P and Q:R. There are also numerous interactions across the R-axis but much 
less across the Q-axis.2 Each subunit has an NBD, a CTD, and an S-loop, which is at the tetramer 
interface (Figure 4.1b) and covers the dehydrogenase active-site and the nicotinamide binding of 
the cofactor. This moiety binds close to the catalytic Cys152, which is partially solvent exposed. 
The deprotonated Cys152 and protonated His179 are stabilized by a strong H-bond interaction 
(Figure 4.1c). Cys156 on the same helix as Cys152 is buried inside the protein matrix, which 











Figure 4.1. Structure of human GAPDH (PBD 1U8F). (a-b) The secondary structure of the GAPDH 
tetramer indicating the molecular axes defined relative to subunit-O. Subunit-P, -Q and -R interact with 
subunit-O across the P-, Q- and R-axis, respectively. There is a decreasing number of contacts across these 
axes in the order of P > R > Q. Note that the tetramer is a dimer of OP (blue) and QR (green) dimers with 
subunits interacting across the P-axis in each dimer. The cofactor NAD+ of each subunit is shown as 
magenta sticks. (c) Subunit-O showing the NAD-binding domain (NBD; residues 1-151 and 315-335; 
cyan), catalytic domain (CTD; residues 152-314; grey) and the S-loop (residues 181-205; orange), which 
covers the active-site as well as the nicotinamide moiety of NAD+. Inset: active-site residues Cys152, 




4.2.2. NAD cofactor - polypeptide interactions in GAPDH  
From the coordinates of human GAPDH (PDB 1U8F), we generated a 2D ligand plot using the 
Ligand Interaction Diagram module in Schrödinger Maestro 11.1 (Maestro, Schrödinger, LLC, 
New York, NY, 2017) to visualize the interactions of NAD+ with its binding site (Figure 4.2). The 
NAD+ molecule can be divided into three parts, the adenosine ribose group (away from the active-
site), the phosphate groups (at the center), and nicotinamide ribose group (close to the active-site). 
It has been previously proposed that adenine moiety binds first to initiate the folding of the NBD 
and then the nicotinamide moiety binds to complete the folding of GAPDH.2  
The adenine ring is buried in a hydrophobic pocket forming T-shaped π-π interactions with 
Phe37 and Phe102 on the other side of the adenine ring. The amino group of the adenosine points 
toward the protein matrix (Figure S4.1) and forms H-bond interaction with the backbone carbonyl 
of Arg80. The two hydroxyls of the adenosine ribose are directed towards the protein matrix and 
donate H-bonds to Asp35. The peptide N atoms of Arg13 and Ile14 donate H-bonds to the 
phosphate groups. The hydroxyl group of Ser122 donates a H-bond to the O atom of the ribose 
ring of the nicotinamide ribose.  
The nicotinamide ring sits in a hydrophobic pocket but the nicotinamide ribose group is more 
exposed to the solvent. The nicotinamide amide points toward a polar groove and accepts an H-
bond from Asn316. The cation- interaction between N+ of NAD and Tyr320 at a distance of 5.6 
Å and its ionic interaction with the catalytic Cys152 thiolate at 5.6 Å holds the nicotinamide in 
place. Also, an indirect H-bond to the Glu317 via a bridged water molecule further stabilizes 
nicotinamide moiety at the active-site. The nicotinamide ribose ring forms an H-bond with Ser122 
while its two hydroxyl groups point toward solvent. In contrast, adenine ribose ring points toward 
protein matrix with the hydroxyl groups forming H-bonds with Asp35. Similar to the ribose 
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groups, the phosphate groups are partly solvent exposed and stabilized by H-bond interaction with 
Arg13 and Ile14. Overall, NAD+ forms 11 H-bond interactions with water molecules and the NAD-
binding site is partially open with solvent-exposed phosphate groups and ribose rings. 
 
Figure 4.2. Interaction map of NAD+ binding human GAPDH (PDB 1U8F). All possible interactions 
showing H-bond, cation-π, π-π, hydrophobic, polar interactions of NAD+ with GAPDH. Thick and thin 
magenta lines indicate the interaction of NAD+ with polypeptide (7 interactions) and water molecules (11 
interactions), respectively. The distance (green dotted line) between S atom of Cys152 and positively 
charged N atom of NAD+ is shown to highlight the ionic interaction between these two atoms. The 3D 
structural image of the NAD+ interactions is shown in Figure S4.1 of the SI. 
4.3. Computational Methods 
4.3.1. Normal mode analysis (NMA) using the anisotropic network model (ANM) 
NMA is an efficient method to predict large-scale motions of subdomains of a protein. NMA 
decomposes the global dynamics of a protein into a collection of normal modes corresponding to 
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large motions of its subdomains. NMA was performed to visualize the backbone dynamics of 
NBD, CTD and the S-loop of human GAPDH. We focus on a few low frequencies/large amplitude 
modes that are expected to be relevant to function and remove random high-frequency 
modes.169,170 We used the backbone atoms (C, Cα, N, O) and NAD+ of the crystal structure of the 
human GAPDH tetramer (PBD 1U8F) after adding the coordinates of a fourth NAD+ in subunit-
O, which is in the apo-form in the crystal. 105   
NMA was performed using the ANM102–104 of ProDy171. In ANM, the backbone atoms (i.e., 
nodes) within a cut-off distance of rc are connected by elastic springs with a force constant 𝛾 and 









Here, M is the number of springs, (𝑅𝑖𝑗 − 𝑅𝑖𝑗
0 ) the distance between nodes 𝑖 and 𝑗 with respect 
to the crystal structure, and 𝑖𝑗 is the element of the Kirchhoff matrix corresponding to the inter-
residue contact between nodes 𝑖 and 𝑗. The second derivative of V generates a 3N x 3N Hessian 
Matrix H, which is decomposed in 3N-6 nonzero λ𝑖 eigenvalues and their corresponding 
eigenvectors μ𝑖.171 The modes defined by the lowest frequencies describe functionally relevant 
motions of the protein and are analyzed here.170,172 
4.3.2. Molecular dynamics (MD) simulations 
All-atom MD simulations describe the motions and conformations of a system at the atomic 
level. MD simulations of a protein allow us to visualize the motions of residues that are sensitive 
to binding of a molecule (i.e. cofactor), the quaternary/tertiary structural changes, the motions of 
ions/water molecules and the stability of subdomains. We investigated the effect of cofactor on 
motions of subdomain and residues within the cofactor binding site and the active-site using MD 
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simulations. In the crystal structure of human GAPDH (PBD 1U8F), subunit-O is in the apo form 
105 so we superimposed subunit-P on subunit-O to copy the NAD+ coordinates to the latter. We 
replaced NAD+ with NADH by adding a hydride (H–) to the positively charged N-atom of the 
nicotinamide moiety of each NAD+ and apo-GAPDH was generated by removing the three NAD+ 
from the crystal structure. The protonation states of the residue sidechains were assigned using 
PROPKA173 and we manually deprotonated Cys152 and protonated His179 to form a strong H-
bond interaction between these residues. Cys152 has pKa of 6.03 88 in GAPDH-NAD+  and we 
retained the Cys152-His179 H-bond interaction in GAPDH-NADH and apo-GAPDH.  
The three forms of GAPDH were hydrated in a 10 Å-layer of TIP3P water from the protein 
boundary and 0.15 M Na+ and Cl– ions were added to represent physiological conditions. MD 
simulations were performed using the CHARMM27 106,174 force field and NAMD2.9 99 program. 
The system was subjected to 20,000 steps of conjugate gradient minimization and 1 ns of 
equilibration before production runs of 100 ns were carried out. Simulations were performed in 
the NPT ensemble at 300 K and 1 atm using Langevin dynamics and the time step was set to 2 fs. 
Five independent simulations of 100 ns (5 x 100 ns) were run for each form of GAPDH and the 
results were analyzed using VMD 175. Good-Turing statistical analysis was carried out to analyze 
the convergence of the MD simulations trajectories.176  
4.3.3. Principal component analysis (PCA) 
Unlike NMA, the MD trajectories include nonharmonic movements of the residues and generate 
accessible conformational ensembles. However, the motions are highly multidimensional and 
include a large number of degrees of freedom. Multivariate statistical analysis such as PCA reduces 
the dimensionality of the data and extracts dominant motions from the MD trajectories.177  
72 
 
To carry out PCA, based on the Cα coordinates from the MD trajectories, the covariance matrix 
C is constructed:  
C =  (R −  R)(R −  R)T 
R is the 3N-dimensional configurational vector composed of instantaneous Cα coordinates of the 
N residues of the protein and R is the average position over the trajectory. C is a 3N x 3N 
symmetric matrix that is diagonalized by orthogonal coordinate transformation T. The principal 
components (PCs) are derived from the eigenvalue decomposition of C:  





Here p𝑖 is the 𝑖th PC (or eigenvector) and 𝑖 is the corresponding eigenvalue of matrix C.  The PCs 
are ordered in descending order with respect to 𝑖. The 𝑖 scale with the magnitude of the motion 
along p𝑖.100,101 Thus, PC1 (p1) and its variance 1 define the shape and size of the dominant 
motions of the Cα atoms of the protein over 5 x 100 ns MD trajectories in our analysis. 
Visualization of the PCA and ANM results were carried out using the Normal Mode Wizard 
(NMWiz)171 of VMD. 
4.4. Results 
4.4.1. Convergence of the MD trajectories of GAPDH-NAD+, GAPDH-NADH and apo-
GAPDH 
We carried out all-atom MD simulations of the three forms of GAPDH over 100 ns. Five replicates 
were obtained for each form of GAPDH. The convergence of each 100 ns MD simulations 
trajectories was evaluated using Good-Turing statistical analysis (Figure S4.2a). This approach 
reveals that the trajectories are converged after 50 ns. Also, the root-mean-square deviation 
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(RMSD) of the fluctuation of all Cα atoms from their reference crystal structure at each time point 
over 100 ns MD trajectories does not change significantly for each GAPDH form. Thus, the MD 
simulations are stable over 100 ns for the three forms of GAPDH (Figure S4.2b) so we used 100 
ns MD simulations for further analysis. 
Root mean square fluctuation (RMSF) of the Cα atoms from their reference crystal structure 
over a concatenated 5 x 100 ns MD trajectory reveals increasing subunit flexibility going from 
GAPDH-NAD+ to GAPDH-NADH to apo-GAPDH (Figure 4.3). The atoms in the NBD and the 
S-loop are more flexible compared to those in the CTDs for the three forms of GAPDH. However, 
the subunits of GAPDH-NADH and apo-GAPDH show more variation than those of GAPDH-
NAD+. In contrast, the dynamics of the CTD are largely insensitive NAD+ or NADH binding. 
 
Figure 4.3. Root mean square fluctuations (RMSF) of the Cα atoms of (a) GAPDH-NAD+, (b) GAPDH-
NADH and (c) apo-GAPDH. RMSFs were calculated using a concatenated 5 x 100 ns MD trajectories. 
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4.4.2. Cross-correlation analysis (CCA) of Cα atoms of GAPDH from the MD simulations  
CCA indicates whether the motions between two atoms are correlated, anticorrelated or 
noncorrelated. Thus, CCA shows how atoms move with respect to each other, highlighting the 
global motions of a protein. Correlated and anticorrelated motions reveal residues that move at the 
same time in the same and opposite directions, respectively. We carried out CCA using the MD 
trajectories and found no significant differences in the cross-correlated motions between GAPDH-
NAD+ and GAPDH-NADH (Figure 4.4a and Figure S4.3). However, the highly anticorrelated 
motions between subunits in GAPDH-NAD are clearly absent in apo-GAPDH (Figure 4.4b), This 
indicates that subunit motions in apo-GAPDH are not concerted motions and that concerted inter-
subunit dynamics are lost on NAD removal.  
Looking closely at the cross-correlated motions in GAPDH-NAD+ reveals that subdomain 
NBDO exhibit highly anticorrelated motions with subdomain CTDP located across the P-axis 
(Figure 4.4a). Similarly, the NBD and CTD of subunits interacting across the P-axis and Q-axis 
show anticorrelated motions but noncorrelated motions between the NBDs of these subunits. 
However, there are anticorrelated motions between NBDO and NBDR interacting across R-axis, 
which indicates the NBDs move away from each other. Similar anticorrelated motions are also 
observed for NBDP and NBDQ of interacting across R-axis. The inter- and intra-subdomain 
motions between and within NBD and CTD of each subunit can be examined by inspection of the 
four squares at the diagonal. The bottom and top corner of the square at the diagonal represents 
the NBD and the CTD, respectively (Figure 4.4a). There are mostly noncorrelated motions 





Figure 4.4. CCA of the Cα atoms of (a) GAPDH-NAD+ and (b) apo-GAPDH. CCA is carried out using the 
Cα atoms of concatenated 5 x 100 ns MD simulations trajectories. Each square represents a subunit and the 
diagonals show the correlated motions of each Cα atom with itself. The blue, green and orange lines at the 
axes indicate NBD, CTD and S-loop of each subunit, respectively. Note that similar cross-correlated 
motions are seen for GAPDH-NAD+ and GAPDH-NADH (See Figure S4.3). 
4.4.3. CCA of the motions of NAD+ and backbone atoms from the NMA of the crystal 
structure of GAPDH-NAD+  
A significant amount of information about dynamics, allostery, and mechanism can be extracted 
from protein crystal structures using NMA, which allows the global motions of a protein to be 
extracted from changes in the x-ray coordinates by applying harmonic forces.172 However, NMA, 
unlike MD simulations, does not include anharmonic fluctuations and is computationally less 
expensive. CCA analysis based on the results of NMA will give us an overview of how large or 
global motions of the backbone atoms of a subunit influence the motions of another subunit. CCA 
of the GAPDH-NAD+ crystal structure calculated from NMA (Figure S4.4a) reveals similar cross-
correlated motions between subdomains (NBD and CTD) as shown by CCA of the MD simulations 
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trajectories (Figure 4.4a). This confirms that the 5 x 100 ns MD simulations capture most of the 
global motions of the subunits. 
Cofactor NAD+ is essential for the dehydrogenase activity of GAPDH. Thus, we also 
visualized cross-correlated motions of NAD+ with the backbone atoms of the protein (Figure S4.4 
and Figure 4.5). The motions of NAD+ are highly correlated with the backbone atoms of its own 
NBD and weakly correlated with its own CTD (Figure S4.4b). We note that NAD+O and NAD
+
R 
exhibit highly anticorrelated motions with NBDs interacting across the R-axis, as shown in Figure 
4.5a. In contrast, NAD+P and NAD
+
Q bound to the less flexible NBDs show less correlated and 
anticorrelated motions within their own subunit and subunits interacting across the R-axis (Figure 
4.5b and S4b-f). Here again, there is less cross-correlation between NBD backbone motions and 
NAD+ bound in the more flexible NBDs. Additionally, motions of NBDs interacting across the P- 
and Q-axes are noncorrelated with motions of NAD+ in the opposite subunits (Figure S4.4b-f).  
Overall, the motions of NAD+ are weakly correlated with the CTD of its own subunit and non-
correlated with the CTDs of other subunits (Figure 4.5a,b and Figure S4.4b-f). However, 
exceptions are the highly anticorrelated motions of NAD+O with residues 153-173 and 213-229 of 





Figure 4.5. Cross-correlation analysis (CCA) of protein backbone atoms (N, Cα, C, O) with NAD+ 
calculated using NMA. Correlated (red tube) and anticorrelated (blue tube) motions of (a) NAD+O (cyan 
spheres) (b) NAD+P (cyan spheres) with backbone atoms of other subunits.  Note that we show cross-
correlated motions of NAD+ with other subunits only. NAD+ has highly correlated motions with backbone 
atoms of its own subunit (i.e. NAD+O with backbone atoms of subunit-O, See Figure S4.4b). NAD+O has 
anticorrelated motions with NBDR and residues 153-173 and 213-229 of CTDP but correlated motions with 
backbone atoms of S-loopR and S-loopQ. S-loopO and S-loopP are non-correlated with NAD+O and appear 
as thin grey lines like another backbone in the image. The cross-correlated motions of NAD+P, NAD+Q and 
NAD+R with backbone atoms of other subunits are identical to NAD+O but there are more motions in 
subunit-O and -R (thick tubes) compared to subunit-P and -Q (thin tubes) (Figure S4.4b-f). Plots of cross-
correlated motions of all NAD+ are shown in Figure S4.4b-f. 
4.4.4. PCA of the MD trajectories of GAPDH-NAD+, GAPDH-NADH, and apo-GAPDH  
It has been shown that global protein dynamics can be described by a low number of collective 
degrees of freedom.178 Thus, filtering the main modes of collective motions from local fluctuations 
could be used to separate functionally relevant motions from random fluctuations. PCA separates 
dominant persistent motion from random motion during MD trajectories. The principal 
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components with the highest eigenvalues describe the main modes that could be functionally 
important.172,177  
PCA of 5 x 100 ns concatenated MD trajectories of the three forms of GAPDH was carried out 
and the free energy landscape (FEL) was plotted to visualize the conformational sampling of each 
form. FEL is a plot of two variables derived from the MD trajectories (e.g., principal components, 
RMSD, radius of gyration, torsion angle, etc.) vs. the free energy. The free energy is estimated 
from the probability distribution of the frequency of each variable. Thus, the FEL identifies the 
relative population of two conformational states. The FEL calculated using PC1 and PC2 (Figure 
S4.5a-c) for the three forms of GAPDH reveals that conformational sampling is distributed around 
the crystal structure with more conformations sampled by GAPDH-NAD+. We show only 
intrasubunit motions by superimposing the four subunits of a given form of GAPDH (Figure 
S4.5d-f). For example, Figure S4.5d shows the superimposition of the four subunits of GAPDH-
NAD+ and its conformational states are different from those in GAPDH-NADH (Figure S4.5e) 
and apo-GAPDH (Figure S4.5f). This highlights the variation in the subdomain motions in the 
three forms of GAPDH.  
The first three principal components, PC1, PC2, and PC3 reveal that the major and functionally 
important motions are centered on the NBD as shown by. The square fluctuations indicate the 
mobility of each Cα atom along the respective PCs (Figure S4.6), whereas the arrows indicate the 
direction of motion of each Cα atom along the respective PCs (Figure S4.7). GAPDH-NAD
+ and 
GAPDH-NADH show similar directions of motions along PC1 and PC2. In fact, NBDO and NBDR 
move in opposite directions in all three forms of GAPDH (Figure S4.7). NBDP and NBDQ of 
GAPDH-NAD+ and GAPDH-NADH also move in opposite direction but in the same direction in 
apo-GAPDH (Figure S4.7a, d, g, b, e, h).  
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Examining the motions along PC1 for GAPDH-NAD+ reveal concerted motions of decreasing 
amplitude: NBDR > NBDO > NBDP ~ NBDQ (Figure 4.6a,b). NBDO and NBDR interacting across 
R-axis show higher fluctuation than the NBDs of the other subunits interacting across the same 
axis. Moreover, the direction of motion of NBDs interacting across the R-axis is opposite, 
indicating that the NBDs move away from each other.  
 
Figure 4.6. The mobility of the Cα atoms of GAPDH as revealed by PC1. (a) Square fluctuation of each Cα 
atom in PC1. (b) Arrows showing square fluctuations ≥ 0.5 Å2 of Cα atoms in NBD (blue), CTD (green) 
and S-loop (orange). Note that the arrows reveal the concerted motion of decreasing amplitude NBDR > 
NBDO > NBDP ~ NBDQ. The NAD+ cofactors are omitted for clarity. 
4.4.5. Square fluctuations of the backbone N, Cα, C and O atoms from NMA of GAPDH-
NAD+ crystal structure 
The low-frequency normal modes calculated with NMA reveal functionally important motions of 
a protein similar to the principal components with the highest variance or largest eigenvalues. 
However, as mentioned previously, NMA is computationally less expensive than MD simulations. 
For the GAPDH tetramer, the amplitude of the lowest frequency mode (normal mode 1; NM1) 
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shows that residues in the CTD and S-loop have superimposable low fluctuations. NBDO and 
NBDR of the subunits interacting across the R-axis are almost twice as flexible as the second pair 
of NBDs (NBDP and NBDQ) that interact across the same axis (Figure 4.7a). Subunits interacting 
across the Q-axis (NBDO:NBDQ and NBDR:NBDP) and the P-axis (NBDO:NBDP and 
NBDQ:NBDR) (Figure 4.1) also have one more flexible and one less flexible NBD. Note that 
similar behavior is revealed by PC1 of the MD trajectories of GAPDH-NAD+ except the NBDR is 
more flexible than NBDO in PCA (Figure 4.6a vs. Figure 4.7a).  
 
Figure 4.7. Normal mode analysis (NMA) of GAPDH-NAD+ carried out using ANM. (a) Square fluctuation 
of Cα atoms of each subunit along normal mode 1 (NM1). Note that NBDO and NBDR exhibit higher 
flexibilities compared to NBDP and NBDQ. (b) Square fluctuations of each subunit in the OP and QR dimers 
extracted from the tetramer along NM1. Subunits in the OP/QR dimers relate to each other across the Q-
axis.  
When we break the tetramer into its dimer of dimers (OP and QR) and examine the square 
fluctuations of the subunits in the dimers (Figure 4.7b), we again clearly see that the NBD exhibits 
high flexibility compared to the CTD and the S-loop. Remarkably, the NBD has identical 
flexibility in all subunits and is more flexible than any NBD in the tetramer. Thus, we conclude 
that the asymmetry in the tetramer occurs across the R-axis. Furthermore, NBDP and NBDQ are 
stabilized in the tetramer by interaction across the R-axis.  
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4.4.6. PCA of the Cα and sidechain heavy atoms of residues within 4 Å of NAD+  
To look at the conformational sampling of the residues that interact with NAD+, we performed 
PCA of residues within 4 Å of the cofactor. These represent the NAD binding-site residues in 
GAPDH-NAD+ and the same atoms were selected in GAPDH-NADH and apo-GAPDH. Also, we 
aligned the four subunits on subunit-O in this analysis. We see from the PCA that the residues 
within 4 Å of NAD access conformations that fall mainly within one cluster in GAPDH-NAD+ 
and GAPDH-NADH but two clusters in apo-GAPDH (Figure S4.8). Conformations in cluster-1 
(Figure 4.8a) are close to the conformation of subunit-O in the crystal structure. However, residues 
in cluster-2 (Figure 4.8b) in apo-GAPDH adopt different conformations (Figure 4.8b).  
The average structures of cluster-1 and cluster-2 from the FEL plots (Figure S4.8) are shown 
in Figure 4.8a, b. This figure confirms that apo-GAPDH accesses different conformations 
compared to GAPDH-NAD+ and GAPDH-NADH. We quantified these conformational 
differences by calculating the dihedral angle of the Arg80 sidechain (C-Cα-Cβ-Cγ) and the RMSDs 
of Cα and sidechain heavy atoms of Gly100-Phe102 in the three forms of GAPDH (Figure 4.8c-
h). Arg80, which interacts with the adenine ring of adenosine moiety (Figure 4.2 and Figure S4.1), 
exhibits increasing flexibility in GAPDH-NAD+ < GAPDH-NADH < apo-GAPDH. Note that 
Arg80 accesses a dihedral angle of 50-90° more frequently in apo-GAPDH. Also, residues Gly100-
Phe102 accesses conformations with RMSD > 3 Å more frequently in apo-GAPDH compared to 




Figure 4.8. The difference in the conformations of the NAD+-binding residues of GAPDH-NAD+, GAPDH-
NADH and apo-GAPDH. The average structure of (a) cluster-1 and (b) cluster-2 extracted from the FEL 
plots (see Figure S4.8) for the three forms of GAPDH. Green, red, blue and pink sticks in (a) and (b) 
represent the crystal structure, GAPDH-NAD+, GAPDH-NADH and apo-GAPDH, respectively. (c-e) The 
dihedral angle of the Arg80 sidechain and (f-h) RMSDs of residues Gly100-Phe102 from the crystal 
structure (PDB 1U8F) in concatenated 5 x 100 ns MD trajectories for GAPDH-NAD+, GAPDH-NADH 




4.4.7. Effect of cofactor on the Cys152 and His179 interaction  
The catalytic Cys152 transfers a proton to His179 to give the active thiolate form of the GAPDH.88 
The stability of ion-pairing between deprotonated Cys152 and protonated His179 at neutral pH is 
important for dehydrogenase activity because this maintains Cys152 in the thiolate form.71 Thus, 
we evaluated whether NAD+ cofactor removal or reduction alter the stability of the ion-pairing 
between Cys152 and His179, and hence the dehydrogenase activity of GAPDH.   
The Sγ(Cys152)–Nε(His179) distance varies between 3.4–3.7 Å in the subunits of the crystal 
structure of human GAPDH (PDB 1U8F). A distance of ~3.2 Å is accessed more frequently in 
GAPDH-NAD+ and GAPDH-NADH, whereas a distance of > 5 Å is more frequently accessed in 
apo-GAPDH during the MD simulations (Figure 4.9). A larger Sγ–Nε separation also has been 
observed in apo-GAPDH (4.04.2 Å) vs. GAPDH-NAD+ (3.43.5 Å) in the crystal structures of 
the Group B Streptococcus enzyme (PDB 5JYF, 5JY6). Loss of interaction between the positively 
charged N-atom of NAD+ and the Cys152-thiolate (Figure 4.2) weakens the Sγ–Nε interaction in 
GAPDH-NADH (Figure 4.9a vs. Figure 4.9b). Also, the loss of steric constraints imposed by NAD 
increases the flexibility of Cys152 and His179, which further weakens the Sγ–Nε interaction in 





Figure 4.9. (a) The distance between Sγ(Cys152)–NƐ(His179) in GAPDH-NAD+, GAPDH-NADH, and 
apo-GAPDH. (b) The position of Cys152 and His179 in the active-site of GAPDH-NAD+ (3.4 Å; red 
dotted line). Distance is obtained from the concatenated 5 x 100-ns MD trajectories.  
4.4.8. Effect of NAD on Cys152Cys156 separation and on Cys152 oxidation  
The Sγ(Cys152)Sγ(Cys156) separation (Figure 4.10a) during the MD simulations is examined 
to evaluate the possibility of disulfide bond formation. The SγSγ distance is > 7 Å in all subunits 
of GAPDH-NAD+, GAPDH-NADH and apo-GAPDH and the average distance is ~ 9 Å (Figure 
4.10a-c). Since the SγSγ bond length is 2.05 ± 0.11 Å,179 disulfide formation is highly unlikely in 
any of the three forms of GAPDH examined here.  
Cys156 is implicated in indirectly controlling the oxidation of Cys152 in GAPDH-NAD+ from 
reported MD simulations on human GAPDH.167 Cys156 imposes steric constraints on Tyr314 
which promotes the formation of a moderately strong H-bond interaction with Thr153. This 
residue partakes in proton relay to H2O2 bound at Cys152 and facilitates its oxidation to the sulfenic 
acid.167 Thus, to evaluate the effect of cofactor on the H2O2 sensitivity of Cys152, we looked at 
the changes in the H-bond interaction between Thr153-Tyr314 (Figure 4.10e-h). The 
Oγ(Thr153)Oζ(Tyr314) separation is 2.7-2.8 Å in the crystal structure (PDB 1U8F) indicating a 
strong H-bond interaction (Figure 4.10h). The average OγOζ distance is larger and fluctuates 




NAD+ (2.98 ± 0.37 Å) during the MD simulations (Figure 4.10e-g).  Thus, NAD+ binding may 
increase the H2O2 sensitivity of Cys152, which could be examined experimentally. 
 
Figure 4.10. (a-c) Sγ(Cys152)–Sγ(Cys156) (e-g) Oγ(Thr153)Oζ(Tyr314) distances in (a,e) GAPDH-
NAD+, (b,f) GAPDH-NADH and (c,g) apo-GAPDH. Panels (d) and (h) show the positions of the residues 
in the active-site and dotted lines indicate the plotted distances. The distances in the graphs are obtained 
from the concatenated 5 x 100-ns MD trajectories. 
4.4.9. Effect of cofactor on the selectivity cleft identified in GAPDH 
GAPDH is a target for antiparasitic drugs against protozoan parasites like T. cruzi 38 or Leishmania 
Mexicana.34 N6-(1-naphthalenemethyl)-20-deoxy-20-(3,5-dimethoxybenzamido) adenosine 
(NMDBA) and its analogs are designed to selectively inhibit GAPDH in the parasite and not 
human GAPDH. It has been proposed that L. Mexicana GAPDH has an open cleft near O2’ of 
adenine ribose ring and N-6 of adenine ring of NAD+ that accommodates the dimethoxybenzamide 
and naphthalene groups of NMDBA, respectively. These clefts appear to be closed in human 




form the selectivity cleft that accommodates inhibitors with substitution at O2’ of the adenine 
ribose ring, whereas substitutions at N-6 of the adenine ring are accommodated between residues 
38 and 92 of subunit-O of L. Mexicana GAPDH. We aligned the adenine and ribose groups of 
NMDBA in L. Mexicana GAPDH with NAD+ in human GAPDH to visualize the residues that 
form the selectivity clefts in human GAPDH (Figure 4.11a). The alignment reveals that residues 
37-39 (subunit-O) and 191-193 (subunit-R), which also were identified by Jenkins and Tanner,105 
forms cleft near O2’ of adenine ribose ring, whereas the N-6 substitution is located between Phe37 
and Arg80 of subunit-O in human GAPDH. Note that the residues 37-39 and 191-193 are from the 
two separate subunits interacting across the R-axis (subunit-O and -R or subunit-P and -Q).  
Residues Phe37, Ile38 and Pro191, which are involved in the opening and closing of the cleft 
(Figure 4.11a), have direct steric clashes with NMDBA. The Phe37-Pro191 (6.77.8 Å) and Ile38-
Pro191 (7.17.5 Å) separations in the crystal structure of human GAPDH (PDB 1U8F) are ~2.5 
Å shorter than the corresponding Met39-Val206 (9.610.0 Å) and Ser40-Val206 (9.810.1 Å) 
separation in the crystal structure of L. Mexicana GAPDH (PDB 1I32). The average Ile38-Pro191 
separation (Å) in GAPDH-NAD+ (7.34 ± 0.75), GAPDH-NADH (7.79 ± 0.71) and apo-GAPDH 
(7.37 ± 0.79) varies little in the three forms of GAPDH (Figure 4.11b-d) and it is short enough to 
create steric clashes with the inhibitor. However, distances (Å) equal or larger than those in the 
crystal structure of L. Mexicana GAPDH ( > 9) between Phe37-Pro191 are accessed during MD 
simulations in GAPDH-NAD+ (7.94 ± 1.40), GAPDH-NADH (8.65 ± 1.28) and apo-GAPDH 
(7.81 ± 1.24) (Figure S4.9a-c). The large distances arise due to the flexibility of Phe37 and may 
promote NMDBA binding despite the short distance between Ile38-Pro191. Thus, NMDBA 





In the crystal structures, the distance between Phe37 and Arg80 are 6.7-6.8 Å in human 
GAPDH but ~ 3.0 Å larger in L. Mexicana GAPDH (9.7-9.9 Å). However, we observe a Phe37-
Arg80 distance of 8-9 Å in GAPDH -NAD+ (8.57 ± 1.48), GAPDH-NADH (8.40 ± 1.46) and apo-
GAPDH (9.08 ± 1.72) (Figure S4.9d-f). Thus, the MD simulations indicate that the selectivity cleft 
is open in all three forms of GAPDH. Hence, substitutions at N-6 of adenine are unlikely to be as 
selective as predicted by the crystal structures. 
4.5. Discussion  
4.5.1. GAPDH tetramer behaves as a dimer of dimers  
Square fluctuations along NM1 calculated using NMA of the backbone atoms reveal that NBDO 
and NDBR, which are related across the R-axis are more flexible than NBDP and NBDQ
 interacting 
across the same axis (Figure 4.7a). Thus, one NBD is more flexible than the other in the OP and 
QR dimers. Presumably, NAD+ binds more tightly to the more rigid NBDs, which is supported by 
experiment where rabbit muscle GAPDH was found to have two moles of tight bound NAD+ and 
two moles of loosely bound NAD+.83 Additionally, a crystal structure of mixed-holo Group B 
Streptococcus GAPDH was reported (PDB 5JYE) with NAD+ occupying NBDO and NBDR 
only.163 Moreover, maleylation of active of swine muscle apo-GAPDH decreases the ability of the 
enzyme to rebind all four NAD+ molecules. Only two NAD+ molecules are capable of re-binding 
to the inactive enzyme.83 These findings support that tetramer behaves as a dimer of dimers 
because only one NAD+ is bound per dimer. However, the loss in differential mobility if the NBDs 
in the tetramer in OP or QR dimer (Figure 4.7a,b) indicates that the OP and QR behave as two 
semi-independent dimers. These results are consistent with a model of tetrameric GAPDH that is 






Figure 4.11. Dynamics of the selectivity cleft in the three forms of GAPDH. (a) Residues that form the 
selectivity cleft in human GAPDH (PDB 1U8F; green) and L. Mexicana GAPDH (PDB 1I32; cyan) are 
shown after aligning the adenine moiety of NAD+ (yellow) and those of the inhibitor, NMDBA (magenta). 
Adenosine analogs like NMDBA with substitution at O2’ of adenine ribose and N-6 of adenine are designed 
to selectively inhibit L. Mexicana GAPDH. Phe37, Ile38 and Pro191 form a closed cavity in human 
GAPDH that lead to steric clashes with the O2’ substituent of NBDBA. Distribution of distance (shown by 
dashed lines) between the center of mass of residues Ile38 and Pro191 (shown by black spheres) of subunits 
interacting across the R-axis (O:R or P:Q) from the concatenated 5 x 100-ns MD trajectories for subunits 




4.5.2. Effect of cofactor binding on the motions of the NBD and CTD subdomains of GAPDH 
Figure 4.3 shows that the flexibility of the NBD decreases as apo-GAPDH > GAPDH-NADH > 
GAPDH-NAD+. Flexible NBDs are also seen in the crystal structure of P. versicolor and B. 
stearothermophilus apo-GAPDH, NAD+-binding residues are more compact in the cofactor-bound 
vs. apo-enzyme.67,164 Our MD simulations show that cofactor binding makes NBDs more compact 
(Figure 4.3). 
CCA of MD trajectories reveals anticorrelated motions between the NBDs of the subunits 
interacting across the R-axis in GAPDH-NAD+ and GAPDH-NADH but not in apo-GAPDH 
(Figure 4.4 and Figure S4.3). The presence of noncorrelated motions in apo-GAPDH indicates that 
its subunit motions are not concerted even though the NBDs are more flexible as seen from the 
calculated RMSF (Figure 4.3). Thus, cofactor binding induces concerted motions between the 
NBDs (Figure 4.4). The anticorrelated motions between the NBDs interacting across the R-axis 
are further confirmed by dominant opposite motions of the NBDs in PC1 and PC2 of GAPDH-
NAD+ and GAPDH-NADH (Figure S4.7a,b,d,e).  
Conformational sampling visualized by FEL calculated with PC1 and PC2 of the three forms 
of GAPDH (Figure S4.5b) shows that all three forms access different conformations. PCA and 
CCA clearly suggest that the conformational differences arise from the variable fluctuation of 
NBDs in each GAPDH form. Motions are centered on NBDs in the three forms of GAPDH and 
concerted motions between NBDs are induced by NAD+. 
4.5.3. Effect of cofactor binding on the cofactor binding site and the active-site:  
The NAD-binding residues are affected upon removal of cofactor as shown in Figure 4.8. 
However, the changes are not apparent from the RMSFs (Figure 4.3); thus, we use PCA to 




binding residues in apo-GAPDH attain a specific subset of conformation as shown by cluster-2 of 
FEL (Figure S4.8 and Figure 4.8). In all four subunits of apo-GAPDH, cluster-2 represents an open 
conformation for residues Gly100-Phe102 and the sidechain of Arg80 (Figure 4.8). These residues 
form a binding groove for the adenine moiety of NAD (Figure 4.2). So, the conformation of these 
residues indicates that an adenine binding groove is an open form in apo-GAPDH. It has been 
previously proposed that adenine binding initiates the folding of the NBD then the nicotinamide 
moiety binds to complete the folding of GAPDH.2 Also, large positively charged and flexible 
sidechain of Arg80 in apo-GAPDH could initiate the interaction between the GAPDH polypeptide 
and NAD+, leading to binding of adenosine moiety in the groove close to Arg80.    
Apo-GAPDH has no stable Sγ(Cys152)-Nε(His179) interaction compared to GAPDH-NADH 
and GAPDH-NAD+ (Figure 4.9).  The weak interaction between Cys152 and His179 should affect 
the formation of the Cys152 thiolate and decrease the reactivity of the catalytic Cys152. Thus, we 
hypothesize that nucleophilic attack on Cys152 of GAPDH is favored in presence of NAD+. In 
terms of H2O2 sensitivity of Cys152,
167 we show that removal of cofactor has little effect on the 
H-bond interaction between Thr152-Tyr314 (Figure 4.10d-f), nevertheless, a decrease in Cys152 
thiolate population would render apo-GAPDH less sensitive as compared to GAPDH-NAD+.   
4.5.4. The R-axis is important for negative cooperativity  
CCA of the NMA (Figure S4.4) and MD data (Figure 4.4a) reveal anticorrelated motion between 
NBDs interacting across R-axis and noncorrelated motions between NBDs interacting across P- 
and Q-axes (Figure 4.4, Figure 4.5 and Figure S4.4). Additionally, NAD+ shows highly 
anticorrelated with NBD and correlated motions with the S-loop of the subunits related across R-
axis, respectively (Figure S4.4b-f and Figure 4.5). NAD+ also has weak correlated and 




respectively. The strong cross-correlated motions across the R-axis could explain the binding of 
NAD+ to GAPDH with negative cooperativity. For example, NAD+O binds first and forces S-loopR 
to move opposite to NBDR since NAD
+
O has correlated motions with S-loopR but anticorrelated 
motions with NBDR (Figure 4.5 and Figure S4.4). This opens NBDR so NAD
+
R does not bind as 
tightly as NAD+O. Additionally, NAD
+
O shows weakly correlated motion with S-loopQ, which will 
influence the binding of NAD+P because S-loopQ interacts with NAD
+
P (Figure 4.5 and Figure 







to bind second, but this in turn strongly affects the binding of NAD+P so NAD
+
R binds third and 
NAD+P binds last. In essence, each time NAD
+ binds, the NBD across the R-axis becomes more 
flexible, which decreases its NAD+ affinity and gives rise to negative cooperativity in NAD+ 
binding to human GAPDH.  
4.5.5. Selectivity cleft in human GAPDH  
The selectivity cleft close to O2’ of the adenosine ribose ring might be open because the slightly 
large distance between Phe37-Pro191 (Figure S4.9d-f) is accessed, although the distance Ile38-
Pro191 is short during MD simulation (Figure 4.11). This suggests that trypanosomatid GAPDH 
may be selectively inhibited by O2’ substituted inhibitors. However, the cleft near N-6 adenine 
ring is open during MD simulations of the three forms of GAPDH, rendering N-6 substituted 
inhibitors to be as selective as O2’ substituted inhibitors. 
4.6. Conclusions   
Our study shows that cofactor binding affects the motions of NBDs since NAD+ binding makes 
the NBD of its own subunit more rigid. Cofactor removal could influence the reactivity of Cys152 




and Cys156, irrespective of cofactor binding. We also predict that the oxidation sensitivity of 
Cys152 does not change on cofactor binding due to change in the active-site of GAPDH but the 
reactivity it may be affected by the increasing the thiolate formation at Cys152 on NAD+ binding.  
Our study shows that cofactor binding induces concerted motions between NBDs interacting 
across the R-axis. This highlights the importance of interaction across the R-axis in the asymmetry 
of GAPDH tetramer. Our study also shows how the tetramer behaves as a dimer of OP and QR 
dimers and not of other dimer pairs. Overall, our study provides insights into the complex 
dynamics of GAPDH structure and how they impact its asymmetry. 
4.7. Supporting Information   
 
Figure S4.1. All possible interactions of NAD+ with human GAPDH (PDB 1U8F). The residues interacting 
with NAD+, discussed in the main text based on the 2D interaction map (Figure 4.2), are shown in the 
licorice representation. The rest of the structure is shown in cartoon representation and the red spheres 





Figure S4.2. Convergence of the MD trajectories. (a-c) Good-Turing statistical analysis of convergence. 
The 5 x 100-ns MD trajectories were separated into 5 x 25, 5 x 50, 5 x 75, and 5 x 100 ns trajectories. The 
separated trajectories were used for Good-Turing statistical analysis. The overlapping curves for the 5 x 50, 
5 x 75 and 5 x 100 ns trajectories indicate that the root-mean-square deviations (RMSD) are converged. (d-
f) RMSD from crystal structure geometry calculated for each of the five 100 ns trajectories for the three 








Figure S4.3. Cross-correlation analysis (CCA) calculated using Cα atoms of GAPDH-NADH from MD 
simulations trajectories. CCA is carried out using Cα atoms of concatenated 5 x 100 ns MD simulations 
trajectories. Each square represents a subunit and the diagonal show the correlated motions of each Cα atom 












Figure S4.4. CCA of protein backbone atoms (N, Cα, C, O) and NAD+ calculated using NMA. (a) Plot 
showing cross-correlated motions of subunits with each other. Each square represents cross-correlated 
motions of a subunit with itself and other subunits. (b) Plot showing cross-correlated motions of protein 
backbone atoms with NAD+. Each square represents cross-correlated motions of a NAD+ with backbone 
atoms of a subunit. There are mostly correlated motions between the protein backbone and NAD+ atoms of 
the same subunit as seen in the four squares at the diagonal. Note that the blue, green and orange lines at 
the axes indicate NBD, CTD, and S-loop of each subunit, respectively. (c-f) Correlated (orange) and 
anticorrelated (blue) motions of residues with respect to given NAD+ (cyan). See captions to Figure 4.5 of 






Figure S4.5. Free energy landscape (FEL) plotted using a projection of Cα atoms along PC2 and PC1. PCA 
was carried out using (a-c) Cα atoms of tetramer and (d-f) Cα atoms of all four superimposed subunits for 
(a,d) GAPDH-NAD+, (b,e) GAPDH-NADH and (c,f) apo-GAPDH. We used concatenated 5 x 100 ns MD 
simulations trajectories for PCA. The black dot represents the conformations of the crystal structure of the 
tetramer in panels (a-c) and the conformations of the crystal structure of subunit-O in panels (d-f). The unit 





Figure S4.6. The mobility of the Cα atoms of three forms of GAPDH as revealed by PCA. Square fluctuation 
of each Cα atom of (a-c) GAPDH-NAD+, (d-f) GAPDH-NADH and (g-i) apo-GAPDH in (a, d, g) PC1, (b, 


















Figure S4.7. Directions of dominant motions of the Cα atoms of the three forms of GAPDH as revealed by 
PCA. Arrows showing square fluctuation of each Cα atom of (a-c) GAPDH-NAD+, (d-f) GAPDH-NADH 
and (g-i) apo-GAPDH in (a, d, g) PC1, (b, f, h) PC2, and (c, g, i) PC3. The NBD (blue) , CTD (green), and 





Figure S4.8. FEL plotted using a projection of the NAD-binding residues along PC2 vs PC1. PCA of the 
Cα and sidechain heavy atoms of residues within 4 Å of NAD+ of the four subunits of (a) GAPDH-NAD+ 
(b) GAPDH-NADH and (c) apo-GAPDH aligned on each other. Data from concatenated 5 x 100 ns MD 
trajectories were used for the analysis. The black dot represents the conformations of Cα and sidechain 
heavy atoms of residues within 4 Å of NAD+ in the subunit-O of the crystal structure (PDB 1U8F). Cluster-
1 and cluster-2 are highlighted by black and magenta circles, respectively. The unit for free energy is 
kcal/mol. 
 
Figure S4.9. Change in size of the selectivity cleft in human GAPDH with the cofactor. (a) Distribution of 
distance between center of mass of residues (a-c) Phe37 and Arg80 of subunits interacting across R-axis 
(O:R or P:Q) (d-f) Phe37 and Arg80 of the same subunit calculated from 5 x 100 ns MD trajectories for 
each subunit of (a,d) GAPDH-NAD+ (b,e) GAPDH-NADH and (c,f) apo-GAPDH. See Figure 4.11 of the 
















Chapter 5. Dynamics of Glyceraldehyde-3-Phosphate Dehydrogenase 



























Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) exhibits various moonlighting functions 
depending on its oligomeric states, tetramer, dimer and monomer. However, no report has 
evaluated the relation of functional diversity with the structure and dynamics of these oligomeric 
states. The GAPDH homotetramer has identical subunits, so functional diversity could arise due 
to alteration in subunit or subdomain dynamics upon deoligomerization from the tetramer to dimer 
or monomer. The global motions calculated using normal mode analysis (NMA) of the crystal 
structure of the human GAPDH show that the tetramer behaves as a dimer of dimers. This is 
evident from the varied dynamics of the NAD-binding domain (NBD) in the tetramer. The catalytic 
domain (CTD), which is at the center of the tetramer, becomes highly dynamic depending on the 
dimer pairs (OP/OQ/OR) examined which reveals dimer-OP and dimer-QR are the most stable 
dimer pairs. The highly dynamic nature of the S-loop, which moves away from NBD in the 
monomer, is also revealed by NMA. Variation in subunit and subdomain dynamics in the three 
oligomeric states was confirmed by molecular dynamics (MD) simulations and multivariate 
statistical analysis, including principal component analysis (PCA) and cross-correlation analysis 
(CCA). For example, PCA confirms that the major dominant motions are centered on the NBD in 
the tetramer and dimer whereas S-loop motions are dominant in the monomer. The NBD of all 
four subunits of the tetramer have varying displacements, which we correlate with NAD+ binding 
with negative cooperativity to GAPDH. CCA reveals that highly anticorrelated motions between 
subdomains in the QR dimer are absent in tetramer, showing that the tetramer is more stable than 
the dimer. The highly correlated motions within the CTD of the tetramer and dimer are lost in the 
monomer, confirming that deoligomerization disrupts the CTD, which may lead to loss of activity. 




behaves as an intrinsically disordered domain that may promote binding of the monomer to many 
of GAPDH’s multitude of protein partners in the cell. Overall, our study shows that dissociation 
of tetramer to the dimer or monomer alters inter- and intradomain dynamics in addition to subunit 






5.2. Introduction  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a well-known glycolytic enzyme, exhibits 
remarkable moonlighting functions. For example, it has been implicated in physiological functions 
as diverse as cell signaling, gene regulation, and apoptosis as well as in the pathologies of diabetes, 
neurodegeneration, and malaria.1,3,15,43 Additionally, GAPDH’s role in nitric oxide biochemistry 
has been demonstrated by our group and others.48,180,181  For example, we showed that GAPDH 
catalyzes nitrite generation from glyceryl trinitrate.48  
GAPDH is translated as a 37 kDa monomer but mainly exists as a tetramer.2 The tetramer of 
GAPDH is composed of four identical subunits, labeled O, P, Q and R (Figure 5.1a). Each subunit 
has a nicotinamide adenine dinucleotide (NAD) binding domain (NBD; residues 1-151 and 315-
335) and a catalytic domain (CTD; residues 152-314) (Figure 5.1a). However, various post-
translational modifications give rise to dimer and monomer.14,77–79 GAPDH’s function is 
determined by its oligomeric state. For example, the monomer 182,183 and dimer 77 exhibits no 
dehydrogenase activity. Only the monomer and dimer are implicated in GAPDH aggregation, 
which is associated with neurodegenerative diseases.19,86 In the cell, the tetramer and monomer are 
found mainly in the cytoplasm 33 and nucleus,19 respectively, but little is known about the cellular 
localization of dimer. Non-native forms of GAPDH, which are implicated in apoptosis, are also 
found in the nucleus, but the oligomeric status of the non-native forms is obscure.184  
Evidently, cellular localization will dictate some functions of GAPDH since glycolytic activity 
is confined to the cytosol and the involvement of the monomer in DNA repair 87 will occur in the 
nucleus. The post-translational modification of GAPDH regulates localization and oligomerization 
that in turn determines the multifold functions of GAPDH. However, GAPDH is a homotetramer 




in conformations or dynamics of the oligomeric states. However, no studies have compared the 
dynamics of the different oligomeric states of GAPDH. 
Various double mutations transform the Bacillus stearothermophilus GAPDH tetramer to 
dimers like dimer-OP and dimer-OR, that exhibit different cooperativity compared to the 
tetramer.77,185 For example, dimer-OP 77,185 binds NAD+ with positive cooperativity as oppose to 
the negative cooperativity seen for the tetramer,68,69 whereas dimer-OR shows no cooperativity for 
the binding of NAD+.77,185 Also, the rabbit muscle GAPDH tetramer was converted to dimers by 
incubation with RNA90  but no similar studies have been reported on human GAPDH. The 
conformational changes upon deoligomerization of the tetramer to the dimer can be seen from the 
crystal structure of dimeric Kluyveromyces marxianus GAPDH which reveals a very high B-factor 
for the S-loop (residues 181-205). This loop partly covers the active-site and the cofactor binding 
site (Figure S5.1), indicating that tetramer to dimer dissociation destabilizes the S-loop.165 
However, there are no other human GAPDH crystal structures of the dimer or monomer mostly 
due to the instability of these oligomeric states. The T227K mutation in rat GAPDH produced a 
wide range of molecular weights from 37–148 kDa with the highest amount eluted in gel filtration 
at 37 kDa, corresponding to the monomer.186 It was also shown that thermal aggregation involves 
stages of reversible dissociation of the enzyme tetramer into oligomeric forms of lesser size, like 
the dimer or monomer.187 Thus, human GAPDH could be partially stable as a dimer or monomer 
oligomeric state in addition to tetramer form. 
Overview of GAPDH structure: As we discussed in Chapter 4, the GAPDH homotetramer has 
most inter-subunit interactions across P-axis, between O:P and Q:R. GAPDH homotetramer 
behaves as a dimer of dimers (OP and QR dimers) located across Q-axis (Figure 5.1a). 31,105  Note 




across P-axis. We use subunits-QR as dimer and subunit-P as a monomer for MD simulation 
(Figure 5.1b,c). The important structural regions, the NBD, the CTD and the S-loop of each subunit 
are shown in Figure S5.1. Note that the NBDs are located at the periphery of the tetramer and the 
CTDs are at the center of the tetramer. The nicotinamide moiety of NAD+ binds close to the 
catalytic Cys152, which is partially solvent exposed. GAPDH active-site contains the catalytic 
Cys152 (deprotonated or cysteine thiolate form) and His179 (protonated form) at neutral pH,88 
which are essential for dehydrogenase activity.71 Deprotonated Cys152 and protonated His179 are 
stabilized by a strong H-bond interaction (Figure S5.1). Cys156 on the same helix as Cys152 is 
buried inside the protein matrix, which hinders the disulfide bond formation between them (Figure 
S5.1). 
 
Figure 5.1. Location of subdomains of human GAPDH structure (PBD 1U8F). (a) The secondary structure 
of the GAPDH tetramer. Note that the tetramer is a dimer of OP (blue) and QR (green) dimers with subunits 
interacting across P-axis as a dimer. Thus, we used dimer-QR for MD simulation as shown in panel (b). 
Panel (c) shows the monomer GAPDH (subunit-P). The cofactor NAD+ is shown as magenta sticks. NAD-
binding domain (NBD; residues 1-151 & 315-335) are shown in ribbon with NBDO and NBDP in green 
color, whereas NBDQ and NBDR in blue color. Catalytic domain (CTD; residues 152-314) are shown in 
cartoon representation with CTDO and CTDP in green color whereas, CTDQ and CTDR in blue color. The 




in orange color with S-loopO and S-loopP in ribbon format, whereas S-loopQ and S-loopR in the tube. See 
Figure S5.1 for the location of active-site residues. 
Studies on the dynamics of the human GAPDH tetramer have looked at effects of Cys156 
modification by persulfide (-SSH),188 Met46 oxidation,189 H2O2 sensitivity of Cys152 
167 (Section 
4.4.10). However, there are no reported attempts to correlate conformational change to with the 
function of GAPDH upon deoligomerization of tetramer to dimer or monomer. In the present 
study, we describe the changes in the dynamics of subunit and subdomains upon 
deoligomerization. The variable dynamics could change the reactivity of each oligomeric state and 
could allow GAPDH to interact with different protein partners to drive the functional diversity of 
GAPDH.  
5.3. Computational Methods 
5.3.1. Normal mode analysis (NMA) using anisotropic network model (ANM): 
The large-scale motions of subdomains of a protein can be extracted into a collection of normal 
modes using NMA.169,170 Thus, we performed NMA using the anisotropic network model 
(ANM)102–104 of ProDy171 and analyzed the low-frequency normal modes to extract the 
functionally relevant motions of GAPDH.170,172 See section 4.3.1 for details. We used the backbone 
atoms (C, Cα, N, O) and NAD+ of the crystal structure of the human GAPDH tetramer (PBD 
1U8F) after adding coordinates of fourth NAD+ in subunit-O 105 as a tetramer for NMA. We used 
the edited tetramer structure to extract two subunits for dimer (dimer-OP, -QR, -OQ, -PR, _OR, -




5.3.2. Molecular dynamics simulations: 
We prepared crystal structure of human GAPDH (PBD 1U8F) 105 as described in section 4.3.2 for 
MD simulations of a tetramer. We extracted subunit-Q and -R as dimer and subunit-P as a 
monomer from the tetramer structure. These three structures were further used to generate systems 
for MD simulations.  
The tetramer, dimer (dimer-QR) and monomer (monomer-P) were hydrated in a 10 Å-layer of 
TIP3P water from the protein boundary and 0.15 M Na+ and Cl– ions were added to represent 
physiological conditions. MD simulations were performed using the CHARMM27106,174 force 
field and the NAMD2.999 software. The system was subjected to 20,000 steps of conjugate gradient 
minimization and 1 ns of equilibration before production runs of 100 ns were carried out. We also 
performed a 300 ns production run for the three oligomeric forms of GAPDH, tetramer, dimer, 
and monomer. Simulations were performed in the NPT ensemble at 300 K and 1 atm using 
Langevin dynamics and the time step was set to 2 fs. Seven independent simulations of 100 ns (7 
x 100 ns) were run for each form of GAPDH and the results were analyzed using VMD 175 and 
ProDy171. Good-Turing statistical analysis was carried out to analyze the convergence of the MD 
trajectories.176 
5.3.3. Principal component analysis (PCA): 
MD trajectories include nonharmonic residues motions and generate accessible conformational 
ensembles.  However, the motions are highly multidimensional and include a large number of 
degrees of freedom. Multivariate statistical analysis such as PCA reduces the dimensionality of 
the data and allows us to extract the dominant motions from the large data sets that comprise the 




To carry out PCA, we selected three sets of atoms (1) all Cα atoms, (2) the Cα atoms and the 
heavy atoms of the sidechains of the S-loop, and (3) the Cα atoms and the heavy atoms of the 
sidechains of residues within 4 Å of NAD+ (NAD-binding residues) from the 7 x 100 ns MD 
trajectories of the tetramer, dimer and monomer to carry out PCA. PCA and ANM results were 
visualized using the Normal Mode Wizard (NMWiz)171 of VMD.  
The variation in a conformational sampling of the three oligomeric forms of GAPDH is 
evaluated by calculating the free energy landscape (FEL). PC1 and PC2 calculated by PCA of the 
concatenated 7 x 100 ns MD trajectories are plotted vs. free energy for the three oligomeric forms.  
5.4. Results 
5.4.1. Square fluctuations of the backbone atoms N, Cα, C, and O calculated by NMA   
NMA allows extraction of the global motions of a protein by applying harmonic forces to the x-
ray crystal structure (See Chapter 4).172 Square fluctuations of the Cα atoms along the lowest 
frequency normal mode (NM1) are high for residues 25-35, 60-95 and 107-120 of NBDO and 
NBDR compared to NBDP and NBDQ (Figure 5.2a,b). The differences in the square fluctuation of 
the NBDs are lost, when we extracted dimer-OP and -QR, and NBDs become more flexible (Figure 
5.2c,d). This reveals the characteristics of tetramer to behaves as a dimer of dimers (See Chapter 
4). Also, NM1 is centered on the NBD in the tetramer and dimer, which reveals the importance of 
NBD motions in these oligomeric states. Extraction of subunit as monomer-O, -P, -Q and -R 
dramatically increases the square fluctuation of their S-loop (Figure 5.2e,f). Thus, the functionally 
important motions switch to the S-loop in the monomer from the NBD in the tetramer and dimer. 
We also extracted dimer-OQ, -PR, -OR and -PQ from the tetramer. The square fluctuations of 




5.2c,d, and Figure S5.2), revealing the loss of stabilizing interaction across the R-axis. Dimer-OP 
and -QR also were found to be stable in Bacillus stearothermophilus GAPDH.77 Additionally, their 
identical square fluctuations indicate that dimer-OP and -QR exhibit similar dynamics and the 
similar square fluctuation are seen for other dimer pairs related across P- (dimer-OQ and -PR) and 
Q-axis (dimer-OR and -PQ) (Figure S5.2).  
NBDQ and NBDR move in the opposite direction to NBDO and NBDP, respectively in tetramer 
(Figure 5.2a,b). However, the motions of the NBDQ and NBDR change in such a way that they 
move away from their respective CTDs in the dimer (Figure 5.2c,d) indicating the dimer’s 
instability. The NBD and the S-loop move opposite to each other in the monomer and there is an 
opening of the S-loop in the monomer (Figure 5.2e,f). Notably, the S-loop is not as dynamic in 
dimer or tetramer. 
NMA reveals that dimer-OP and -QR are most stable dimers and exhibit identical dynamics 
(Figure 5.2c). Thus, MD simulations of dimer-QR are used to evaluate the dynamics of both dimer-
OP and -QR. In case of monomer, all four subunits have identical normal modes, so the monomer 
dynamics are examined for subunit-P. We also looked at the cross-correlated motions between 
subunits and subdomains of tetramer, dimer, and monomer calculated from NMA (Figure S5.3). 





Figure 5.2: Normal mode analysis (NMA) of the tetramer, dimer, and monomer performed using ANM. 
Square fluctuation and the direction of Cα atoms of the (a, b) tetramer, (c, d) dimer-OP and -QR, and (e, f) 
monomer-O, -P, -Q, -R along normal mode 1 (NM1). NMA was carried on the crystal structure of the 
human GAPDH tetramer (PDB 1U8F), and the dimers and monomers extracted from it. Note that the 
monomer is in the pose shown in Figure S5.1 but NAD+ is omitted for clarity. 
5.4.2. Convergence of the MD trajectories of the tetramer, dimer, and monomer 
We carried out seven replicate 100-ns (7 x 100 ns) all-atom MD simulations of the tetramer, dimer, 
and monomer of the human GAPDH. The convergence of the 100-ns MD trajectories was 
evaluated using the Good-Turing statistical analysis (Figure S5.4a). This approach reveals that 
100-ns MD trajectories are converged because the probability of the unobserved RMSDs from the 
already sampled RMSDs remains unchanged between 100- and 300-ns MD trajectories for the 




(1.50 ± 0.24 Å; Figure S5.4d), dimer (1.80 ± 0.36 Å; Figure S5.4e) and monomer (2.32 ± 0.50 Å; 
Figure S5.4f) is stable for each 100 ns trajectory with minute differences between trajectories. 
Thus, we used the 100-ns MD trajectories for further analysis.  
5.4.3. Flexibilities in the NBD and CTD subdomains calculated from MD simulations 
Root-mean-square fluctuation (RMSF) of each Cα atom in the concatenated 7 x 100 ns MD 
trajectories is used to quantify the subdomain flexibilities of the three oligomeric states (Figure 
5.3b). All the regions of the tetramer exhibit low RMSF values (< 2 Å; Figure 5.3a). Similarly, the 
dimer and monomer have low RMSF values for most subunit regions, except the S-loop. The S-
loop is more flexible in the dimer (2-5 Å; Figure 5.3b) and highly flexible in the monomer (2-10 
Å; Figure 5.3c). The RMSF values confirm high flexibility of the S-loop in monomer shown by 
NMA (Figure 5.2e).   
 
Figure 5.3: Root-mean-square fluctuation (RMSF) of the Cα atoms of the (a) tetramer, (b) dimer and (c) 
monomer. We analyzed concatenated 7 x 100 ns MD trajectories to calculate the RMSF from the crystal 





5.4.4. Correlated motions changes upon deoligomerization 
We compared the cross-correlated motions of subunit-O with -P (Figure 5.4a) and subunit-Q with 
-R (Figure 5.4b) of the tetramer with those of the dimer (Figure 5.4c). Each square in Figure 5.4 
represents a subunit of the tetramer or dimer with identical information on both sides of the 
diagonal. There are highly anticorrelated motions between the NBD and CTD of the subunits in 
the tetramer interacting across the P-axis, NBDO and CTDP, NBDP and CTDO, NBDQ and CTDR, 
NBDR and CTDQ (Figure 5.4a,b).  However, there are noncorrelated motions between the NBDs 
of the subunits interacting across P-axis, NBDO and NBDP, NBDQ and NBDR (Figure 5.4a,b). 
These noncorrelated motions convert to anticorrelated motions in the dimer (Figure 5.4c). We also 
observe that there are highly correlated motions between CTDQ and CTDR in the dimer, which are 
anticorrelated in the tetramer. We previously showed that there are highly anticorrelated motions 
between the NBDs of subunits interacting across R-axis, e.g., NBDO and NBDR in the tetramer 
(Section 4.4.4). 
We also examined intra-subunit cross-correlated motion, which highlights the motions within 
a subdomain or between subdomains, of a single subunit of the tetramer (Figure 5.4d), and 
compared with a subunit of the dimer (Figure 5.4e) and monomer (Figure 5.4f). There are highly 
correlated motions within the NBD and CTD in the tetramer and dimer. However, the 
noncorrelated motions between the subdomains in tetramer change to highly anticorrelated 
motions in the dimer (Figure 5.4d,e), signifies that the subdomains move in opposite directions in 
the dimer. The monomer exhibits the cross-correlated motions that differ significantly from those 
of the tetramer and dimer. In particular, the S-loop shows highly anticorrelated motion with all 
other residues, indicating that it moves opposite to the rest of the subunit (Figure 5.4f). Also, the 





Figure 5.4: CCA carried out for Cα atoms of tetramer, dimer, and monomer using the concatenated 7 x 100 
ns MD trajectories of the three oligomeric states. Inter-subunit cross-correlated motions of (a) subunit-O 
and subunit-P, (b) subunit-Q and subunit-R of the tetramer and (c) the dimer. The intra-subunit cross-
correlated motions of (d) a tetramer subunit, (e) a dimer subunit, and (f) the monomer. Each square 
represents a subunit in panels (a-c) and a subdomain in panels (d-f). The blue, green and orange lines on 
the axes indicate NBD, CTD, and S-loop of each subunit, respectively. Note that the diagonals show the 
correlated motions of each Cα atom with itself.  
To visualize the global motions of the three oligomeric states, we calculated cross-correlated 
motions using ANM and backbone atoms of the crystal structures the tetramer, and dimer and 
monomer extracted from it (Figure S5.3). The ANM cross-correlated motions are similar to the 
those from MD trajectories of the three oligomeric states (Figure 5.4a-f vs Figure S5.4a-f). 
However, the dominant S-loop anticorrelated motions eclipse the other anticorrelated motions 
during the MD simulation (Figure 5.4f vs Figure S5.4f). The similar cross-correlated motions 
generated by ANM and from the MD trajectories indicate that ANM captures the similar global 




5.4.5. Varied conformational sampling of subdomains  
PCA is used to separate functionally relevant motions from local fluctuation in the MD 
trajectories.172,177,178 PCA of the 7 x 100 ns concatenated MD trajectories were performed and the 
free energy landscapes (FEL) based on principal component 1 (PC1) and PC2 allow us to visualize 
the conformational sampling of the three oligomeric states. The projection of the Cα atoms of each 
subunit on PC1 and PC2 indicates that the tetramer and dimer sample different conformations from 
the monomer, which exhibits the largest conformational space (Figure S5.5).  
We projected the motions of the Cα atoms on PC1 to visualize their dominant displacements. 
The square fluctuations of all Cα atoms of the tetramer indicate the varied displacement of the 
NBDs between subunits (Figure 5.5a). This could reflect the binding of NAD+ with negative 
cooperativity to GAPDH because flexible NBDs bind NAD+ less tightly than rigid NBDs. 
Additionally, the direction represented as black arrows in the structures indicate that NBDO and 
NBDR move opposite to each other as do NBDP and NBDQ (Figure 5.5a). These motions highlight 
the importance of interactions across the R-axis. Most of the dynamics are centered on the NBDs, 
which move away from each other and from their respective CTDs in the dimer (Figure 5.5b). The 
S-loop is the most dynamical region of the monomer and its residues have the highest square 
fluctuation compared to all other residues. Also, the direction of motion indicates the opening of 





Figure 5.5: Square fluctuations of the tetramer, dimer, and monomer along PC1. PCA analysis was carried 
out using the 7 x 100 ns concatenated MD trajectories. Regions at the periphery in the tetramer and dimer 
structures correspond to the NBDs, whereas the CTDs are at the center. The arrows indicate the motions of  
Cα atoms with the square fluctuation of > 0.5 Å2 in the tetramer and > 1 Å2 in the dimer and monomer. The 
color blue, green and orange in structure represent the NBD, CTD, and S-loop, respectively. Note that the 
monomer is in the pose shown in Figure S5.1. 
5.4.6. PCA of the S-loop  
The FEL calculated using the Cα atoms of the S-loop projected along PC1 and PC2 reveals the 
limited conformational space close to the crystal structure in the four subunits of tetramer (Figure 
5.6a-d). In the dimer, the S-loop accesses larger conformational space with two populations. In the 





Figure 5.6: Free energy landscape (FEL) plotted using the projection of the Cα atoms of the S-loop of the 
tetramer, dimer, and monomer. PCA was carried out using the concatenated 7 x 100 ns MD trajectories of 
the S-loop of (a-d) the tetramer subunits, (e, f) the dimer subunits and (g) the monomer. The black dot in 
each panel indicates the crystal structure geometry of subunit-O of the tetramer. The unit for free energy is 
kcal/mol. 
Since the S-loop accesses different conformational clusters in the monomer, we carried out 
200-, 300- and 500-ns longer MD simulations to see if the S-loop attains a stable conformation as 
determined by PCA. The FEL show the three minima in the 7 x 100 ns MD simulations trajectories 
(Figure 5.7a), cluster-1, which has an S-loop conformation close to the crystal structure, cluster-2 
with a closed S-loop conformation and cluster-3 with an open S-loop conformation. Cluster-1 and 
cluster-2 are accessed in the longer MD simulations of 200, 300 and 500-ns (Figure 5.7b-d). 
Cluster-2 is more populated in longer MD simulation compared to 100 ns MD simulations.  
The closed S-loop conformations in cluster-2 arise due to NAD+ movement. The nicotinamide 
moiety moves away from its binding site (away from Cys152) but, the less constrained S-loop 
interacts with the nicotinamide moiety and restricts NAD+ from leaving its binding site in the 




binds far from Cys152. However, the interaction of the nicotinamide moiety with the S-loop, as 
seen in cluster-2, could facilitate cofactor binding and in turn promote monomer to tetramer 
folding. The opening of the S-loop in cluster-3 could expose the active-site residues including 
catalytic Cys152 to the solvent, which could affect the reactivity of the monomer. However, we 
do not see this conformation accessed in longer MD simulations.    
 
Figure 5.7: FEL plotted using the projection of all Cα atoms along PC2 vs PC1 calculated with all Cα atoms 
from 7 x 100 ns, 1 x 200 ns, 1 x 300 ns and 1 x 500 ns MD trajectories of the monomer. The black dot in 
each FEL plot indicates the conformation of subunit-O in the crystal structure. Structural images in red and 
blue tube indicate crystal structure and the average structure of the cluster, respectively. The unit for free 
energy is kcal/mol. 
5.4.7. PCA of the NAD-binding residues  
To evaluate the changes in the dynamics of the NAD binding residues, we carried out PCA of 




conformational space of the NAD-binding residues in the subunits of the tetramer indicate the 
dynamical asymmetry in NAD-binding (Figure S5.6a-d). There are two major clusters in the four 
subunits of the tetramer, and their intensity varies between the subunits. The two clusters differ in 
the sidechain orientation of Phe37, one cluster has a Phe37 dihedral angle of 74° between the C-
Cα-Cβ-Cγ atoms and the other cluster has a dihedral angle of 173° (Figure 5.8a,b, and Figure 5.5a-
b). Phe37 forms a T-shaped π-π interaction with the adenine group of NAD+. This interaction is 
lost in cluster-2, which lead to weak binding of adenine moiety. These two clusters also are seen 
in the dimer subunits and monomer (Figure S5.6e-g), but the conformational space accessed varies 
significantly from the tetramer. Furthermore, these conformational variations are not dominant and 
cannot be separated based on cluster analysis. 
 
Figure 5.8: Free energy landscape (FEL) plotted using the projection of the Cα atoms and heavy atoms of 
the sidechains of residues within 4 Å of NAD+ (NAD-biding residues) of subunit-O of the tetramer. (a) 
PCA was carried out using the concatenated 7 x 100 ns MD trajectories. (b) Average structure of the NAD-
binding residues from cluster-1 and -2 are compared with the crystal structure of subunit-O of the tetramer. 




5.4.8. Variable stability of the Cys152 and His179 interaction  
The interaction between catalytic Cys152 and His179 is important for dehydrogenase activity.2,88 
The distance between Sγ(Cys152) and NƐ(His179) in the crystal structure of human GAPDH (PDB 
1U8F) is between 3.4–3.7 Å in all four subunits of the tetramer. There are two populations of 
distances accessed in the tetramer and dimer. The first population has the Sγ(Cys152)–NƐ(His179) 
distance of ~ 3.3 Å and the second population has the distance of ~ 5 Å (Figure 5.9). However, the 
monomer accesses only one population of the distance of ~ 3.1 Å (Figure 5.9) suggesting the H-
bond interaction between Cys152 and His179 is strongest in the monomer compared to the dimer 
and tetramer.  
 
Figure 5.9: The Sγ(Cys152)–NƐ(His179) separation in the tetramer, dimer, and monomer. Relative 
frequency of the distance is determined from the concatenated 7 x 100 ns MD trajectories of the (a) tetramer, 
(b) dimer, and (c) monomer. (d) The position of Cys152 and His179 in the active-site of the crystal structure 
of subunit-O GAPDH tetramer (PDB 1U8F). The measured distance is shown as a red dotted line.  
5.4.9. NAD+ binding to the three oligomeric states of GAPDH 
NAD+ moves away from its binding site in the tetramer during the MD simulations. Thus, the 
RMSF of selected atoms of NAD+, shown as spheres, are calculated to quantify its motions (Figure 
5.10). Atoms AO4’ and AN9, O3, plus NO4’ and NN1 represent the adenosine, pyrophosphate, 
and nicotinamide groups of NAD+, respectively. NAD+ fluctuates away from its binding site in 




cooperativity of NAD+ binding to the tetramer. Note, NAD+P moves out of its binding site in run-
5 (> 28 Å RMSF). The negative cooperativity of the tetramer is also observed in different crystal 
structures of GAPDH e.g. PDB 1U8F 105, 1J0X 190, 1ML3 191. In the dimer, part of NAD+ moves 
away from its binding site in all trajectories but the cofactor does not completely leave its binding 
site as seen for the tetramer. NAD+ remains in its binding site, except in run-5, suggesting a higher 
affinity for NAD+ in the monomer.  
The fluctuations of NAD+ do not affect the global dynamics of the subunits in the tetramer 
because there is no difference in the RMSD (Figure S5.4) and RMSF (Figure 5.3) values between 
subunits that have large and small fluctuations in NAD+.  
 
Figure 5.10: RMSF of selected atoms of NAD+ in the tetramer, dimer, and monomer. RMSF is calculated 
for the selected atoms, shown as spheres, to quantify NAD+ motion during individual 100-ns MD 
trajectories (run 1 to 7, bottom to top) for the tetramer, dimer, and monomer. Each graph represents a single 
trajectory and each line in the graph represents the RMSF of the selected NAD+ atoms from each subunit 




Similar significant fluctuations of the nicotinamide moiety of NAD+ were also observed in MD 
simulations of Trypanosoma cruzi GAPDH-NAD+ in the tetramer form.166 MD simulations of the 
transition of T. cruzi apo- to holo-GAPDH shows that the angle between the Cα atoms of Arg80-
Glu317-Ser192 (residue number according to human GAPDH) decreases due to binding of 
NAD+.166 The large angle between Cα atoms of these three residues in apo- compared to holo-
GAPDH indicates an open form of NAD binding site in T. cruzi apo-GAPDH.166 We compared 
the angle between these residues (56-59 ° in crystal structure of the human GAPDH) with the 
movement of NAD+ measured by the distance between Cys152 and the positively charged nitrogen 
of NAD+ [Sγ(Cys152)–N+(NAD+); 5.5-5.6 Å in human GAPDH crystal structure] (Figure S5.7). 
The angle does not change with the increase in the distance indicates that fluctuation of NAD+ 
does not immediately affect the opening or closing of the NAD+ binding site in the GAPDH 
tetramer.  
5.4.10. GAPDH tetramer asymmetry and negative cooperativity  
It has been shown that the Cys152 is close to His179 in two subunits (one subunit from each stable 
dimer) and near the nicotinamide of NAD+ in the other two subunits of lobster GAPDH.192 This 
phenomenon is associated with the asymmetry in the GAPDH tetramer and indirectly represents 
NAD+ binding with the negative cooperativity to GAPDH tetramer. Thus, we compared the 
Sγ(Cys152)-NƐ(His179) and Sγ(Cys152)–N+(NAD+) distances in 9 runs of 100 ns of tetramer 
GAPDH (Table 5.1). Cys152 is close to His179 in one subunit and away in the other subunit of 
the OP or QR stable dimers of tetramer 11/18 times. This agrees with the observation of Rossmann 
and coworkers 192 that the distance Sγ(Cys152)-NƐ(His179)  is smaller in one subunit of each stable 




from the nicotinamide of NAD+ for 19/36 times suggesting Cys152 interaction with His179 could 
influence the negative cooperativity to NAD+ binding.  
 
Table 5.1 Variation in Sγ(Cys152)-NƐ(His179) and Sγ(Cys152)–N+(NAD+) distances in the human GAPDH 
tetramer a  
Run Distance Subunit-O Subunit-P Subunit-Q Subunit-R 
1 CH 9 89 4 99  
CN 100 22 52 100 
2 CH 28 13 54 86  
CN 5 100 100 100 
3 CH 24 96 100 38  
CN 68 99 100 69 
4 CH 43 71 96 90  
CN 100 99 100 99 
5 CH 12 68 100 100  
CN 37 67 100 2 
6 CH 48 55 16 18  
CN 100 69 80 99 
7 CH 100 41 85 18  
CN 100 96 100 100 
8 CH 22 97 76 98  
CN 16 100 50 38 
9 CH 26 31 98 90  
CN 100 26 100 52 
 
a The CH and CN denote Sγ(Cys152)-NƐ(His179) and Sγ(Cys152)–N+(NAD+) distances. The distances are monitored 
for each 100-ns trajectory of GAPDH tetramer. The number represents the time (ns) when the CH or CN distance 




5.5.1. Changes in the dominant motions upon deoligomerization of the GAPDH tetramer to 
dimer and monomer 
NMA (Figure 5.2) and PCA (Figure 5.5) reveal that the dominant motions are centered on the 




the direction opposite to the CTD of the same subunit reveal that dimer is less stable compared to 
tetramer. Also, the increase in anticorrelated motions (Figure 5.4a-c) between the NBD and CTD 
of the same subunit reveals destabilization of the interaction between the NBD and CTD 
subdomains in the dimer. Thus, deoligomerization of tetramer to dimer changes subdomain 
motions within a subunit. 
NMA reveals that the S-loop is more flexible, not the NBD, in the monomer. The MD 
simulations further confirm that the major motions are centered on the S-loop, as shown by the 4-
fold higher RMSFs (Figure 5.3c) and 25-fold higher square fluctuation along PC1 (Figure 5.5c,f) 
of the S-loop compared to other residues in the monomer. This signifies the importance of S-loop 
dynamics in the monomer and the NBD dynamics the in dimer and tetramer. Although the 
monomer retains highly correlated motions within the NBD, these are lost within the CTD (Figure 
5.4f) revealing its destabilization. However, NMA reveals instability in both NBD and CTD 
subdomains of the monomer (Figure S5.3f). Thus, the loss of highly correlated motions within 
subdomains reveals the monomer is less stable compared to the tetramer and dimer. The instability 
of the monomer is also represented by the highly anticorrelated motions of the S-loop with all 
other residues. Since the S-loop and NBD move opposite to each other, this allows the S-loop to 
attain the open/closed conformation as shown by FEL (Figure 5.7a).  
5.5.2. Importance of S-loop flexibility in the function of the GAPDH monomer and dimer 
NMA of the crystal structure and MD simulations reveal that the S-loop is highly flexible in the 
monomer. The S-loop also is more dynamic in the dimer compared to the tetramer, but less 
dynamic in the monomer. S-loop flexibility is observed in the crystal structure of apo-GAPDH 
from K. marxianus (PDB: 2I5P), which is proposed to be a transition structure from the tetramer 




bound NAD+.165 Also, dimeric B. stearothermophilus GAPDH has less affinity for NAD+ 
compared to its tetramer.77 Thus, the large movement of the S-loop during MD simulations of the 
dimer and monomer could be a pathway for the dissociation of the GAPDH tetramer to the dimer 
and to the monomer. The dissociation of the tetramer is highly likely to occur because of the 
simultaneous process of removal of NAD+ from its binding site and increased flexibility in the S-
loop.  
Moreover, the inactivity of the dimer (equivalent to the dimer-QR) in B. stearothermophilus 
GAPDH77 can be explained by its flexible S-loops, which expose the active-site to the solvent and 
inactivate the dimer. Additionally, disulfide bond formation between catalytic Cys152 residue to 
form the aggregates, implicated in neurodegenerative disease,193 could be explained by the flexible 
S-loop in the monomer. Because Cys152 is buried in the protein matrix in the tetramer, as it is 
covered by the S-loops, disulfide bond formation between the catalytic Cys152 of two subunits is 
impossible due to steric clashes (Figure 5.1c), as shown previously.189 However, a highly flexible 
S-loop would expose Cys152 and allow disulfide bond formation in monomer or dimer. Note that 
the same report proposed that Cys281 (residue number according to rabbit muscle GAPDH) is 
involved in aggregation, but the equivalent cysteine residue is not present in human GAPDH. 
The increased flexibility in the S-loop could induce binding of monomer or dimer of GAPDH 
to other proteins. Also, the exposure of the catalytic Cys152 could allow it to react with residues 
of other proteins. Thus, S-loop motions could play an important role in different functions of 
monomer or dimer of GAPDH.  
Apart from the S-loop, residues Arg234–Asn239 and Glu278–Thr290 are more flexible than 
other residues of the CTD in the monomer. Interestingly, Arg234-Asn239 are part of the residues 




neuronal cell death after S-nitrosation of GAPDH (See Chapter 6).14 Siah1 is assumed to bind to 
the GAPDH tetramer, but the large movement in this region during MD simulations of the GAPDH 
monomer suggests that the Arg234-Asn239 loop could play important role in GAPDH-Siah1 
binding. 
5.5.3. Insight into the glycolytic active-site  
The weak interaction between Sγ(Cys152)-NƐ(His179) in dimer and tetramer compared to the 
monomer indicate that the reactivity of Cys152 may change upon deoligomerization. However, 
the interaction is mostly stable during MD simulations, which suggests that the charged Cys152 
and His179 stabilize the active-site in the tetramer, dimer, and monomer. Residues Cys152 and 
Cys156 in the glycolytic active-site of GAPDH are in proximity to each other, but Cys156 is buried 
inside the protein matrix (Figure 5.1). Additionally, Cys156 is located in a helix, which adds 
additional structural constraints to keep Cys152 and Cys156 away from each other. This is evident 
from the Sγ(Cys152)-Sγ(Cys156) distance (>8 Å) in the tetramer, dimer, and monomer calculated 
during MD simulations (Figure S5.8). Thus, a disulfide bond between Cys512 and Cys156 is 
highly unlikely in the three oligomeric states of GAPDH.  
Water molecules are readily accessible to the Cys152, but not Cys156 (Figure S5.9). This 
suggests that Cys152 can be readily oxidized, but Cys156 oxidation is less probable. Additionally, 
the oxidation sensitivity of Cys152 and Cys156 does not change upon opening of the S-loop in the 
monomer. Although, Cys156 might not be directly involved in the oxidation of Cys152 but could 
influence it by a proton relay mechanism as proposed by Peralta et al. (Section 4.4.10).167 We 
observed a similar strong H-bond interaction between Oγ(Thr153)-Oζ(Tyr314) in the tetramer, 
dimer, and monomer (Figure S5.10).  




5.5.4. Cooperativity of NAD+ binding to GAPDH  
NAD+ movement in one or two subunits only may be attributed to the negative cooperativity of 
NAD+ binding to the tetramer. There is no change in Arg80-Glu317-Ser192 angle (Figure S5.7), 
indicating no changes in the size of the NAD+ binding site upon NAD+ movement. Also, there is 
no direct correlation between the movement of a specific residue and NAD+. Thus, the negative 
cooperativity could be due to collective motions of the NBDs in the tetramer as shown by PCA 
(Figure 5.5).  
The flexible S-loop in its closed conformation stabilizes the interaction of NAD binding 
residues with nicotinamide of NAD+ (cluster-2) in the monomer (Figure 5.7). Similarly, the 
flexible S-loop could stabilize interaction with NAD+, making up for the loss of affinity for NAD+ 
upon solvent exposure of the adenosine binding site in the dimer. This explains the positive 
cooperativity found in the dimer of B. stearothermophilus GAPDH, where the first NAD+ (K1 = 
5.20 ± 0.43 μM) binds less tightly than the second NAD+ (K2 = 1.51 ± 0.16 μM).77  
5.6. Conclusions 
Our study highlights the alterations in the dominant motions of the subdomains upon 
deoligomerization of the GAPDH tetramer to the dimer or monomer. Specifically, we show that 
NBD motions are dominant in the tetramer and dimer. NBD and CTD of the same subunit move 
in opposite direction to each other in the dimer. Also, the dominant motions are centered on the S-
loop in monomer. The highly flexible S-loop in the monomer and in the dimer to lesser extent 
suggests that the monomer and dimer favor binding with other protein partners to stabilize the 
disordered S-loop. Interactions of monomer or dimer of GAPDH with other protein partners could 




We show that the dimer and monomer are less stable compared to the GAPDH tetramer. 
Deoligomerization of the tetramer to the dimer leads to increased anticorrelated motions between 
NBD and CTD of the same subunit. Further deoligomerization to monomer leads to anticorrelated 
motions within both the NBD and CTD. Lower stability is also evident from the more flexible S-
loop in dimeric and monomeric GAPDH.  
NAD+ binding is very dynamic as shown by its fluctuations during MD simulations of the 
tetramer, dimer and monomer. However, there are no significant changes in the NAD-binding 
residues upon deoligomerization of the tetramer to the dimer or monomer. Also, our study 
confirms that disulfide bond formation is highly unlikely between Cys152-Cys156 in the three 
oligomeric states of GAPDH but tetramer dissociation to the monomer might affect the oxidation 
sensitivity of GAPDH due to the increased flexibility of the active-site. In sum, our study shows 
that the tetramer, dimer, and monomer posses specific structural dynamics that could influence 





5.7. Supporting Information 
 
Figure S5.1: Subdomains and active-site residues in the GAPDH subunit. (a) Subdomains including the 
NAD-binding domain (NBD; residues 1-151 & 315-335; cyan), catalytic domain (CTD; residues 152-314; 
white) and S-loop (residues 181-205; orange) are shown. (b) The position of catalytic Cys152 and other 
active-site residues are shown as sticks. NAD+ is shown in magenta colored sticks.  
 
Figure S5.2: Normal mode analysis (NMA) of the dimer-OQ, -PR, -OR and -PQ carried out using ANM. 
Square fluctuation of the Cα atoms of (a) dimer-OQ, (b) dimer-PR (c) dimer-OR and (d) dimer-PQ along 






Figure S5.3: CCA carried out for C, Cα, N, and O backbone atoms of the tetramer, dimer, and monomer 
using ANM. We used the crystal structure of the tetramer of human GAPDH and extracted the dimer and 
monomer. Inter-subunit cross-correlated motions of (a) subunit-O and subunit-P of the tetramer, (b) 
subunit-Q and subunit-R of the tetramer are compared with (c) dimer. The intra-subunit cross-correlated 
motions of (d) a tetramer subunit, (e) a dimer subunit and (f) monomer are compared to highlight the 







Figure S5.4: Convergence of MD simulations trajectories evaluated with Good-Turing statistical analysis 
and root mean square deviation (RMSD). Good-Turing statistical analysis was carried out using the Cα 
atoms extracted at every 20 ps for tetramer, dimer, and monomer from a 300 ns trajectory. No change in 
the shape of the curve going from 100- to 300-ns trajectory indicates that 100-ns trajectories are converged. 
RMSD was calculated for the 7 x 100 ns MD trajectories for the three oligomeric states. RMSD does not 





Figure S5.5: Free energy landscape (FEL) plotted using a projection of the Cα atoms along PC1 and PC2. 
PCA was carried out using the concatenated 7 x 100 ns MD trajectories of (a-d) tetramer subunits, (e,f) 
dimer subunits and (g) monomer. The black dot in each panel indicates crystal structure geometry of 
subunit-O of the tetramer. The unit for free energy is kcal/mol. 
 
 
Figure S5.6: FEL plotted using a projection of Cα atoms and heavy atoms of sidechains of residues around 
4 Å of NAD+ (NAD binding site residues). PCA was carried out using the concatenated 7 x 100 ns MD 
trajectories of (a-d) tetramer subunits, (e, f) dimer subunits and (g) monomer. The black dot in each panel 





Figure S5.7: Flexibility of NAD binding site with respect to NAD+ fluctuation. Comparison between Arg80-
Glu317-Ser192 (red line) angle and Sγ(Cys152)–N+(NAD+) distance (SN distance; blue line) of (a) subunit-
O (b) subunit-P (c) subunit-Q (d) subunit-R of tetramer in 7 individual 100 ns MD trajectories (run 1 to 7, 





Figure S5.8: The distance between Sγ(Cys152)– Sγ(Cys156) in the tetramer, dimer, and monomer. (a) 
Relative frequency of the distance is calculated using concatenated 7 x 100 ns MD simulations trajectories. 
(b) The position of Cys152 and Cys156 in the active-site of subunit-O of the crystal structure of human 
GAPDH. The distance is shown as a red dotted line.  
 
 
Figure S5.9: Number of water molecules near Cys152 and Cys156. Relative frequency of a number of water 
molecules near 3 Å of (a-c) Cys152 and (d-f) Cys156 calculated using the concatenated 7 x 100-ns 







Figure S5.10: The distance between Oγ(Thr153)-Oζ(Tyr314) in the tetramer, dimer, and monomer. (a) 
Relative frequency of the distance is from the concatenated 7 x 100 ns trajectories of the tetramer, dimer, 
and monomer. (b) The position of Cys152 and Cys156 in the active-site of subunit-O of the crystal structure 





























Chapter 6. Computational Modeling of Glyceraldehyde-3-Phosphate 


























6.1. Abstract  
The role of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in apoptosis is associated with 
complexation and stabilization of seven-in-absentia homolog 1 (Siah1). Upon GAPDH S-
nitrosation the complex, formed between S-nitrosylated GAPDH and Siah1, is translocated to the 
nucleus, which initiates a cascade of events to trigger apoptosis. It is proposed that the GAPDH 
tetramer forms a complex with four Siah1 dimers to give ~400 kDa complex. However, our 
docking analysis of the GAPDH tetramer and monomer with the Siah1 dimer and monomer 
indicates stronger complex formation between the GAPDH monomer and Siah1 dimer (~110 kDa 
complex) or monomer (~80 kDa complex), compared to that between the GAPDH tetramer and 






Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is implicated in apoptosis. This is a 
mechanism of cell death, which in neurons contributes to neurodegenerative diseases.1,15,24,194,195 
However, the mechanism of GAPDH’s accumulation in the nucleus during apoptosis was poorly 
understood until recently because the enzyme does not have a nuclear localization signal (NLS). 
Nuclear translocation of GAPDH is associated with S-nitrosation of its catalytic Cys152, which 
leads to its binding to the unstable seven-in-absentia homolog 1 (Siah1),14,181 an E3 ubiquitin ligase 
that has a NLS. It was shown that binding to S-nitrosated GAPDH stabilizes Siah1 in cells. The 
complex is translocated into the nucleus by the NLS on Siah1 and Siah1 facilitates degradation of 
nuclear targets to promote apoptosis.14 A further study by the same group reported that GAPDH 
is acetylated at Lys160 by the acyltransferase P300/cAMP response element-binding protein 
(P300/CBP) in the nucleus to increase cytotoxicity.196 GOSPEL (GAPDH’s competitor Of Siah 
Protein Enhances Life) was found to compete with Siah1 for complex formation with GAPDH to 
retain GAPDH in the cytoplasm and decrease cytotoxicity of the GAPDH-Siah1 complex.28  
The question arises as to how a small post-translational modification such as S-nitrosation 
initiates complex formation between GAPDH and Siah1. What structural changes occur in 
GAPDH on S-nitrosation? What are the molecular level interactions between Siah1 and GAPDH? 
It is proposed that the GAPDH tetramer binds to Siah1 but, monomeric GAPDH is found in the 
nucleus.87 Also, nitric oxide-induced S-nitrosation of GAPDH is proposed to alter the equilibrium 
between monomers, dimers, and tetramers of GAPDH.197 Thus, we hypothesize that the GAPDH 
monomer is formed upon S-nitrosation, and it interacts with Siah1 to form a stable complex rather 




Human GAPDH, a homotetramer, is 150 kDa protein. Each subunit (labelled O, P, Q and R) 
contains a NAD-binding domain (NBD; residues 1-151, 315-335) and a catalytic domain (CTD; 
residues 181-205) (Figure 6.1a,b). Residues 222-240 (yellow), implicated in Siah1 binding, are 
located at the dimer interface of subunits interacting across the P-axis.14 Mutation of Lys227 
(yellow spheres) causes loss of Siah1 binding, indicating the importance of this GAPDH residue 
in complex formation.14 The Siah1 subunit consists of an N-terminal RING (Really Interesting 
New Gene) domain, which is involved in its ligase function, two zinc-finger subdomains and a C-
terminal substrate-binding domain (SBD; residues 90-282), which is involved in the formation of 
the Siah1 dimer.198,199 All the crystal structure of Siah1 do not have resolved the structure of the 
RING domains. Residues 270-282 of Siah1 are involved in its binding with GAPDH. These 
residues are part of the SBD (residues 90-282), which is located at the dimer interface of Siah1.  
Based on the information about the residues involved in GAPDH and Siah1 complex 
formation, a docking study was carried out to probe binding between these two proteins.105 This 
study proposed that the GAPDH tetramer binds with four Siah1 dimers, making the complex of ~ 
400 kDa.105 Although, the NLS can translocate large nucleic acids of 100-200 kDa,200,201 the large 
complexes of ~ 400 kDa size are not that easy to translocate. Our hypothesis is that the GAPDH 
monomer forms a complex with either the monomer or dimer of Siah1 to create a complex of ~ 80 
or ~ 110 kDa, respectively.  
We carried out docking analysis to model the complex of GAPDH and Siah1. The electrostatic 
surface of GAPDH and Siah1 were evaluated for the complementarity between both the GAPDH 





Figure 6.1. Structural features of human GAPDH (PDB 1U8F) and Siah1 (PDB 4C9Z). The secondary 
structure of the human GAPDH (a) homotetramer and (b) its subunit, showing the NAD binding domain 
(NBD, blue; residues 1-151, 315-335), the catalytic domain (CTD, green; residues 152-314) and the S-loop 
(orange; residues 181-205). Residues 222-240 of the CTD (yellow) are implicated in Siah1 binding and the 
yellow spheres are Lys227. (c,d) The secondary structure of Siah1. Residues 215-232 (magenta) correspond 
to nuclear localization signal (NLS) and residues 270-282 (grey) are implicated in binding to GAPDH. Note 




6.3. Computational Methods 
We used the crystal structures of human GAPDH (PDB 1U8F) and human Siah1 (PDB 4C9Z) to 
generate electrostatic surfaces of these proteins. The crystal structures do not have hydrogen atoms 
so we used the PDB2PQR server 202 to generate forcefield parameters, add hydrogen atoms, and 
protonate residues to optimize the hydrogen bonding networks in order to prepare the structures 
for calculations of the electrostatic potential surface. The distribution of electrostatic charges in 
the two protein structures was calculated in water with 0.15 M NaCl using Adaptive Poisson-
Boltzmann Solver (APBS) software 203 and mapped onto their molecular surfaces. PyMol 204 was 
used to visualize the electrostatic surfaces and the secondary structure of the proteins.  
A combination of webservers, PatchDock 205,206 and FireDock 207,208 was used for the docking 
studies. PatchDock carries out rigid-body docking by dividing the surfaces of the two proteins into 
small patches based on their shapes. These patches are matched and superimposed based on their 
surface complementarity. Complexes with steric clashes are filtered and the remaining complexes 
are ranked based on a shape complementarity score. PatchDock generates 1000 complexes, and 
the top 20 complexes were further refined and scored by FireDock. This refines the complexes by 
side-chain rearrangement, which were modeled based on their rotamers. The complexes were 
further refined by soft rigid-body rotation of the proteins and the refined complexes were ranked 
based on the binding score. We visualized the top 10 binding complexes based on the score and 





6.4. Results and Discussion 
6.4.1. Electrostatic surfaces of GAPDH   
The electrostatic charges mapped on the GAPDH tetramer show a large positively charged surface 
area (blue) along the P-axis with small scattered negatively charged surface regions (red) (Figure 
6.2a). The electrostatic surface close to Lys227 is mostly negatively charged (Figure 6.2b), 
indicating that the proposed binding site of Siah1 close to Lys227 should have a complementary 
positively charged surface. We also observe a narrow negatively charged cavity along the Q-axis 
(Figure 6.2c). A similar negatively charged cavity is observed in the crystal structure of GAPDH 
from other species (e.g. P. versicolor and B. stearothermophilus GAPDH, data not shown) but, the 
corresponding cavity is positively charged in lactate dehydrogenase and mitochondrial aldehyde 
dehydrogenase (ALDH2). Thus, this structural feature might be unique to GAPDH but its role in 
the different functions of GAPDH has not been investigated.  
In contrast to the GAPDH tetramer (Figure 6.2a,b), the electrostatic surface of the GAPDH 
monomer shows a positively charged surface area close to Lys227 on removal of the other 
subunits, especially those interacting across the P-axis (Figure 6.3a,b).  Also, residues 222-240 of 
GAPDH implicated in Siah1 binding are exposed, enabling direct interaction with Siah1. The 
electrostatic surface in the monomer has large positively charged surface on one side and large 





Figure 6.2. Electrostatic surface of the GAPDH tetramer. The structural pose in panel (a) is similar to that 
in Figure 6.1a. The tetramer is rotated in panel (b) to show the electrostatic surface close to Lys227, which 
is implicated in Siah1 binding. Note that residues 222-240, implicated in Siah1 binding, are mainly buried 
in the protein matrix between the subunits interacting across the P-axis. Panel (c) shows the electrostatic 
surface of cavities inside the GAPDH tetramer. The large positively charged cavities along the R-axis 
represent the NAD-biding sites, whereas the negatively charged cavity along the Q-axis represents a tunnel 
between subunits interacting across the Q-axis. The secondary structure of the protein is shown as white 
tubes. The contour scale for electrostatic surface is -1 kT/e (red) and +1 kT/e (blue). PyMol was used for 
visualization of electrostatic potential surface. 
 
Figure 6.3. Electrostatic surface of the GAPDH monomer. The structural pose in panel (a) is similar to the 
one shown in Figure 6.1b. The monomer structure is rotated by 90  ̊in panel (b) to show the electrostatic 
surface area close to residues 222-240, including Lys227, which are implicated in Siah1 binding. Note that 




6.4.2. Electrostatic surface of the Siah1 dimer and monomer  
The Siah1 dimer has a large negatively charged electrostatic surface with a small positively 
charged area near the zinc-finger domain (Figure 6.4a,b). The surface close to residues 270-282, 
implicated in GAPDH binding, are highly negatively charged (Figure 6.4b). However, the 
electrostatic surface area of the GAPDH tetramer near Lys227 is mostly negatively charged 
(Figure 6.2b) suggesting that the tetramer is unlikely to form a strong complex with the Siah1 
dimer. Separation of the GAPDH subunits exposes a positively charged electrostatic surface patch 
near Lys227 and residues 222-240 in the GAPDH monomer (Figure 6.3). This positively charged 
area should favor the interaction of Siah1 with the GAPDH monomer. Siah1 is known to exist as 
a dimer, but the monomer also could interact with GAPDH. Thus, we looked at the electrostatic 
surface at the Siah1 dimer interface and find that the interface has a complementary positive and 
negative charged regions between to subunits. Hence, Siah1 monomer could be a better binding 
partner for monomer GAPDH. 
6.4.3. Docking of the GAPDH tetramer with the Siah1 dimer 
We carried out docking analysis with the GAPDH tetramer as a target and the Siah1 dimer as 
a substrate without targeted docking. The Siah1 dimer was allowed to explore interactions with all 
regions of the GAPDH tetramer without any constraints. However, multiple runs with different 
parameters did not reveal any docking pose where residues 270-282 of Siah1 bind close to Lys227 
of GAPDH. Thus, we defined a binding site in GAPDH close to Lys227 and Siah1 close to residues 
281-282, which are part of the residues implicated in GAPDH binding, to perform a targeted 
docking analysis. Only one docking pose was found , where Lys227 interacts with residue 281 and 
282 (Figure 6.5a,b). The GAPDH tetramer interacts mainly with the zinc-finger domain of the 




GAPDH interacts with the SBD of Siah1. They further used the symmetry of GAPDH to generate 
a complex of the GAPDH tetramer with four Siah1 dimers, two the dimers OP and QR of the 
GAPDH tetramer. However, our analysis produces no docking pose similar to the published 
report.105 Furthermore, our analysis indicates that the complex formed by the GAPDH tetramer 
and Siah1 dimer is weak with very small interface area. 
 
Figure 6.4. Electrostatic surface of the Siah1 dimer. The poses in panels (a) and (b) are similar to those 
shown in Figure 6.1c and 6.1d, respectively. The electrostatic surface of the Siah1 dimer is mostly 
negatively charged, so its interaction with GAPDH requires positively charged complementary regions. 
Residues 270-282, implicated in GAPDH binding, are in the region highlighted by the yellow lines. The 
green curved lines mark residues 215-232, which contains the nuclear localization signal (NLS). Panels (c) 
and (d) show the interacting electrostatic surface of subunit-A with subunit-B. Positive and negative region 
complement each other at the binding interface. Note that the structural pose in panels (c) and (d) is similar 




   
Figure 6.5. Docking analysis of the GAPDH tetramer and the Siah1 dimer. (a) The secondary structure of 
the docking pose of the GAPDH tetramer (green) interacting with the Siah1 dimer (cyan). Residue Lys227 
(yellow sphere) of GAPDH interacting with residues 281-282 (grey) of Siah1. (b) Electrostatic surface of 
the GAPDH tetramer - Siah1 dimer complex from the docking analysis. The green lines on Siah1 indicate 
residues 270-280. The interacting electrostatic surface of (c) the GAPDH tetramer and (d) the Siah1 dimer 
shows little complementarity between them, which indicates weak interactions between the two proteins. 
Note that the structures in panels (c) and (d) are rotated to show the interacting surface, which is similar to 
the pose shown in Figure 6.2b. See caption to Figure 6.2 for details. 
6.4.4. Docking of the GAPDH monomer with the Siah1 dimer 
The docking analysis, without specifying any interacting residues, shows that among the top 10 
poses, the top two poses and three others involve interactions with Lys227 of the GAPDH 
monomer and residues 281-282 of the Siah1 dimer (Figure 6.6). The remaining five poses do not 




they are not preferred binding poses. The preferred docking pose would be similar to that shown 
in Figure 6.6.  
We refined the docking analysis by defining Lys227 of the GAPDH monomer and residues 
281-282 of the Siah1 dimer as interacting regions. This analysis imposes constraints to keep the 
defined regions close to each other and filters out docking poses that lack interactions between the 
specified residues. We visualized the top ten poses and show one in Figure 6.7, which reveals that 
the largely positively charged electrostatic surface area of the GAPDH monomer interacts with the 
negatively charged electrostatic surface area of the SBD of the Siah1 dimer. These interactions 
represent the large electrostatic surface complementarity and strong interaction between the 
GAPDH monomer and the Siah1 dimer.  
Note that the binding pose in Figure6.7a shows that the SBD of Siah1 is near the S-loop of 
GAPDH (orange, residues 181-205), which is disordered and highly dynamic in the GAPDH 
monomer (Section 5.4.6). Our MD simulations show that the S-loop of the GAPDH monomer 
moves away from its NBD and attains an open/closed conformation (Figure 5.7). Stabilization of 
the S-loop by the binding of the Siah1 dimer to the GAPDH monomer will further promote the 






Figure 6.6. Blind docking analysis of the GAPDH monomer (green; left) and Siah1 dimer. The five poses 
from the top ten with interactions between residues of 222-240 of GAPDH (yellow β-sheet) and 270-282 
of Siah1 (black β-sheet). The preferred binding pose for the Siah1 dimer - GAPDH monomer complex 
should be similar to those shown in this image. 
 






Figure 6.7. Docking analysis of the GAPDH monomer and the Siah1 dimer. (a) The secondary structure of 
the docking pose of the GAPDH monomer (green) interacting with the Siah1 dimer (cyan). Residue 222-
240 (yellow β-sheet) and Lys227 (yellow spheres) of GAPDH are in close proximity to residues 270-282 
(black β-sheets) of Siah1. (b) Electrostatic surface of the complex in the same pose. Note that mostly the 
SBD (residues 90-282) of Siah1 interacts with GAPDH. The interacting electrostatic surface of (c) the 
GAPDH monomer and (d) Siah1 dimer show the high complementarity between the interacting residues. 
Largely positively charged surfaces of GAPDH interact with the mostly negatively charged surface of 
Siah1, indicating strong interaction between the GAPDH monomer and Siah1 dimer. Note that the 




6.4.5. Docking of the GAPDH monomer with the Siah1 monomer 
The results of blind docking of the GAPDH monomer with Siah1 monomer show that in four of 
the top ten docking poses, residue Lys227 of GAPDH and residues 281-282 of Siah1 are near each 
other (Figure 6.8). Thus, the preferred docking pose should be similar to Figure 6.8, where residues 
222-240 of GAPDH are close to residues 270-282 of Siah1.  
 
Figure 6.8. Blind docking analysis of the GAPDH monomer (green) and Siah1 monomer. The four poses 
from the top ten poses show interactions between residues of 222-240 of GAPDH (yellow β-sheet) and 
270-282 of Siah1 (black β-sheet). The preferred binding pose for Siah1 monomer - GAPDH monomer 






Figure 6.9. Docking analysis of the GAPDH monomer and the Siah1 monomer. (a) The secondary structure 
of the docking pose of GAPDH monomer (green) interacting with the Siah1 monomer (cyan). Residue 222-
240 (yellow β-sheet) and Lys227 (yellow spheres) of GAPDH monomer are in close proximity to residues 
270-282 (black β-sheets) of Siah1. (b) Electrostatic surface of the complex in the same docking pose. Note 
that mostly the SBD (residues 90-282) of Siah1 interacts with GAPDH. The interacting electrostatic surface 
of the (c) GAPDH monomer and (d) Siah1 monomer. Note, the high complementarity between the 
interacting residues. Largely positively charged surfaces of GAPDH interacts with the negatively charged 
surface of Siah1, indicating strong interactions between the GAPDH and Siah1 monomers. Note that the 




Targeted docking analysis performed by defining the binding site near Lys227 of GAPDH and 
residues 281-282 of Siah1 showed similar docking poses to those in Figure 6.8. One of the selected 
docking poses in Figure 6.9 reveals that the positively charged electrostatic surface of GAPDH 
monomer interacts with the negatively charged electrostatic surface of the Siah1 monomer. Similar 
complementarity is seen for the interacting surface between GAPDH monomer and Siah1 dimer 
complex (Figure 6.7) but the GAPDH monomer interface with Siah1 dimer (interface area 1121 
Å2)  is larger than with the Siah1 monomer (723 Å2) as calculated with PDBePISA server.209 
Similar to the GAPDH monomer and Siah1 dimer complex, the binding pose for the GAPDH 
monomer - Siah1 monomer complex also shows interactions between the S-loop of GAPDH and 
the SBD of Siah1. This would stabilize the S-loop of the GAPDH monomer and favor complex 
formation. 
6.5. Conclusions  
Analysis of electrostatic surfaces predicts that the GAPDH monomer has a large complementary 
surface area for Siah1 binding, but not the GAPDH tetramer. The docking analyses further confirm 
the formation of a stable complex between the GAPDH monomer and the Siah1 dimer or monomer 
but the GAPDH tetramer does not form a stable Siah1 complex. Complex formation with the 
GAPDH monomer would stabilize its S-loop, which is disordered and highly dynamic. Also, 
stabilization of the S-loop in the GAPDH monomer by protein partners other than Siah1 could be 
favored and contribute to the numerous moonlighting functions of GAPDH. Further experimental 



















Chapter 7. Quantum Mechanics / Molecular Mechanics Simulations of 




























7.1. Abstract  
Thionitrates (E-Cys-NO2) are active intermediates, which are implicated in the biotransformation 
of organic nitrates by enzymes containing active thiols (E-Cys). Our study on the decomposition 
of CH3SNO2, a model compound for E-Cys-NO2, indicate that the activation barriers are small for 
thionitrate decomposition by hydrolysis and thiolysis and can even involve a barrierless pathway. 
However, the activation barriers were not evaluated in an enzyme active-site. Thus, we carried out 
quantum mechanics / molecular mechanics (QM/MM) simulations to investigate E-Cys-NO2 
decomposition in the active-site of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
QM/MM simulations reveal that hydrolysis of E-Cys-NO2 by OH
– involve proton relay between 
3 water molecules and the activation free energy is ~ 50 kcal/mol, which is comparable to the 
decomposition of CH3SNO2 by one water molecule. We do not see the attack of OH
– along S–N 
bond, thus further QM/MM simulations are required to investigate all the pathways for 





Thionitrates are active intermediates in organic nitrate decomposition.54 Many enzymes such as 
mitochondrial aldehyde dehydrogenase (ALDH2)52 and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 48 are implicated in the biotransformation of glyceryl trinitrate (GTN), 
a prodrug that releases nitrite (NO2
–) or nitric oxide (NO) upon decomposition. The consensus 
emerged that the catalytic cysteine residue of these enzymes forms a thionitrate (E-Cys-NO2) in 
the enzyme active-site.54 This was further confirmed by the crystal structure of a triple mutant of 
ALDH2, which showed for the first time E-Cys-NO2 formation in the enzyme active-site.
55,58 
Various computational and experimental studies of small molecule thionitrates (RSNO2) were 
carried out to explain the underlying mechanism of E-Cys-NO2 decomposition.
56,62,64,65,115,117  
In Chapter 2 of this thesis, we use CH3SNO2 as a model compound for E-Cys-NO2 to 
understand the mechanism of its decomposition using state-of-the-art quantum mechanics (QM) 
calculations. We calculated activation barriers for all the proposed pathways for decomposition of 
thionitrate (Figure 2.1) in the gas phase and solvent effects were included using an implicit solvent 
model. Our study shows that the activation barriers for thionitrate decomposition via homolysis, 
which releases NO, are prohibitively high (> 40 kcal/mol), whereas hydrolysis and thiolysis, which 
releases NO2
–, are substantially smaller (~ 17 kcal/mol). We further showed that linear attack along 
S–N bond by anionic nucleophiles, such as OH– and CH3S–, are barrierless (~ 0 kcal/mol). The 
implicit solvent model includes solvation effect using different dielectric constant but the effect of 
the enzyme active-site was not included in our previous study. However, a computational study 
treating the whole protein using quantum mechanics is impossible thus, we used a hybrid quantum 
mechanics / molecular mechanics (QM/MM) approach to include the effect of the enzyme active-




investigate the hydrolysis of E-Cys-NO2 in the GAPDH active-site. We evaluated hydrolysis by 
an attack of water and OH– in the active-site of GAPDH. Hydrolysis by H2O does not give the 
expected reaction coordinates so, we show the only hydrolysis by OH– in the GAPDH active-site.  
7.3. Computational Methods 
We extracted a subunit-P from the crystal structure of human GAPDH (PDB 1U8F) 105 to generate 
thionitrate at catalytic Cys152. We used a similar approach to that described in Section 3.3 to 
prepare the GAPDH-monomer-Cys152-NO2 (here onwards denoted as GAPDH-NO2) for 
molecular dynamics (MD) simulations. We carried out 10 ns MD simulations using the NPT 
ensemble with CHARMM27 force field 106,174 and NAMD2.9 99 software. We chose one of the 
consensus poses as the reactant starting point for the QM/MM calculations. 
QM/MM calculations were carried out using the CP2K program 210. The energy for the QM 
region was calculated by the Becke−Lee−Yang−Parr (BLYP)  density functional method 211 and 
triple zeta plane wave Gaussian basis sets with Goedecker−Tetter−Hutter pseudopotential (TZVP-
GTH).212,213 The link atoms between the QM and MM region were defined by integrated molecular 
orbital molecular mechanics (IMOMM) approach. QM/MM simulations were performed at a 
constant temperature and volume.   
We constrained the S(Cys152-NO2)---O(OH
–) distance and the mean force calculated based 
on the time average of Lagrange parameter obtained from the simulations with imposed constraint. 
The potential of mean force is then calculated by numerical integration of the mean force.214  
7.4. Results and Discussion 
In Section 2.1 of this thesis, we proposed that Glu317 in the vicinity of Cys152 in the GAPDH 




nitrite. We also showed that reaction of CH3SNO2 with OH
– has small activation barrier of ~ 17 
kcal/mol for top OH– attack (Figure 2.6a), whereas the linear attack along the S–N bond by OH– 
is barrierless (Figure 2.6c). The first GAPDH-NO2 MD simulation carried out showed a water 
molecule close to Cys152-NO2 and Glu317 (Figure 7.1a). We replaced the water molecule with 
OH– and carried out MD simulations to investigate the reaction of OH– with Cys152-NO2. We 
examined two scenarios: one where MD simulations were performed with Glu317 in the glutamate 
form (deprotonated) and one with Glu317 in the glutamic acid (neutral) form. OH– moves towards 
the protonated His179 and forms strong H-bond interactions within a short MD simulation (2 ns), 
when Glu317 is in the deprotonated form. However, OH– forms a strong H-bond with the neutral 
sidechain of Glu317.  
 
Figure 7.1. Water and OH– in the vicinity of Cys152-NO2 in the active-site of GAPDH. (a) MD simulations 
indicate that a water molecule is present in the vicinity of Cys152-NO2 and Glu317. (b) MD simulations 
with OH– in the active-site and Glu317 in its glutamate form show that OH– moves towards the protonated 
His179 to form H-bond interactions. (c) MD simulations with OH– in the active-site and Glu317 in neutral 
form show OH– forms a strong H-bond interaction with Glu317 and remains in a position to attack the 
sulfur of Cys152-NO2. 
 
We used one of the consensus snapshots from the MD simulations with OH– in the active-site 




distance in sidechain of Glu317 so it does not interact with OH– to form a water molecule. We 
selected the sidechains of residues Ile14, Cys152, His179, Asn316, Glu317, Tyr320 (ball-stick 
model) and five water molecules around Cys152 and Glu317 as the QM region (Figure 7.2a). The 
rest of the system was treated as the MM region. The S(Cys152)----O(OH–) distance was scanned 
at a window of 0.2 Å and a 2-ps QM/MM simulation was carried out, with a total of 24 ps. At the 
end of each 2-ps QM/MM simulation window, the last geometry was used for the new window.  
OH– forms a H-bond interaction with a water molecule, which is bridged between OH– and 
Glu317 (Figure 7.2). OH– extracts a proton from the water molecule and is converted to a water 
molecule, which attacks sulfur of Cys152-NO2.  Thus, the reaction coordinates indicate a top attack 
of a water molecule assisted by 3 water molecules seen in Section 2.4.3.  
The potential of mean force for the reaction indicates that the formation of Cys152-OH, where 
the S–O distance is 1.71 Å, requires ~ 48 kcal/mol activation free energy. Thus, the QM/MM 
values agree with that calculated for CH3SNO2 hydrolysis by one water molecule (Table 7.1). 
However, the QM/MM reaction involves three water molecules (Figure 7.2) and hence 
overestimates the activation free energy compared to CH3SNO2 hydrolysis by three water 






Figure 7.2. Reaction coordinates for OH– attack on Cys152-NO2 calculated with QM/MM. Residues Ile14, 
Cys152, His179, Asn316, Glu317, Tyr320 (ball-stick model), OH– (ball-stick model) and 5 water molecules 
(stick model) are included in the QM region, while the rest of the system is considered as the MM region. 
The snapshots of the reaction are taken at S(Cys152-NO2)–O(OH–) distances of (a) 3.3, (b) 2.9, (c) 2.3, (d) 







Figure 7.3. The potential mean force of OH– attack on Cys152-NO2 calculated with QM/MM. Cys152-OH 
with S–O distance of 1.7 Å formation requires ~ 48 kcal/mol.  
 











CCSD(T)//MP2/aug-cc-pVTZ  61.2 35.7 
BLYP/6-311G(2df,2pd) 45.8 28.2 
BLYP/6-311G+(2df,2pd) 51.1 32.6 
BLYP/Def2TZVP 49.8 30.7 
BLYP/Def2TZVPP 50.3 31.7 
 
QM/MM simulation showed that H2O, not OH
–, attacks S atom. Thus, the simulations were 
carried out with constrained O–H distances of the QM water molecules and the sidechain of 




7.5) due to favorable electrostatic interactions between anionic nucleophile OH– and σ-hole on 
sulfur atom (See section 2.4.5). The attack of OH– along the S–N bond in the active-site of GAPDH 
is barrierless (Figure 7.5), as also seen for CH3SNO2 (Section 2.4.4). 
 
Figure 7.4. Reaction coordinates for OH– attack on Cys152-NO2 with constrained O–H distances of QM 
water molecules and Glu317 sidechain. The snapshots of the reaction are taken at S(Cys152-NO2)–O(OH–






Figure 7.5. The potential mean force of OH– attack on Cys152-NO2 with constrained O–H distances of QM 
water molecules and Glu317 sidechain. The OH– attack along the S–N bond is barrierless in GAPDH active-
site. 
7.5. Summary  
QM/MM simulations for GAPDH-NO2 hydrolysis by OH
–, which has reaction coordinates similar 
to the gas-phase hydrolysis of CH3SNO2 by three water molecules, indicate that the activation free 
energy for hydrolysis is ~ 50 kcal/mol in the GAPDH active-site. The calculated activation free 
energy is comparable to CH3SNO2 hydrolysis by one water molecule in the gas phase. Allowing 
OH– to attack the S atom linearly along the S–N bond is barrierless. Additional QM/MM 
simulations with (1) Cys152-NO2 in a conformation with sulfur interaction with protonated 
His179, and (2) neutral His179 are necessary to better define the mechanism of E-Cys-NO2 






























The goal of my thesis was to investigate the structural and dynamical role of GAPDH in GTN 
bioactivation and to shed more light on GAPDH’s role in NO Biochemistry. We used various 
computational techniques starting from a QM investigation of the mechanism of decomposition of 
a small molecule, to QM/MM investigation of the same reaction in an enzyme active-site. The 
computational modeling approaches, including protein-protein docking and MD simulations, were 
carried out to understand and predict the reactivity and dynamics of GAPDH.   
An investigation of CH3SNO2 decomposition using QM as model compound for E-Cys-NO2 
decomposition helped distinguish energetically favorable and unfavorable decomposition 
pathways. We found that thionitrate can be readily attacked by anionic nucleophiles, which 
explains their low stability. The QM calculations also provided the starting geometry and reaction 
coordinates for a decomposition pathway to set up the QM/MM calculations for E-Cys-NO2 
decomposition in the active-site of GAPDH.  
To further understand the different functions of GAPDH, we carried out MD simulations of 
GAPDH-NAD+, GAPDH-NADH and apo-GAPDH to investigate its cofactor-dependent structural 
dynamics. We show that cofactor binding results in concerted motions of the NBD in the GAPDH 
tetramer and stabilizes the active-site. Thus, the cofactor controls the dynamics of the tetramer and 
hence moderates the functions of GAPDH.  
We further investigated the dynamics of the GAPDH tetramer, dimer and monomer to explore 
how deoligomerization changes dynamics and contributes to controlling GAPDH’s different 
functions. We identify a structurally disordered region, the S-loop, which is highly dynamic in the 
monomer. This intrinsically disordered region is stabilized by binding with protein partners, which 
could dictate some functions of GAPDH. One such protein partner is Siah1, which is known to 




binds to GAPDH monomer and stabilize the disordered S-loop. This, in turn, stabilizes the 
complex, which translocated to the nucleus to initiate apoptosis.  
In sum, our study reveals important structural and dynamical characteristics of GAPDH, which 
is well-known for its moonlighting functions. These structural characteristics likely play a role in 
the diverse functions of GAPDH. Our results provide a basis for GAPDH analysis not only as a 




The QM studies on CH3SNO2 decomposition indicate that attack of anionic nucleophiles (OH
– or 
CH3S
–) along S–N bond is barrierless. Also, hydrolysis with 3-4 water molecules, which represents 
the linear attack of water along the S–N bond lowers the activation barrier significantly. Thus, 
QM/MM simulation of 3-4 water molecules attack along the S–N bond of E-Cys-NO2 should be 
evaluated to estimate the activation barrier in the active-site.  
ALDH2 is also implicated in catalysis of GTN and decomposition is known to E-Cys-NO2 
with it catalytic Cys302.55 However, ALDH2 turn over GTN 10-fold faster than GAPDH (Section 
2.5.3). Thus, comparison of OH– attack on E-Cys-NO2 in ALDH2 and GAPDH using QM/MM 
simulations would provide insight into the variation of GTN turnover by these enzymes. Also, 
Cys156 present in the active-site of GAPDH in addition to catalytic Cys152, is buried in the protein 
matrix. Thus, Cys156 is not able to attack Cys152 so it is not possible to examine thiolysis of E-
Cys-NO2 in GAPDH using QM/MM simulations. In contrast, ALDH2 contains Cys301 and 




QM/MM to provide insight into the contributions of hydrolysis and thiolysis pathways in E-Cys-
NO2 decomposition in the same enzyme.  
MD simulations of GAPDH-NAD+ and apo-GAPDH compare the effect of all four NAD+ 
bound and unbound on GAPDH tetramer dynamics, respectively. Removal of one, two or three 
cofactors would provide more insight into the cofactor induced dynamic changes in the GAPDH 
tetramer. Also, pulling one, two or three cofactors out of their binding sites may provide insight 
into the folding of NAD binding site. ATP also destabilizes the tetramer so its effect on GAPDH 
dynamics should be investigated. Additionally, the dynamics of GAPDH with Cys152 and His179 
in their neutral forms should be compared with the data obtained here. 
We analyzed the dynamics of the GAPDH dimer and monomer, which provides insight into 
how deoligomerization changex the tetramer dynamics. However, a detailed study on how the 
subunits dissociate to generate the dimer or the monomer has not yet been carried out. Thus, pulling 
one or two subunits from the tetramer and observing the changes in its dynamic could provide 
insight into the unfolding mechanism of the tetramer. Coarse-grained or accelerated MD 
simulation would be suitable techniques to carry out these studies. A further potential of mean 
force calculation of pulling a subunit from either tetramer or dimer in presence or absence of a 
cofactor would provide insight into the energy barrier for deoligomerization of the tetramer or the 
dimer. 
The crystal structure predicts the selectivity cleft to be closed in human GAPDH whereas our 
MD simulations suggest that this cleft is open in human apo-GAPDH. MD simulations of L. 
Mexicana GAPDH in presence and absence of NAD+ have not been carried out to compare the 




understand the dynamics of selectivity cleft and in turn help design selective inhibitors of 
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